<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01586910</url>
  </required_header>
  <id_info>
    <org_study_id>IDE #G120169</org_study_id>
    <nct_id>NCT01586910</nct_id>
  </id_info>
  <brief_title>Safety and Efficacy Study of the Medtronic CoreValve® System in the Treatment of Severe, Symptomatic Aortic Stenosis in Intermediate Risk Subjects Who Need Aortic Valve Replacement (SURTAVI).</brief_title>
  <acronym>SURTAVI</acronym>
  <official_title>Surgical Replacement and Transcatheter Aortic Valve Implantation (SURTAVI)</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Medtronic Cardiovascular</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Medtronic Cardiovascular</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>Yes</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of the study is to investigate the safety and efficacy of transcatheter aortic
      valve implantation (TAVI) in patients with severe, symptomatic Aortic Stenosis (AS) at
      intermediate surgical risk by randomizing patients to either Surgical Aortic Valve
      Replacement (SAVR) or TAVI with the Medtronic CoreValve® System.

      Single Arm: The purpose of this trial is to evaluate the safety and effectiveness of
      transcatheter aortic valve implementation (TAVI) in patients with severe symptomatic Aortic
      Stenosis (AS) at intermediate surgical risk with TAVI. This is a non-randomized phase of the
      pivotal clinical trial.
    </textblock>
  </brief_summary>
  <overall_status>Active, not recruiting</overall_status>
  <start_date type="Actual">April 2012</start_date>
  <completion_date type="Anticipated">November 2026</completion_date>
  <primary_completion_date type="Actual">July 2018</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>All-cause Mortality or Disabling Stroke Rate Expressed as a Posterior Probability</measure>
    <time_frame>24 months</time_frame>
    <description>All-cause mortality: all deaths from any cause after valve intervention. This includes all cardiovascular and non-cardiovascular deaths.
Disabling Stroke: a modified rankin (mRS) score of 2 or more at 90 days and an increase in at least one mRS category from an individual's pre-strike baseline.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Percentage of Participants With Major Adverse Cardiovascular and Cerebrovascular Events (MACCE)</measure>
    <time_frame>30 days, 6 months, 12 months, 18 months, and 24 months. Data for 3-5 years will be posted once data is complete.</time_frame>
    <description>MACCE is defined as a composite of:
All-cause death
Myocardial infarction (MI)
All stroke, and
Reintervention (defined as any cardiac surgery or percutaneous reintervention catheter procedure that repairs, otherwise alters or adjusts, or replaces a previously implanted valve)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Percentage of Participants With Individual MACCE Components</measure>
    <time_frame>30 days, 6 months, 12 months, 18 months, and 24 months. Data for 3-5 years will be posted once data is complete.</time_frame>
    <description>MACCE is defined as a composite of:
All-cause death
Myocardial infarction (MI)
All stroke, and
Reintervention (defined as any cardiac surgery or percutaneous reintervention catheter procedure that repairs, otherwise alters or adjusts, or replaces a previously implanted valve)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Percentage of Participants With Major Adverse Events (MAE)</measure>
    <time_frame>30 days, 6 months, 12 months, 18 months, and 24 months. Data for 3-5 years will be posted once data is complete.</time_frame>
    <description>Major Adverse Events (MAE) include all death, MI, all stroke, reintervention, cardiac perforation, cardiac tamponade, cardiogenic shock, valve malpositioning, prosthetic valve dysfunction, acute kidney injury, major vascular complication, life threatening or disabling bleed, major bleed, and valve endocarditis.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Percentage of Participants With Conduction Disturbance Requiring Permanent Pacemaker Implantation</measure>
    <time_frame>30 day, 6 months, 12 months, 18 months, and 24 months. Data for 3-5 years will be posted once data is complete.</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Change in NYHA Class From Baseline</measure>
    <time_frame>Baseline to 30 days, 6 months, 12 months, 18 months, and 24 months. Data for 3-5 years will be posted once data is complete.</time_frame>
    <description>Change from baseline (continuous variable). A positive number corresponds to NYHA worsening; a negative number corresponds to NYHA improvement.
New York Heart Association (NYHA) Classification:
Class I: Subjects with cardiac disease but without resulting limitations of physical activity.
Class I: Subjects with cardiac disease resulting in slight limitation of physical activity.
Class III: Subjects with cardiac disease resulting in marked limitation of physical activity.
Class IV: Subjects with cardiac disease resulting in inability to carry on any physical activity without discomfort.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Change in Distance Walked During 6-minute Walk Test (6MWT)</measure>
    <time_frame>From baseline to 30 days, baseline to 12 months, and baseline to 24 months</time_frame>
    <description>Change in distance walked during 6MWT from baseline</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Ratio of Days Alive Out of Hospital Versus Total Days Alive</measure>
    <time_frame>12 and 24 months</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Quality of Life (QoL) Change From Baseline</measure>
    <time_frame>Baseline, 30 days, 3 months, 6 months, 12 months, and 24 months. Data for 3-5 years will be posted once data is complete.</time_frame>
    <description>QoL summary score change from baseline using the following measures:
Kansas City Cardiomyopathy Questionnaire (KCCQ): Quantifies physical function, symptoms, social function, self-efficacy and knowledge, and quality of life. Scores are transformed to a range of 0-100, in which higher scores reflect better health status.
36 Item Short Form Health Survey (SF-36): Measures functional health and well-being. Scores are transformed to a range of 0-100, in which higher scores reflect better health status.
European QoL (EQ-5D): Measures 5 domains (mobility, self-care, usual activities, pain/discomfort, and anxiety/depression) that can be converted to utilities using an algorithm. Utilities range from 0 to 1, with 1 representing perfect health, and 0 corresponding to the worst imaginable health state.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Transvalvular Mean Gradient (in mmHg) as an Assessment of Prosthetic Valve Performance</measure>
    <time_frame>discharge, 6 months, 12 months, and 24 months. Data for 3-5 years will be posted once data is complete</time_frame>
    <description>Using the following measure:
-Transvalvular mean gradient</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Effective Orifice Area as an Assessment of Prosthetic Valve Performance</measure>
    <time_frame>discharge, 6 months, 12 months, and 24 months. Data for 3-5 years will be posted once data is complete</time_frame>
    <description>Using the following measure:
-Effective Orifice Area (cm^2)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Degree of Aortic Valve Regurgitation as an Assessment of Prosthetic Valve Performance</measure>
    <time_frame>discharge, 6 months, 12 months, and 24 months. Data for 3-5 years will be posted once data is complete</time_frame>
    <description>Using the following measure:
- Degree of Aortic Valve Regurgitation (Transvalvular and Paravalvular)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Percentage of Participants With Aortic Valve Disease Related Hospitalizations</measure>
    <time_frame>30 days, 6 months, 12 months, 18 months, and 24 months. Data for 3-5 years will be posted once data is complete.</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Percentage of Participants With Cardiovascular Deaths and Valve-Related Deaths</measure>
    <time_frame>30 days, 6 months, 12 months, 18 months, and 24 months. Data for 3-5 years will be posted once data is complete</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Percentage of Participants With Stroke and TIAs</measure>
    <time_frame>30 days, 6 months, 12 months, 18 months, and 24 months. Data for 3-5 years will be posted once data is complete.</time_frame>
    <description>Strokes (of any severity) and Transient Ischemic Attacks (TIAs)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Peri-procedural Neurological Injury</measure>
    <time_frame>discharge or 7 days post index procedure (whichever occurred first)</time_frame>
    <description>Neurological injury (stroke, TIA, or encephalopathy)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Index Procedure Related Major Adverse Events (MAEs)</measure>
    <time_frame>Procedure through 30 day visit</time_frame>
    <description>Index procedure related MAEs were defined as events occurring during, or as a direct result of, the index procedure.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Length of Index Procedure Hospital Stay</measure>
    <time_frame>Number of days from admission to discharge (expected average of 7 days)</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Presence of Atrial Fibrillation</measure>
    <time_frame>post-procedure, discharge, 30 days, 6 months, 12 months, 18 months, and 24 months. Data for 3-5 years will be posted once data is complete.</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Device Success (Medtronic CoreValve® System Subjects Only)</measure>
    <time_frame>Number of days from admission to discharge (expected average of 7 days)</time_frame>
    <description>Absence of procedural mortality
Correct positioning of a single prosthetic heart valve into the proper anatomical location
Intended performance of the prosthetic heart valve (no prosthesis-patient mismatch and mean aortic valve gradient &lt;20 mmHg or peak velocity &lt;3 m/s, AND no moderate or severe prosthetic valve regurgitation)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Procedural Success (Medtronic CoreValve® System Subjects Only)</measure>
    <time_frame>Number of days from admission to discharge (expected average of 7 days)</time_frame>
    <description>Defined by device success and absence of in-hospital major adverse cardiovascular and cerebrovascular events (MACCE)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Evidence of Prosthetic Valve Dysfunction (Medtronic CoreValve® System Subjects Only)</measure>
    <time_frame>6 months, 12 months, and 24 months. Data for 3-5 years will be posted once data is complete.</time_frame>
    <description>Prosthetic Valve Dysfunction (PVD) was defined according to Valve Academic Research Consortium (VARC) II using the Core Lab Echocardiography assessments including aortic regurgitation (AR) and aortic stenosis (AS) evaluations. Total aortic regurgitation (AR) reported as moderate or severe was considered
PVD defined as:
Mean aortic valve gradient ≥20 mmHg AND ((EOA ≤0.9 cm2 if BSA &lt;1.6 or ≤1.1 cm2 if BSA ≥1.6) OR DVI &lt;0. 35 m/s) OR
moderate or severe total AR</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Percentage of Participants With Early Safety Endpoint</measure>
    <time_frame>30 Days</time_frame>
    <description>Percentage of participants with VARC II early safety composite at 30 days</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Percentage of Participants With Clinical Efficacy (After 30 Days)</measure>
    <time_frame>6 months, 12 months, 18 months, and 24 months. Data for 3-5 years will be posted once data is complete</time_frame>
    <description>Combined clinical efficacy after 30 days was defined as the composite of all-cause mortality, all strokes (disabling and non-disabling), hospitalization for valve-related symptoms or worsening congestive heart failure, NYHA III or IV, and valve-related dysfunction.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Percentage of Participants With Time-Related Safety</measure>
    <time_frame>30 days, 6 months, 12 months, 18 months, and 24 months. Data for 3-5 years will be posted once data is available.</time_frame>
    <description>The VARC II time-related valve safety composite was defined as the rate of valve-related dysfunction (mean aortic valve gradient ≥ 20 mm Hg, EOA ≤ 0.9-1.1 cm2 depending on body surface area and/or DVI &lt;0.35, AND/ OR moderate or severe prosthetic valve regurgitation), aortic valve reintervention, prosthetic valve endocarditis, prosthetic valve thrombosis, thromboembolic events, and VARC II bleeding events.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Resheath and Recapture Success (Evolut R Only)</measure>
    <time_frame>Procedure</time_frame>
    <description>The Evolut™ R system provides operators with the ability to resheath or recapture the valve before it is completely deployed in the event of initial suboptimal positioning. Successful resheath was defined as successfully retrieving a portion of the valve into the capsule of the delivery catheter, and successful recapture was defined as successfully recapturing the entirety of the valve into the capsule of the delivery catheter.</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">1746</enrollment>
  <condition>Severe Aortic Stenosis</condition>
  <arm_group>
    <arm_group_label>Medtronic CoreValve® System TAVI</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Medtronic CoreValve® System Transcatheter Aortic Valve Implantation (TAVI)</description>
  </arm_group>
  <arm_group>
    <arm_group_label>SAVR</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Surgical Aortic Valve Replacement (SAVR)</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Medtronic CoreValve® System Transcatheter Aortic Valve Implantation (TAVI)</intervention_name>
    <arm_group_label>Medtronic CoreValve® System TAVI</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Surgical Aortic Valve Replacement (SAVR)</intervention_name>
    <arm_group_label>SAVR</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Medtronic CoreValve® Evolut R System Transcatheter Aortic Valve Implantation (TAVI)</intervention_name>
    <arm_group_label>Medtronic CoreValve® System TAVI</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Subject must have co-morbidities such that Heart Team agrees predicted risk of
             operative mortality is ≥3% and &lt;15% at 30 days (Intermediate Clinical Risk
             classification). Heart team evaluation of clinical surgical mortality risk for each
             patient includes the calculated STS score for predicted risk of surgical mortality
             augmented by consideration of the overall clinical status and co-morbidities
             unmeasured by the STS risk calculation;

          -  Heart Team unanimously agree on treatment proposal and eligibility for randomization*
             based on their clinical judgement (including anatomy assessment, risk factors, etc.);

          -  Subject has severe aortic stenosis presenting with;

               1. Critical aortic valve area defined as an initial aortic valve area of ≤1.0cm2 or
                  aortic valve area index &lt; 0.6cm2/m2 AND

               2. Mean gradient &gt; 40mmHg or Vmax &gt; 4m/sec by resting echocardiogram or simultaneous
                  pressure recordings at cardiac catherization [or with dobutamine stress, if
                  subject has left ventricular ejection fraction (LVEF) &lt;55%] or velocity ratio &lt;
                  0.25;

          -  Subject is symptomatic from his/her aortic valve stenosis, as demonstrated by New York
             Heart Association (NYHA) Functional Class II or greater;

          -  Subject and the treating physician agree that the subject will return for all required
             post-procedure follow-up visits;

          -  Subject meets the legal minimum age to provide informed consent based on local
             regulatory requirements;

        Exclusion Criteria:

          -  Subject has refused surgical aortic valve replacement (SAVR) as a treatment option;
             (not applicable for Single Arm)

          -  Any condition considered a contraindication for placement of a bioprosthetic valve
             (i.e., subject requires a mechanical valve);

          -  A known hypersensitivity or contraindication to all anticoagulation/antiplatelet
             regimens (or inability to be anticoagulated for the index procedure), nitinol, or
             sensitivity to contrast media which cannot be adequately pre-medicated;

          -  Blood dyscrasias as defined: leukopenia (WBC &lt;1000mm3), thrombocytopenia (platelet
             count &lt;50,000 cells/mm3), history of bleeding diathesis or coagulopathy;

          -  Ongoing sepsis, including active endocarditis;

          -  Any condition considered a contraindication to extracorporeal assistance;

          -  Any percutaneous coronary or peripheral interventional procedure performed within 30
             days prior to randomization* (Subjects with recent placement of drug eluting stent(s)
             should be assessed for ability to safely proceed with SAVR within the protocol
             timeframe);

          -  Symptomatic carotid or vertebral artery disease or successful treatment of carotid
             stenosis within six weeks of randomization*;

          -  Cardiogenic shock manifested by low cardiac output, vasopressor dependence, or
             mechanical hemodynamic support;

          -  Recent (within 6 months of randomization*) cerebrovascular accident (CVA) or transient
             ischemic attack (TIA);

          -  Active gastrointestinal (GI) bleeding that would preclude anticoagulation;

          -  Subject refuses a blood transfusion;

          -  Severe dementia (resulting in either inability to provide informed consent for the
             trial/procedure, prevents independent lifestyle outside of a chronic care facility, or
             will fundamentally complicate rehabilitation from the procedure or compliance with
             follow-up visits);

          -  Multivessel coronary artery disease with a Syntax score &gt;22 and/or unprotected left
             main coronary artery (Syntax score calculation is not required for patients with
             history of previous revascularization if repeat revascularization is not planned);

          -  Estimated life expectancy of less than 24 months due to associated non-cardiac
             comorbid conditions;

          -  Other medical, social, or psychological conditions that in the opinion of the
             Investigator precludes the subject from appropriate consent or adherence to the
             protocol required follow-up exams;

          -  Currently participating in an investigational drug or another device trial (excluding
             registries);

          -  Evidence of an acute myocardial infarction ≤30 days before the index procedure;

          -  Need for emergency surgery for any reason;

          -  True porcelain aorta (i.e. Heart Team agrees the aorta is not clampable for SAVR);

          -  Extensive mediastinal radiation;

          -  Liver failure (Child-C);

          -  Reduced ventricular function with left ventricular ejection fraction (LVEF) &lt;20% as
             measured by resting echocardiogram;

          -  Uncontrolled atrial fibrillation (e.g. resting heart rate &gt; 120 bpm);

          -  Pregnancy or intent to become pregnant prior to completion of all protocol follow-up
             requirements;

          -  End stage renal disease requiring chronic dialysis or creatinine clearance &lt; 20
             cc/min;

          -  Pulmonary Hypertension (systolic pressure&gt; 80mmHg);

          -  Severe Chronic Obstructive Pulmonary Disease (COPD) demonstrated by Forced Expiratory
             Volume (FEV1) &lt; 750cc;

          -  Frailty assessments identify:

               1. Subject is &lt; 80 years of age and three or more of the following apply

               2. Subject is ≥ 80 years of age and two or more of the following apply

                    -  Wheelchair bound

                    -  Resides in an institutional care facility (e.g., nursing home, skilled care
                       center)

                    -  Body Mass Index &lt; 20 kg/m2

                    -  Grip Strength &lt; 16 kg

                    -  Katz Index Score ≤ 4

                    -  Albumin &lt; 3.5 g/dL;

          -  Marfan syndrome or other known connective tissue disease that would necessitate aortic
             root replacement/intervention; (Not applicable for Single Arm)

        Note: Additional anatomical and vascular exclusion criteria may apply.

        Note: * For purposes of the single arm phase of the trial, &quot;randomization&quot; will refer to
        trial enrollment.
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>N/A</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Stephan Windecker, MD, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Bern University Hospital</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Rüdiger Lange, MD, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Deutsches Herzzentrum München</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Thomas Walther, MD, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Kerckhoff Klinik</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Michael J. Reardon, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>The Methodist Hospital System</affiliation>
  </overall_official>
  <overall_official>
    <last_name>David H. Adams, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Icahn School of Medicine at Mount Sinai</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Nicolas M. Van Mieghem, MD</last_name>
    <role>Study Chair</role>
    <affiliation>Erasmus Medical Center</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Patrick W. Serruys, MD, PhD</last_name>
    <role>Study Chair</role>
    <affiliation>National Heart &amp; Lung Institute of Imperial College in London</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Banner Good Samaritan Medical Center</name>
      <address>
        <city>Phoenix</city>
        <state>Arizona</state>
        <zip>85006</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Cedars-Sinai Medical Center</name>
      <address>
        <city>Hollywood</city>
        <state>California</state>
        <zip>90048</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Scripps Green Hospital</name>
      <address>
        <city>La Jolla</city>
        <state>California</state>
        <zip>92037</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Keck Medical Center of USC</name>
      <address>
        <city>Los Angeles</city>
        <state>California</state>
        <zip>90033</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>El Camino Hospital</name>
      <address>
        <city>Mountain View</city>
        <state>California</state>
        <zip>94040</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>VA Palo Alto Health Care System</name>
      <address>
        <city>Palo Alto</city>
        <state>California</state>
        <zip>94304</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Southern California Permenente Medical Group</name>
      <address>
        <city>Pasadena</city>
        <state>California</state>
        <zip>91101</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Stanford University Medical Center</name>
      <address>
        <city>Stanford</city>
        <state>California</state>
        <zip>94305</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Hartford Hospital</name>
      <address>
        <city>Hartford</city>
        <state>Connecticut</state>
        <zip>06102</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Yale New Haven Hospital</name>
      <address>
        <city>New Haven</city>
        <state>Connecticut</state>
        <zip>06520-8047</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Washington Hospital Center</name>
      <address>
        <city>Washington</city>
        <state>District of Columbia</state>
        <zip>20010</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Morton Plant Hospital</name>
      <address>
        <city>Clearwater</city>
        <state>Florida</state>
        <zip>33756</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>University of Miami</name>
      <address>
        <city>Coral Gables</city>
        <state>Florida</state>
        <zip>33146</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Delray Medical Center</name>
      <address>
        <city>Delray Beach</city>
        <state>Florida</state>
        <zip>33484</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Emory University</name>
      <address>
        <city>Atlanta</city>
        <state>Georgia</state>
        <zip>30308</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Piedmont Healthcare, Inc.</name>
      <address>
        <city>Atlanta</city>
        <state>Georgia</state>
        <zip>30309</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>The Queen's Medical Center</name>
      <address>
        <city>Honolulu</city>
        <state>Hawaii</state>
        <zip>96813</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Loyola University of Chicago</name>
      <address>
        <city>Maywood</city>
        <state>Illinois</state>
        <zip>60153</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>St. Vincent Heart Center of Indiana</name>
      <address>
        <city>Indianapolis</city>
        <state>Indiana</state>
        <zip>46290</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Iowa Heart Center / Mercy Medical Center</name>
      <address>
        <city>West Des Moines</city>
        <state>Iowa</state>
        <zip>50266</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>University of Kansas Hospital</name>
      <address>
        <city>Kansas City</city>
        <state>Kansas</state>
        <zip>66160</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Cardiovascular Institute of the South</name>
      <address>
        <city>Houma</city>
        <state>Louisiana</state>
        <zip>70360</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>The Johns Hopkins University</name>
      <address>
        <city>Baltimore</city>
        <state>Maryland</state>
        <zip>21205</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Beth Israel Deaconess Medical Center, Inc.</name>
      <address>
        <city>Boston</city>
        <state>Massachusetts</state>
        <zip>02215</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>University of Michigan Health Systems</name>
      <address>
        <city>Ann Arbor</city>
        <state>Michigan</state>
        <zip>48109-5864</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Detroit Medical Center</name>
      <address>
        <city>Detroit</city>
        <state>Michigan</state>
        <zip>48201-2018</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Henry Ford</name>
      <address>
        <city>Detroit</city>
        <state>Michigan</state>
        <zip>48202</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>St. John Hospital &amp; Medical Center</name>
      <address>
        <city>Detroit</city>
        <state>Michigan</state>
        <zip>48236</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Spectrum Health Hospitals</name>
      <address>
        <city>Grand Rapids</city>
        <state>Michigan</state>
        <zip>49503</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Abbott NW - MN Heart Institute Foundation</name>
      <address>
        <city>Minneapolis</city>
        <state>Minnesota</state>
        <zip>55407</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Mayo Clinic - St. Mary's Hospital</name>
      <address>
        <city>Rochester</city>
        <state>Minnesota</state>
        <zip>55905</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Saint Luke's Hospital/MAHI</name>
      <address>
        <city>Kansas City</city>
        <state>Missouri</state>
        <zip>64111</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Alegent Creighton Health Research Center</name>
      <address>
        <city>Omaha</city>
        <state>Nebraska</state>
        <zip>68124</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Cooper University Hospital</name>
      <address>
        <city>Camden</city>
        <state>New Jersey</state>
        <zip>08103</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Morristown Medical Center</name>
      <address>
        <city>Morristown</city>
        <state>New Jersey</state>
        <zip>07960</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>North Shore University Hospital</name>
      <address>
        <city>Manhasset</city>
        <state>New York</state>
        <zip>11030</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Winthrop University Hospital</name>
      <address>
        <city>Mineola</city>
        <state>New York</state>
        <zip>11501</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>New York University School of Medicine</name>
      <address>
        <city>New York</city>
        <state>New York</state>
        <zip>10016</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Mount Sinai School of Medicine</name>
      <address>
        <city>New York</city>
        <state>New York</state>
        <zip>10029</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Columbia University Medical Center</name>
      <address>
        <city>New York</city>
        <state>New York</state>
        <zip>10032</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Lenox Hill Hospital</name>
      <address>
        <city>New York</city>
        <state>New York</state>
        <zip>10075</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>University of Rochester</name>
      <address>
        <city>Rochester</city>
        <state>New York</state>
        <zip>14642</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>St. Francis Hospital</name>
      <address>
        <city>Roslyn</city>
        <state>New York</state>
        <zip>11576</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Carolinas HealthCare System</name>
      <address>
        <city>Charlotte</city>
        <state>North Carolina</state>
        <zip>28203</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Duke University Medical Center</name>
      <address>
        <city>Durham</city>
        <state>North Carolina</state>
        <zip>27710</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Wake Forest University Health Sciences</name>
      <address>
        <city>Winston-Salem</city>
        <state>North Carolina</state>
        <zip>27157</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Good Samaritan Hospital</name>
      <address>
        <city>Cincinnati</city>
        <state>Ohio</state>
        <zip>45220</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>University Hospitals Case Medical Center</name>
      <address>
        <city>Cleveland</city>
        <state>Ohio</state>
        <zip>44106</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>The Ohio State University</name>
      <address>
        <city>Columbus</city>
        <state>Ohio</state>
        <zip>43210</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>The OhioHealth Research Institute</name>
      <address>
        <city>Columbus</city>
        <state>Ohio</state>
        <zip>43214</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Oklahoma Heart Institute</name>
      <address>
        <city>Oklahoma City</city>
        <state>Oklahoma</state>
        <zip>73120</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Geisinger Medical Center</name>
      <address>
        <city>Danville</city>
        <state>Pennsylvania</state>
        <zip>17822</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>University of Pennsylvania Health System</name>
      <address>
        <city>Philadelphia</city>
        <state>Pennsylvania</state>
        <zip>19104</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>University of Pittsburgh Medical Center</name>
      <address>
        <city>Pittsburgh</city>
        <state>Pennsylvania</state>
        <zip>15213</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Pinnacle Health Cardiovascular Institute</name>
      <address>
        <city>Wormleysburg</city>
        <state>Pennsylvania</state>
        <zip>17043</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Baptist Memorial Hospital Memphis</name>
      <address>
        <city>Memphis</city>
        <state>Tennessee</state>
        <zip>38120</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Vanderbilt University Medical Center</name>
      <address>
        <city>Nashville</city>
        <state>Tennessee</state>
        <zip>37232</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Baylor Heart and Vascular Hospital</name>
      <address>
        <city>Dallas</city>
        <state>Texas</state>
        <zip>75226</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>The Methodist DeBakey Heart &amp; Vascular Center</name>
      <address>
        <city>Houston</city>
        <state>Texas</state>
        <zip>77030</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>The Heart Hospital - Baylor Plano</name>
      <address>
        <city>Plano</city>
        <state>Texas</state>
        <zip>75093</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Intermountain Medical Center</name>
      <address>
        <city>Murray</city>
        <state>Utah</state>
        <zip>84107</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>University of Vermont</name>
      <address>
        <city>Burlington</city>
        <state>Vermont</state>
        <zip>05401</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Sentara Cardiovascular</name>
      <address>
        <city>Norfolk</city>
        <state>Virginia</state>
        <zip>23507</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Bon Secours St. Mary's Hospital</name>
      <address>
        <city>Richmond</city>
        <state>Virginia</state>
        <zip>23226</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Aurora St. Luke's Medical Center</name>
      <address>
        <city>Milwaukee</city>
        <state>Wisconsin</state>
        <zip>53215</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>London Health Sciences Centre, University Hospital</name>
      <address>
        <city>London</city>
        <state>Ontario</state>
        <country>Canada</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Sunnybrook Research Institute</name>
      <address>
        <city>Toronto</city>
        <state>Ontario</state>
        <zip>M4N 3M5</zip>
        <country>Canada</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Toronto General Hospital (University Health Network)</name>
      <address>
        <city>Toronto</city>
        <state>Ontario</state>
        <zip>M5G 2C4</zip>
        <country>Canada</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>McGill University Health Center - Royal Victoria Hospital</name>
      <address>
        <city>Montreal</city>
        <state>Quebec</state>
        <zip>H3A 1A1</zip>
        <country>Canada</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Montreal Heart Institute</name>
      <address>
        <city>Montreal</city>
        <country>Canada</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Rigshospitalet</name>
      <address>
        <city>Copenhagen</city>
        <country>Denmark</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Universitäts-Herzzentrum Freiburg • Bad Krozingen</name>
      <address>
        <city>Bad Krozingen</city>
        <zip>79106</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Universitätsklinikum Bonn</name>
      <address>
        <city>Bonn</city>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Deutsches Herzzentrum Muenchen</name>
      <address>
        <city>Munich</city>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Amphia Hospital Breda</name>
      <address>
        <city>Breda</city>
        <country>Netherlands</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Medisch Centrum Leeuwarden</name>
      <address>
        <city>Leeuwarden</city>
        <country>Netherlands</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>St. Antonius Hospital, R &amp; D Cardiology</name>
      <address>
        <city>Nieuwegein</city>
        <country>Netherlands</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Erasmus Medical Center - Rotterdam</name>
      <address>
        <city>Rotterdam</city>
        <country>Netherlands</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Servicio de Cardiologia del Hospital Virgen de la Victoria</name>
      <address>
        <city>Malaga</city>
        <country>Spain</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Hospital Universitario Central de Asturias</name>
      <address>
        <city>Oviedo</city>
        <country>Spain</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Karolinska Universitetssjukhuset Stockholm</name>
      <address>
        <city>Stockholm</city>
        <zip>171 76</zip>
        <country>Sweden</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Bern University Hospital</name>
      <address>
        <city>Bern</city>
        <country>Switzerland</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Universitatsspital Zurich</name>
      <address>
        <city>Zurich</city>
        <country>Switzerland</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Leeds General Infirmary</name>
      <address>
        <city>Leeds</city>
        <country>United Kingdom</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Glenfield Hospital, Leicester, UK</name>
      <address>
        <city>Leicester</city>
        <zip>LE5 4PW</zip>
        <country>United Kingdom</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>St. George's Hospital London</name>
      <address>
        <city>London</city>
        <zip>SW170QT</zip>
        <country>United Kingdom</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Canada</country>
    <country>Denmark</country>
    <country>Germany</country>
    <country>Netherlands</country>
    <country>Spain</country>
    <country>Sweden</country>
    <country>Switzerland</country>
    <country>United Kingdom</country>
    <country>United States</country>
  </location_countries>
  <removed_countries>
    <country>Belgium</country>
    <country>France</country>
  </removed_countries>
  <verification_date>July 2020</verification_date>
  <study_first_submitted>April 24, 2012</study_first_submitted>
  <study_first_submitted_qc>April 26, 2012</study_first_submitted_qc>
  <study_first_posted type="Estimate">April 27, 2012</study_first_posted>
  <results_first_submitted>July 17, 2019</results_first_submitted>
  <results_first_submitted_qc>August 28, 2019</results_first_submitted_qc>
  <results_first_posted type="Actual">September 17, 2019</results_first_posted>
  <last_update_submitted>July 7, 2020</last_update_submitted>
  <last_update_submitted_qc>July 7, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">July 9, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Aortic Valve Stenosis</mesh_term>
    <mesh_term>Constriction, Pathologic</mesh_term>
  </condition_browse>
  <provided_document_section>
    <provided_document>
      <document_type>Study Protocol and Statistical Analysis Plan</document_type>
      <document_has_protocol>Yes</document_has_protocol>
      <document_has_icf>No</document_has_icf>
      <document_has_sap>Yes</document_has_sap>
      <document_date>May 31, 2016</document_date>
      <document_url>https://ClinicalTrials.gov/ProvidedDocs/10/NCT01586910/Prot_SAP_000.pdf</document_url>
    </provided_document>
  </provided_document_section>

  <clinical_results>

    <participant_flow>
      <group_list>
        <group group_id="P1">
          <title>Medtronic CoreValve® System TAVI</title>
          <description>Medtronic CoreValve® System Transcatheter Aortic Valve Implantation (TAVI)
Medtronic CoreValve® Evolut R System Transcatheter Aortic Valve Implantation (TAVI)</description>
        </group>
        <group group_id="P2">
          <title>SAVR</title>
          <description>Surgical Aortic Valve Replacement (SAVR)</description>
        </group>
      </group_list>
      <period_list>
        <period>
          <title>Overall Study</title>
          <milestone_list>
            <milestone>
              <title>STARTED</title>
              <participants_list>
                <participants group_id="P1" count="879"/>
                <participants group_id="P2" count="867"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="864"/>
                <participants group_id="P2" count="796"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>NOT COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="15"/>
                <participants group_id="P2" count="71"/>
              </participants_list>
            </milestone>
          </milestone_list>
          <drop_withdraw_reason_list>
            <drop_withdraw_reason>
              <title>Death</title>
              <participants_list>
                <participants group_id="P1" count="4"/>
                <participants group_id="P2" count="4"/>
              </participants_list>
            </drop_withdraw_reason>
            <drop_withdraw_reason>
              <title>Withdrawal by Subject</title>
              <participants_list>
                <participants group_id="P1" count="6"/>
                <participants group_id="P2" count="43"/>
              </participants_list>
            </drop_withdraw_reason>
            <drop_withdraw_reason>
              <title>Physician withdrew Subject</title>
              <participants_list>
                <participants group_id="P1" count="5"/>
                <participants group_id="P2" count="24"/>
              </participants_list>
            </drop_withdraw_reason>
          </drop_withdraw_reason_list>
        </period>
      </period_list>
    </participant_flow>

    <baseline>
      <population>mITT</population>
      <group_list>
        <group group_id="B1">
          <title>Medtronic CoreValve® System TAVI</title>
          <description>Medtronic CoreValve® System Transcatheter Aortic Valve Implantation (TAVI)
Medtronic CoreValve® Evolut R System Transcatheter Aortic Valve Implantation (TAVI)</description>
        </group>
        <group group_id="B2">
          <title>SAVR</title>
          <description>Surgical Aortic Valve Replacement (SAVR)</description>
        </group>
        <group group_id="B3">
          <title>Total</title>
          <description>Total of all reporting groups</description>
        </group>
      </group_list>
      <analyzed_list>
        <analyzed>
          <units>Participants</units>
          <scope>Overall</scope>
          <count_list>
            <count group_id="B1" value="864"/>
            <count group_id="B2" value="796"/>
            <count group_id="B3" value="1660"/>
          </count_list>
        </analyzed>
      </analyzed_list>
      <measure_list>
        <measure>
          <title>Age</title>
          <description>Participant Population= Consisted of all randomized subjects with an attempted implant procedure.</description>
          <units>years</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <class_list>
            <class>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="B1" value="864"/>
                    <count group_id="B2" value="796"/>
                    <count group_id="B3" value="1660"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="79.9" spread="6.2"/>
                    <measurement group_id="B2" value="79.7" spread="6.1"/>
                    <measurement group_id="B3" value="79.8" spread="6.2"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Sex: Female, Male</title>
          <description>Participant Population= Consisted of all randomized subjects with an attempted implant procedure.</description>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="B1" value="864"/>
                    <count group_id="B2" value="796"/>
                    <count group_id="B3" value="1660"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <title>Female</title>
                  <measurement_list>
                    <measurement group_id="B1" value="366"/>
                    <measurement group_id="B2" value="358"/>
                    <measurement group_id="B3" value="724"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Male</title>
                  <measurement_list>
                    <measurement group_id="B1" value="498"/>
                    <measurement group_id="B2" value="438"/>
                    <measurement group_id="B3" value="936"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Race/Ethnicity, Customized</title>
          <population>Data from three race categories (Asian, Black/African American/ Hispanic or Latino Ethnicity) were collected in the study.</population>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="B1" value="43"/>
                    <count group_id="B2" value="50"/>
                    <count group_id="B3" value="93"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <title>Asian</title>
                  <measurement_list>
                    <measurement group_id="B1" value="7"/>
                    <measurement group_id="B2" value="6"/>
                    <measurement group_id="B3" value="13"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Black/African American</title>
                  <measurement_list>
                    <measurement group_id="B1" value="18"/>
                    <measurement group_id="B2" value="21"/>
                    <measurement group_id="B3" value="39"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Hispanic or Latino Ethnicity</title>
                  <measurement_list>
                    <measurement group_id="B1" value="18"/>
                    <measurement group_id="B2" value="23"/>
                    <measurement group_id="B3" value="41"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>NYHA Class</title>
          <description>Measure Description:
New York Heart Association (NYHA) Classification:
Class I: Subjects with cardiac disease but without resulting limitations of physical activity.
Class I: Subjects with cardiac disease resulting in slight limitation of physical activity.
Class III: Subjects with cardiac disease resulting in marked limitation of physical activity.
Class IV: Subjects with cardiac disease resulting in inability to carry on any physical activity without discomfort.
Participant Population= Consisted of all randomized subjects with an attempted implant procedure.</description>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="B1" value="864"/>
                    <count group_id="B2" value="796"/>
                    <count group_id="B3" value="1660"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <title>I</title>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="0"/>
                  </measurement_list>
                </category>
                <category>
                  <title>II</title>
                  <measurement_list>
                    <measurement group_id="B1" value="344"/>
                    <measurement group_id="B2" value="333"/>
                    <measurement group_id="B3" value="677"/>
                  </measurement_list>
                </category>
                <category>
                  <title>III</title>
                  <measurement_list>
                    <measurement group_id="B1" value="472"/>
                    <measurement group_id="B2" value="411"/>
                    <measurement group_id="B3" value="883"/>
                  </measurement_list>
                </category>
                <category>
                  <title>IV</title>
                  <measurement_list>
                    <measurement group_id="B1" value="48"/>
                    <measurement group_id="B2" value="52"/>
                    <measurement group_id="B3" value="100"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Body Surface Area</title>
          <description>Participant Population= Consisted of all randomized subjects with an attempted implant procedure.</description>
          <units>meters squared</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <class_list>
            <class>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="B1" value="864"/>
                    <count group_id="B2" value="796"/>
                    <count group_id="B3" value="1660"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="1.9" spread="0.2"/>
                    <measurement group_id="B2" value="1.9" spread="0.2"/>
                    <measurement group_id="B3" value="1.9" spread="0.2"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>STS Score</title>
          <description>Measure Description: The Society of Thoracic Surgeons (STS) risk model predicts the risk of operative mortality and morbidity after adult cardiac surgery on the basis of patient demographic and clinical variables. After information has been entered on a given case, the online STS risk calculator provides a risk percentage for each of the outcomes. The risk percentage estimates the chance of a specific outcome for a patient with the indicated risk factors. A higher score indicates a higher risk. A lower score indicates a lower risk.</description>
          <units>% risk of mortality</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <class_list>
            <class>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="B1" value="864"/>
                    <count group_id="B2" value="796"/>
                    <count group_id="B3" value="1660"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="4.4" spread="1.5"/>
                    <measurement group_id="B2" value="4.5" spread="1.6"/>
                    <measurement group_id="B3" value="4.5" spread="1.6"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Logistic EuroSCORE</title>
          <description>Measure Description: The European System for Cardiac Operative Risk Evaluation (EuroSCORE) is a method of calculating predicted operative mortality for patients undergoing cardiac surgery. If a risk factor is present, a weight/number is assigned. The weights are added to give an approximate percent of predicted mortality. A higher score indicates a higher risk. A lower score indicates a lower risk.</description>
          <population>Data missing for 1 SAVR subject.</population>
          <units>percentage of predicted mortality</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <class_list>
            <class>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="B1" value="864"/>
                    <count group_id="B2" value="795"/>
                    <count group_id="B3" value="1659"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="11.9" spread="7.6"/>
                    <measurement group_id="B2" value="11.6" spread="8.0"/>
                    <measurement group_id="B3" value="11.8" spread="7.8"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </measure_list>
    </baseline>

    <outcome_list>
      <outcome>
        <type>Primary</type>
        <title>All-cause Mortality or Disabling Stroke Rate Expressed as a Posterior Probability</title>
        <description>All-cause mortality: all deaths from any cause after valve intervention. This includes all cardiovascular and non-cardiovascular deaths.
Disabling Stroke: a modified rankin (mRS) score of 2 or more at 90 days and an increase in at least one mRS category from an individual's pre-strike baseline.</description>
        <time_frame>24 months</time_frame>
        <population>Participant Population= Consisted of all randomized subjects with an attempted implant procedure.</population>
        <group_list>
          <group group_id="O1">
            <title>Medtronic CoreValve® System TAVI</title>
            <description>Medtronic CoreValve® System Transcatheter Aortic Valve Implantation (TAVI)
Medtronic CoreValve® Evolut R System Transcatheter Aortic Valve Implantation (TAVI)</description>
          </group>
          <group group_id="O2">
            <title>SAVR</title>
            <description>Surgical Aortic Valve Replacement (SAVR)</description>
          </group>
        </group_list>
        <measure>
          <title>All-cause Mortality or Disabling Stroke Rate Expressed as a Posterior Probability</title>
          <description>All-cause mortality: all deaths from any cause after valve intervention. This includes all cardiovascular and non-cardiovascular deaths.
Disabling Stroke: a modified rankin (mRS) score of 2 or more at 90 days and an increase in at least one mRS category from an individual's pre-strike baseline.</description>
          <population>Participant Population= Consisted of all randomized subjects with an attempted implant procedure.</population>
          <units>Percentage of Participants</units>
          <param>Median</param>
          <dispersion>95% Confidence Interval</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="864"/>
                <count group_id="O2" value="796"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="12.6" lower_limit="10.2" upper_limit="15.3"/>
                    <measurement group_id="O2" value="14.0" lower_limit="11.4" upper_limit="17.0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <analysis_list>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <groups_desc>Primary Hypothesis: TAVR with the Medtronic TAVR is non-inferior to SAVR for all-cause mortality or disabling stroke rate during a fixed follow-up of 24 months.</groups_desc>
            <non_inferiority_type>Non-Inferiority</non_inferiority_type>
            <non_inferiority_desc>Non-inferiority margin was 0.07. Posterior threshold for non-inferiority was 0.971</non_inferiority_desc>
            <param_type>Posterior Median of the Difference</param_type>
            <param_value>-1.4</param_value>
            <ci_n_sides>2-Sided</ci_n_sides>
            <estimate_desc>95% Bayesian credible interval for the difference (TAVR-SAVR) was (-5.2%, 2.3%). The 95% credible interval is the 2.5th and 97.5th percentiles of the posterior distribution.</estimate_desc>
          </analysis>
        </analysis_list>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Percentage of Participants With Major Adverse Cardiovascular and Cerebrovascular Events (MACCE)</title>
        <description>MACCE is defined as a composite of:
All-cause death
Myocardial infarction (MI)
All stroke, and
Reintervention (defined as any cardiac surgery or percutaneous reintervention catheter procedure that repairs, otherwise alters or adjusts, or replaces a previously implanted valve)</description>
        <time_frame>30 days, 6 months, 12 months, 18 months, and 24 months. Data for 3-5 years will be posted once data is complete.</time_frame>
        <population>Participant Population= Consisted of all randomized subjects with an attempted implant procedure.</population>
        <group_list>
          <group group_id="O1">
            <title>Medtronic CoreValve® System TAVI</title>
            <description>Medtronic CoreValve® System Transcatheter Aortic Valve Implantation (TAVI)
Medtronic CoreValve® Evolut R System Transcatheter Aortic Valve Implantation (TAVI)</description>
          </group>
          <group group_id="O2">
            <title>SAVR</title>
            <description>Surgical Aortic Valve Replacement (SAVR)</description>
          </group>
        </group_list>
        <measure>
          <title>Percentage of Participants With Major Adverse Cardiovascular and Cerebrovascular Events (MACCE)</title>
          <description>MACCE is defined as a composite of:
All-cause death
Myocardial infarction (MI)
All stroke, and
Reintervention (defined as any cardiac surgery or percutaneous reintervention catheter procedure that repairs, otherwise alters or adjusts, or replaces a previously implanted valve)</description>
          <population>Participant Population= Consisted of all randomized subjects with an attempted implant procedure.</population>
          <units>percentage of participants</units>
          <param>Number</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="864"/>
                <count group_id="O2" value="796"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>30 days</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="5.7"/>
                    <measurement group_id="O2" value="7.3"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>6 months</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="9.5"/>
                    <measurement group_id="O2" value="10.7"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>12 months</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="13.0"/>
                    <measurement group_id="O2" value="13.0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>18 months</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="15.6"/>
                    <measurement group_id="O2" value="14.8"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>24 months</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="18.5"/>
                    <measurement group_id="O2" value="18.2"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Percentage of Participants With Individual MACCE Components</title>
        <description>MACCE is defined as a composite of:
All-cause death
Myocardial infarction (MI)
All stroke, and
Reintervention (defined as any cardiac surgery or percutaneous reintervention catheter procedure that repairs, otherwise alters or adjusts, or replaces a previously implanted valve)</description>
        <time_frame>30 days, 6 months, 12 months, 18 months, and 24 months. Data for 3-5 years will be posted once data is complete.</time_frame>
        <population>Participant Population= Consisted of all randomized subjects with an attempted implant procedure.</population>
        <group_list>
          <group group_id="O1">
            <title>Medtronic CoreValve® System TAVI</title>
            <description>Medtronic CoreValve® System Transcatheter Aortic Valve Implantation (TAVI)
Medtronic CoreValve® Evolut R System Transcatheter Aortic Valve Implantation (TAVI)</description>
          </group>
          <group group_id="O2">
            <title>SAVR</title>
            <description>Surgical Aortic Valve Replacement (SAVR)</description>
          </group>
        </group_list>
        <measure>
          <title>Percentage of Participants With Individual MACCE Components</title>
          <description>MACCE is defined as a composite of:
All-cause death
Myocardial infarction (MI)
All stroke, and
Reintervention (defined as any cardiac surgery or percutaneous reintervention catheter procedure that repairs, otherwise alters or adjusts, or replaces a previously implanted valve)</description>
          <population>Participant Population= Consisted of all randomized subjects with an attempted implant procedure.</population>
          <units>percentage of participants</units>
          <param>Number</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="864"/>
                <count group_id="O2" value="796"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>30 day All Cause Mortality</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="2.1"/>
                    <measurement group_id="O2" value="1.6"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>30 day MI</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.8"/>
                    <measurement group_id="O2" value="0.9"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>30 day Stroke</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="3.3"/>
                    <measurement group_id="O2" value="5.4"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>30 day Reintervention</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.8"/>
                    <measurement group_id="O2" value="0.1"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>6 month All Cause Mortality</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="4.2"/>
                    <measurement group_id="O2" value="4.7"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>6 month MI</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="1.2"/>
                    <measurement group_id="O2" value="1.4"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>6 month Stroke</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="4.6"/>
                    <measurement group_id="O2" value="6.6"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>6 month Reintervention</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="1.8"/>
                    <measurement group_id="O2" value="0.3"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>12 month All Cause Mortality</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="6.5"/>
                    <measurement group_id="O2" value="6.7"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>12 month MI</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="1.9"/>
                    <measurement group_id="O2" value="1.4"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>12 month Stroke</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="5.2"/>
                    <measurement group_id="O2" value="6.9"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>12 month Reintervention</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="2.0"/>
                    <measurement group_id="O2" value="0.5"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>18 month All Cause Mortality</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="8.5"/>
                    <measurement group_id="O2" value="7.9"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>18 month MI</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="2.2"/>
                    <measurement group_id="O2" value="1.8"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>18 month Stroke</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="5.7"/>
                    <measurement group_id="O2" value="7.5"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>18 month Reintervention</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="2.4"/>
                    <measurement group_id="O2" value="0.5"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>24 month All Cause Mortality</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="11.5"/>
                    <measurement group_id="O2" value="10.5"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>24 month MI</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="2.7"/>
                    <measurement group_id="O2" value="2.2"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>24 month Stroke</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="6.0"/>
                    <measurement group_id="O2" value="8.5"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>24 month Reintervention</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="2.4"/>
                    <measurement group_id="O2" value="0.5"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Percentage of Participants With Major Adverse Events (MAE)</title>
        <description>Major Adverse Events (MAE) include all death, MI, all stroke, reintervention, cardiac perforation, cardiac tamponade, cardiogenic shock, valve malpositioning, prosthetic valve dysfunction, acute kidney injury, major vascular complication, life threatening or disabling bleed, major bleed, and valve endocarditis.</description>
        <time_frame>30 days, 6 months, 12 months, 18 months, and 24 months. Data for 3-5 years will be posted once data is complete.</time_frame>
        <population>Participant Population= Consisted of all randomized subjects with an attempted implant procedure.</population>
        <group_list>
          <group group_id="O1">
            <title>Medtronic CoreValve® System TAVI</title>
            <description>Medtronic CoreValve® System Transcatheter Aortic Valve Implantation (TAVI)
Medtronic CoreValve® Evolut R System Transcatheter Aortic Valve Implantation (TAVI)</description>
          </group>
          <group group_id="O2">
            <title>SAVR</title>
            <description>Surgical Aortic Valve Replacement (SAVR)</description>
          </group>
        </group_list>
        <measure>
          <title>Percentage of Participants With Major Adverse Events (MAE)</title>
          <description>Major Adverse Events (MAE) include all death, MI, all stroke, reintervention, cardiac perforation, cardiac tamponade, cardiogenic shock, valve malpositioning, prosthetic valve dysfunction, acute kidney injury, major vascular complication, life threatening or disabling bleed, major bleed, and valve endocarditis.</description>
          <population>Participant Population= Consisted of all randomized subjects with an attempted implant procedure.</population>
          <units>percentage of participants</units>
          <param>Number</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="864"/>
                <count group_id="O2" value="796"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>30 days</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="23.7"/>
                    <measurement group_id="O2" value="30.3"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>6 months</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="28.5"/>
                    <measurement group_id="O2" value="33.6"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>12 months</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="33.0"/>
                    <measurement group_id="O2" value="35.8"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>18 months</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="36.6"/>
                    <measurement group_id="O2" value="38.4"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>24 months</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="40.0"/>
                    <measurement group_id="O2" value="41.8"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Percentage of Participants With Conduction Disturbance Requiring Permanent Pacemaker Implantation</title>
        <time_frame>30 day, 6 months, 12 months, 18 months, and 24 months. Data for 3-5 years will be posted once data is complete.</time_frame>
        <population>Participant Population= Consisted of all randomized subjects with an attempted implant procedure.</population>
        <group_list>
          <group group_id="O1">
            <title>Medtronic CoreValve® System TAVI</title>
            <description>Medtronic CoreValve® System Transcatheter Aortic Valve Implantation (TAVI)
Medtronic CoreValve® Evolut R System Transcatheter Aortic Valve Implantation (TAVI)</description>
          </group>
          <group group_id="O2">
            <title>SAVR</title>
            <description>Surgical Aortic Valve Replacement (SAVR)</description>
          </group>
        </group_list>
        <measure>
          <title>Percentage of Participants With Conduction Disturbance Requiring Permanent Pacemaker Implantation</title>
          <population>Participant Population= Consisted of all randomized subjects with an attempted implant procedure.</population>
          <units>percentage of participants</units>
          <param>Number</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="864"/>
                <count group_id="O2" value="796"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>30 days</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="25.6"/>
                    <measurement group_id="O2" value="6.5"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>6 months</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="27.2"/>
                    <measurement group_id="O2" value="7.6"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>12 months</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="28.3"/>
                    <measurement group_id="O2" value="8.6"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>18 months</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="30.1"/>
                    <measurement group_id="O2" value="9.2"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>24 months</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="30.9"/>
                    <measurement group_id="O2" value="9.8"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Change in NYHA Class From Baseline</title>
        <description>Change from baseline (continuous variable). A positive number corresponds to NYHA worsening; a negative number corresponds to NYHA improvement.
New York Heart Association (NYHA) Classification:
Class I: Subjects with cardiac disease but without resulting limitations of physical activity.
Class I: Subjects with cardiac disease resulting in slight limitation of physical activity.
Class III: Subjects with cardiac disease resulting in marked limitation of physical activity.
Class IV: Subjects with cardiac disease resulting in inability to carry on any physical activity without discomfort.</description>
        <time_frame>Baseline to 30 days, 6 months, 12 months, 18 months, and 24 months. Data for 3-5 years will be posted once data is complete.</time_frame>
        <population>Participant Population= Consisted of all randomized subjects with an attempted implant procedure.</population>
        <group_list>
          <group group_id="O1">
            <title>Medtronic CoreValve® System TAVI</title>
            <description>Medtronic CoreValve® System Transcatheter Aortic Valve Implantation (TAVI)
Medtronic CoreValve® Evolut R System Transcatheter Aortic Valve Implantation (TAVI)</description>
          </group>
          <group group_id="O2">
            <title>SAVR</title>
            <description>Surgical Aortic Valve Replacement (SAVR)</description>
          </group>
        </group_list>
        <measure>
          <title>Change in NYHA Class From Baseline</title>
          <description>Change from baseline (continuous variable). A positive number corresponds to NYHA worsening; a negative number corresponds to NYHA improvement.
New York Heart Association (NYHA) Classification:
Class I: Subjects with cardiac disease but without resulting limitations of physical activity.
Class I: Subjects with cardiac disease resulting in slight limitation of physical activity.
Class III: Subjects with cardiac disease resulting in marked limitation of physical activity.
Class IV: Subjects with cardiac disease resulting in inability to carry on any physical activity without discomfort.</description>
          <population>Participant Population= Consisted of all randomized subjects with an attempted implant procedure.</population>
          <units>units on a scale</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="864"/>
                <count group_id="O2" value="796"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>30 day</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="-1.2" spread="0.8"/>
                    <measurement group_id="O2" value="-1.0" spread="0.9"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>6 month</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="-1.3" spread="0.8"/>
                    <measurement group_id="O2" value="-1.3" spread="0.8"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>12 month</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="-1.3" spread="0.8"/>
                    <measurement group_id="O2" value="-1.3" spread="0.8"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>18 month</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="-1.2" spread="0.8"/>
                    <measurement group_id="O2" value="-1.2" spread="0.8"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>24 month</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="-1.2" spread="0.8"/>
                    <measurement group_id="O2" value="-1.2" spread="0.8"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Change in Distance Walked During 6-minute Walk Test (6MWT)</title>
        <description>Change in distance walked during 6MWT from baseline</description>
        <time_frame>From baseline to 30 days, baseline to 12 months, and baseline to 24 months</time_frame>
        <population>Participant Population= Consisted of all randomized subjects with an attempted implant procedure.</population>
        <group_list>
          <group group_id="O1">
            <title>Medtronic CoreValve® System TAVI</title>
            <description>Medtronic CoreValve® System Transcatheter Aortic Valve Implantation (TAVI)
Medtronic CoreValve® Evolut R System Transcatheter Aortic Valve Implantation (TAVI)</description>
          </group>
          <group group_id="O2">
            <title>SAVR</title>
            <description>Surgical Aortic Valve Replacement (SAVR)</description>
          </group>
        </group_list>
        <measure>
          <title>Change in Distance Walked During 6-minute Walk Test (6MWT)</title>
          <description>Change in distance walked during 6MWT from baseline</description>
          <population>Participant Population= Consisted of all randomized subjects with an attempted implant procedure.</population>
          <units>meters</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="864"/>
                <count group_id="O2" value="796"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>30 days</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="35.4" spread="99.2"/>
                    <measurement group_id="O2" value="-14.4" spread="108.7"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>12 months</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="37.1" spread="103.5"/>
                    <measurement group_id="O2" value="17.8" spread="102.0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>24 months</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="26.5" spread="115.4"/>
                    <measurement group_id="O2" value="11.7" spread="102.7"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Ratio of Days Alive Out of Hospital Versus Total Days Alive</title>
        <time_frame>12 and 24 months</time_frame>
        <population>Participant Population= Consisted of all randomized subjects with an attempted implant procedure.</population>
        <group_list>
          <group group_id="O1">
            <title>Medtronic CoreValve® System TAVI</title>
            <description>Medtronic CoreValve® System Transcatheter Aortic Valve Implantation (TAVI)
Medtronic CoreValve® Evolut R System Transcatheter Aortic Valve Implantation (TAVI)</description>
          </group>
          <group group_id="O2">
            <title>SAVR</title>
            <description>Surgical Aortic Valve Replacement (SAVR)</description>
          </group>
        </group_list>
        <measure>
          <title>Ratio of Days Alive Out of Hospital Versus Total Days Alive</title>
          <population>Participant Population= Consisted of all randomized subjects with an attempted implant procedure.</population>
          <units>ratio</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="864"/>
                <count group_id="O2" value="796"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>12 months</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.96" spread="0.12"/>
                    <measurement group_id="O2" value="0.93" spread="0.15"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>24 months</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.96" spread="0.12"/>
                    <measurement group_id="O2" value="0.95" spread="0.15"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Quality of Life (QoL) Change From Baseline</title>
        <description>QoL summary score change from baseline using the following measures:
Kansas City Cardiomyopathy Questionnaire (KCCQ): Quantifies physical function, symptoms, social function, self-efficacy and knowledge, and quality of life. Scores are transformed to a range of 0-100, in which higher scores reflect better health status.
36 Item Short Form Health Survey (SF-36): Measures functional health and well-being. Scores are transformed to a range of 0-100, in which higher scores reflect better health status.
European QoL (EQ-5D): Measures 5 domains (mobility, self-care, usual activities, pain/discomfort, and anxiety/depression) that can be converted to utilities using an algorithm. Utilities range from 0 to 1, with 1 representing perfect health, and 0 corresponding to the worst imaginable health state.</description>
        <time_frame>Baseline, 30 days, 3 months, 6 months, 12 months, and 24 months. Data for 3-5 years will be posted once data is complete.</time_frame>
        <population>Participant Population= Consisted of all randomized subjects with an attempted implant procedure.</population>
        <group_list>
          <group group_id="O1">
            <title>Medtronic CoreValve® System TAVI</title>
            <description>Medtronic CoreValve® System Transcatheter Aortic Valve Implantation (TAVI)
Medtronic CoreValve® Evolut R System Transcatheter Aortic Valve Implantation (TAVI)</description>
          </group>
          <group group_id="O2">
            <title>SAVR</title>
            <description>Surgical Aortic Valve Replacement (SAVR)</description>
          </group>
        </group_list>
        <measure>
          <title>Quality of Life (QoL) Change From Baseline</title>
          <description>QoL summary score change from baseline using the following measures:
Kansas City Cardiomyopathy Questionnaire (KCCQ): Quantifies physical function, symptoms, social function, self-efficacy and knowledge, and quality of life. Scores are transformed to a range of 0-100, in which higher scores reflect better health status.
36 Item Short Form Health Survey (SF-36): Measures functional health and well-being. Scores are transformed to a range of 0-100, in which higher scores reflect better health status.
European QoL (EQ-5D): Measures 5 domains (mobility, self-care, usual activities, pain/discomfort, and anxiety/depression) that can be converted to utilities using an algorithm. Utilities range from 0 to 1, with 1 representing perfect health, and 0 corresponding to the worst imaginable health state.</description>
          <population>Participant Population= Consisted of all randomized subjects with an attempted implant procedure.</population>
          <units>units on a scale</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="864"/>
                <count group_id="O2" value="796"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>30 day KCCQ- Overall</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="18.4" spread="22.8"/>
                    <measurement group_id="O2" value="5.9" spread="27.0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>30 day KCCQ- Clinical</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="14.9" spread="21.2"/>
                    <measurement group_id="O2" value="4.0" spread="26.0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>30 day SF-36-Physical</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="5.7" spread="10.4"/>
                    <measurement group_id="O2" value="-1.1" spread="11.0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>30 day SF-36-Mental</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="2.6" spread="12.3"/>
                    <measurement group_id="O2" value="-0.6" spread="13.7"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>30 day EQ-5D</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.06" spread="0.18"/>
                    <measurement group_id="O2" value="-0.02" spread="0.21"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>3 month SF-36-Physical</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="7.4" spread="10.5"/>
                    <measurement group_id="O2" value="5.6" spread="10.5"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>3 month SF-36-Mental</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="4.6" spread="11.7"/>
                    <measurement group_id="O2" value="4.6" spread="12.6"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>3 month EQ-5D</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.06" spread="0.18"/>
                    <measurement group_id="O2" value="0.05" spread="0.18"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>6 month KCCQ- Overall</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="21.9" spread="22.3"/>
                    <measurement group_id="O2" value="21.3" spread="22.3"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>6 month KCCQ- Clinical</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="16.5" spread="21.5"/>
                    <measurement group_id="O2" value="15.9" spread="21.7"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>6 month SF-36-Physical</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="6.3" spread="10.3"/>
                    <measurement group_id="O2" value="6.3" spread="10.5"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>6 month SF-36-Mental</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="3.9" spread="11.4"/>
                    <measurement group_id="O2" value="3.6" spread="11.9"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>6 month EQ-5D</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.04" spread="0.18"/>
                    <measurement group_id="O2" value="0.05" spread="0.17"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>12 month KCCQ- Overall</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="20.6" spread="22.3"/>
                    <measurement group_id="O2" value="20.5" spread="22.2"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>12 month KCCQ- Clinical</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="15.1" spread="21.4"/>
                    <measurement group_id="O2" value="14.8" spread="21.6"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>12 month SF-36-Physical</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="5.2" spread="9.9"/>
                    <measurement group_id="O2" value="5.2" spread="10.2"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>12 month SF-36-Mental</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="4.0" spread="11.3"/>
                    <measurement group_id="O2" value="4.1" spread="12.0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>12 month EQ-5D</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.04" spread="0.16"/>
                    <measurement group_id="O2" value="0.03" spread="0.18"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>18 month KCCQ- Overall</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="19.7" spread="21.5"/>
                    <measurement group_id="O2" value="20.2" spread="22.1"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>18 month KCCQ- Clinical</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="14.0" spread="20.7"/>
                    <measurement group_id="O2" value="14.0" spread="21.9"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>18 month SF-36-Physical</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="4.2" spread="10.4"/>
                    <measurement group_id="O2" value="4.3" spread="10.8"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>18 month SF-36-Mental</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="4.3" spread="11.1"/>
                    <measurement group_id="O2" value="3.8" spread="11.9"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>18 month EQ-5D</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.03" spread="0.17"/>
                    <measurement group_id="O2" value="0.03" spread="0.17"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>24 month KCCQ- Overall</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="18.9" spread="21.2"/>
                    <measurement group_id="O2" value="18.6" spread="22.9"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>24 month KCCQ- Clinical</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="12.7" spread="20.5"/>
                    <measurement group_id="O2" value="12.3" spread="22.5"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>24 month SF-36-Physical</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="3.9" spread="9.9"/>
                    <measurement group_id="O2" value="4.0" spread="10.8"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>24 month SF-36-Mental</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="3.6" spread="11.3"/>
                    <measurement group_id="O2" value="3.7" spread="12.2"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>24 month EQ-5D</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.02" spread="0.17"/>
                    <measurement group_id="O2" value="0.02" spread="0.19"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Transvalvular Mean Gradient (in mmHg) as an Assessment of Prosthetic Valve Performance</title>
        <description>Using the following measure:
-Transvalvular mean gradient</description>
        <time_frame>discharge, 6 months, 12 months, and 24 months. Data for 3-5 years will be posted once data is complete</time_frame>
        <population>Participant Population= Consisted of all randomized subjects with a valve implanted</population>
        <group_list>
          <group group_id="O1">
            <title>Medtronic CoreValve® System TAVI</title>
            <description>Medtronic CoreValve® System Transcatheter Aortic Valve Implantation (TAVI)
Medtronic CoreValve® Evolut R System Transcatheter Aortic Valve Implantation (TAVI)</description>
          </group>
          <group group_id="O2">
            <title>SAVR</title>
            <description>Surgical Aortic Valve Replacement (SAVR)</description>
          </group>
        </group_list>
        <measure>
          <title>Transvalvular Mean Gradient (in mmHg) as an Assessment of Prosthetic Valve Performance</title>
          <description>Using the following measure:
-Transvalvular mean gradient</description>
          <population>Participant Population= Consisted of all randomized subjects with a valve implanted</population>
          <units>mmHg</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="863"/>
                <count group_id="O2" value="794"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>discharge</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="8.82" spread="3.89"/>
                    <measurement group_id="O2" value="12.39" spread="5.71"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>6 months</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="8.28" spread="3.88"/>
                    <measurement group_id="O2" value="11.10" spread="4.72"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>12 months</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="8.34" spread="3.89"/>
                    <measurement group_id="O2" value="11.57" spread="5.16"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>24 months</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="8.20" spread="3.85"/>
                    <measurement group_id="O2" value="11.55" spread="5.43"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Effective Orifice Area as an Assessment of Prosthetic Valve Performance</title>
        <description>Using the following measure:
-Effective Orifice Area (cm^2)</description>
        <time_frame>discharge, 6 months, 12 months, and 24 months. Data for 3-5 years will be posted once data is complete</time_frame>
        <population>Participant Population= Consisted of all randomized subjects with a valve implanted</population>
        <group_list>
          <group group_id="O1">
            <title>Medtronic CoreValve® System TAVI</title>
            <description>Medtronic CoreValve® System Transcatheter Aortic Valve Implantation (TAVI)
Medtronic CoreValve® Evolut R System Transcatheter Aortic Valve Implantation (TAVI)</description>
          </group>
          <group group_id="O2">
            <title>SAVR</title>
            <description>Surgical Aortic Valve Replacement (SAVR)</description>
          </group>
        </group_list>
        <measure>
          <title>Effective Orifice Area as an Assessment of Prosthetic Valve Performance</title>
          <description>Using the following measure:
-Effective Orifice Area (cm^2)</description>
          <population>Participant Population= Consisted of all randomized subjects with a valve implanted</population>
          <units>cm^2</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="863"/>
                <count group_id="O2" value="794"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>discharge EOA</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="2.13" spread="0.57"/>
                    <measurement group_id="O2" value="1.82" spread="0.63"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>6 months EOA</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="2.14" spread="0.61"/>
                    <measurement group_id="O2" value="1.80" spread="0.57"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>12 months EOA</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="2.13" spread="0.59"/>
                    <measurement group_id="O2" value="1.78" spread="0.59"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>24 months EOA</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="2.15" spread="0.63"/>
                    <measurement group_id="O2" value="1.77" spread="0.55"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Degree of Aortic Valve Regurgitation as an Assessment of Prosthetic Valve Performance</title>
        <description>Using the following measure:
- Degree of Aortic Valve Regurgitation (Transvalvular and Paravalvular)</description>
        <time_frame>discharge, 6 months, 12 months, and 24 months. Data for 3-5 years will be posted once data is complete</time_frame>
        <population>Participant Population= Consisted of all randomized subjects with a valve implanted</population>
        <group_list>
          <group group_id="O1">
            <title>Medtronic CoreValve® System TAVI</title>
            <description>Medtronic CoreValve® System Transcatheter Aortic Valve Implantation (TAVI)
Medtronic CoreValve® Evolut R System Transcatheter Aortic Valve Implantation (TAVI)</description>
          </group>
          <group group_id="O2">
            <title>SAVR</title>
            <description>Surgical Aortic Valve Replacement (SAVR)</description>
          </group>
        </group_list>
        <measure>
          <title>Degree of Aortic Valve Regurgitation as an Assessment of Prosthetic Valve Performance</title>
          <description>Using the following measure:
- Degree of Aortic Valve Regurgitation (Transvalvular and Paravalvular)</description>
          <population>Participant Population= Consisted of all randomized subjects with a valve implanted</population>
          <units>Percentage of participants</units>
          <param>Number</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="863"/>
                <count group_id="O2" value="794"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>Discharge : Total Aortic Regurgitation- None</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="24.9"/>
                    <measurement group_id="O2" value="67.9"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Discharge : Total Aortic Regurgitation- Trace</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="35.7"/>
                    <measurement group_id="O2" value="24.6"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Discharge : Total Aortic Regurgitation- Mild</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="35.9"/>
                    <measurement group_id="O2" value="6.8"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Discharge : Total Aortic Regurgitation- Moderate</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="3.2"/>
                    <measurement group_id="O2" value="0.7"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Discharge : Total Aortic Regurgitation- Severe</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.2"/>
                    <measurement group_id="O2" value="0.0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>6 months : Total Aortic Regurgitation- None</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="28.4"/>
                    <measurement group_id="O2" value="67.0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>6 months : Total Aortic Regurgitation- Trace</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="32.2"/>
                    <measurement group_id="O2" value="24.3"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>6 months : Total Aortic Regurgitation- Mild</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="34.7"/>
                    <measurement group_id="O2" value="7.8"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>6 months : Total Aortic Regurgitation- Moderate</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="4.6"/>
                    <measurement group_id="O2" value="0.8"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>6 months : Total Aortic Regurgitation- Severe</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.1"/>
                    <measurement group_id="O2" value="0.2"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>12 months : Total Aortic Regurgitation- None</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="32.0"/>
                    <measurement group_id="O2" value="67.6"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>12 months : Total Aortic Regurgitation- Trace</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="28.8"/>
                    <measurement group_id="O2" value="23.5"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>12 months : Total Aortic Regurgitation- Mild</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="34.1"/>
                    <measurement group_id="O2" value="8.3"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>12 months : Total Aortic Regurgitation- Moderate</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="5.1"/>
                    <measurement group_id="O2" value="0.7"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>12 months : Total Aortic Regurgitation- Severe</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.0"/>
                    <measurement group_id="O2" value="0.0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>24 months : Total Aortic Regurgitation- None</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="35.1"/>
                    <measurement group_id="O2" value="67.7"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>24 months : Total Aortic Regurgitation- Trace</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="30.5"/>
                    <measurement group_id="O2" value="25.3"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>24 months : Total Aortic Regurgitation- Mild</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="30.0"/>
                    <measurement group_id="O2" value="6.2"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>24 months : Total Aortic Regurgitation- Moderate</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="4.2"/>
                    <measurement group_id="O2" value="0.6"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>24 months : Total Aortic Regurgitation- Severe</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.2"/>
                    <measurement group_id="O2" value="0.2"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Percentage of Participants With Aortic Valve Disease Related Hospitalizations</title>
        <time_frame>30 days, 6 months, 12 months, 18 months, and 24 months. Data for 3-5 years will be posted once data is complete.</time_frame>
        <population>Participant Population= Consisted of all randomized subjects with an attempted implant procedure.</population>
        <group_list>
          <group group_id="O1">
            <title>Medtronic CoreValve® System TAVI</title>
            <description>Medtronic CoreValve® System Transcatheter Aortic Valve Implantation (TAVI)
Medtronic CoreValve® Evolut R System Transcatheter Aortic Valve Implantation (TAVI)</description>
          </group>
          <group group_id="O2">
            <title>SAVR</title>
            <description>Surgical Aortic Valve Replacement (SAVR)</description>
          </group>
        </group_list>
        <measure>
          <title>Percentage of Participants With Aortic Valve Disease Related Hospitalizations</title>
          <population>Participant Population= Consisted of all randomized subjects with an attempted implant procedure.</population>
          <units>percentage of particpants</units>
          <param>Number</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="864"/>
                <count group_id="O2" value="796"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>30 days</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="2.8"/>
                    <measurement group_id="O2" value="4.1"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>6 months</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="6.6"/>
                    <measurement group_id="O2" value="5.8"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>12 months</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="8.6"/>
                    <measurement group_id="O2" value="7.4"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>18 months</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="10.8"/>
                    <measurement group_id="O2" value="8.4"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>24 months</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="12.8"/>
                    <measurement group_id="O2" value="9.5"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Percentage of Participants With Cardiovascular Deaths and Valve-Related Deaths</title>
        <time_frame>30 days, 6 months, 12 months, 18 months, and 24 months. Data for 3-5 years will be posted once data is complete</time_frame>
        <population>Participant Population= Consisted of all randomized subjects with an attempted implant procedure.</population>
        <group_list>
          <group group_id="O1">
            <title>Medtronic CoreValve® System TAVI</title>
            <description>Medtronic CoreValve® System Transcatheter Aortic Valve Implantation (TAVI)
Medtronic CoreValve® Evolut R System Transcatheter Aortic Valve Implantation (TAVI)</description>
          </group>
          <group group_id="O2">
            <title>SAVR</title>
            <description>Surgical Aortic Valve Replacement (SAVR)</description>
          </group>
        </group_list>
        <measure>
          <title>Percentage of Participants With Cardiovascular Deaths and Valve-Related Deaths</title>
          <population>Participant Population= Consisted of all randomized subjects with an attempted implant procedure.</population>
          <units>percentage of participants</units>
          <param>Number</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="864"/>
                <count group_id="O2" value="796"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>30 day cardiovascular deaths</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="2.0"/>
                    <measurement group_id="O2" value="1.6"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>30 day valve related deaths</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.0"/>
                    <measurement group_id="O2" value="0.0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>6 month cardiovascular deaths</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="3.2"/>
                    <measurement group_id="O2" value="3.9"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>6 month valve related deaths</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.0"/>
                    <measurement group_id="O2" value="0.1"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>12 month cardiovascular deaths</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="4.7"/>
                    <measurement group_id="O2" value="5.3"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>12 month valve related deaths</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.0"/>
                    <measurement group_id="O2" value="0.1"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>18 month cardiovascular deaths</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="5.9"/>
                    <measurement group_id="O2" value="6.1"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>18 month valve related deaths</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.0"/>
                    <measurement group_id="O2" value="0.1"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>24 month cardiovascular deaths</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="7.8"/>
                    <measurement group_id="O2" value="7.1"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>24 month valve related deaths</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.0"/>
                    <measurement group_id="O2" value="0.1"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Percentage of Participants With Stroke and TIAs</title>
        <description>Strokes (of any severity) and Transient Ischemic Attacks (TIAs)</description>
        <time_frame>30 days, 6 months, 12 months, 18 months, and 24 months. Data for 3-5 years will be posted once data is complete.</time_frame>
        <population>Participant Population= Consisted of all randomized subjects with an attempted implant procedure.</population>
        <group_list>
          <group group_id="O1">
            <title>Medtronic CoreValve® System TAVI</title>
            <description>Medtronic CoreValve® System Transcatheter Aortic Valve Implantation (TAVI)
Medtronic CoreValve® Evolut R System Transcatheter Aortic Valve Implantation (TAVI)</description>
          </group>
          <group group_id="O2">
            <title>SAVR</title>
            <description>Surgical Aortic Valve Replacement (SAVR)</description>
          </group>
        </group_list>
        <measure>
          <title>Percentage of Participants With Stroke and TIAs</title>
          <description>Strokes (of any severity) and Transient Ischemic Attacks (TIAs)</description>
          <population>Participant Population= Consisted of all randomized subjects with an attempted implant procedure.</population>
          <units>percentage of participants</units>
          <param>Number</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="864"/>
                <count group_id="O2" value="796"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>30 days</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="4.4"/>
                    <measurement group_id="O2" value="6.3"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>6 months</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="6.9"/>
                    <measurement group_id="O2" value="7.8"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>12 months</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="8.0"/>
                    <measurement group_id="O2" value="8.6"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>18 months</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="8.8"/>
                    <measurement group_id="O2" value="9.4"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>24 months</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="9.5"/>
                    <measurement group_id="O2" value="11.2"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Peri-procedural Neurological Injury</title>
        <description>Neurological injury (stroke, TIA, or encephalopathy)</description>
        <time_frame>discharge or 7 days post index procedure (whichever occurred first)</time_frame>
        <population>Participant Population= Consisted of all randomized subjects with an index procedure</population>
        <group_list>
          <group group_id="O1">
            <title>Medtronic CoreValve® System TAVI</title>
            <description>Medtronic CoreValve® System Transcatheter Aortic Valve Implantation (TAVI)
Medtronic CoreValve® Evolut R System Transcatheter Aortic Valve Implantation (TAVI)</description>
          </group>
          <group group_id="O2">
            <title>SAVR</title>
            <description>Surgical Aortic Valve Replacement (SAVR)</description>
          </group>
        </group_list>
        <measure>
          <title>Peri-procedural Neurological Injury</title>
          <description>Neurological injury (stroke, TIA, or encephalopathy)</description>
          <population>Participant Population= Consisted of all randomized subjects with an index procedure</population>
          <units>percentage of participants</units>
          <param>Number</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="863"/>
                <count group_id="O2" value="795"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="4.8"/>
                    <measurement group_id="O2" value="12.3"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Index Procedure Related Major Adverse Events (MAEs)</title>
        <description>Index procedure related MAEs were defined as events occurring during, or as a direct result of, the index procedure.</description>
        <time_frame>Procedure through 30 day visit</time_frame>
        <population>Participant Population= Consisted of all randomized subjects with an index procedure</population>
        <group_list>
          <group group_id="O1">
            <title>Medtronic CoreValve® System TAVI</title>
            <description>Medtronic CoreValve® System Transcatheter Aortic Valve Implantation (TAVI)
Medtronic CoreValve® Evolut R System Transcatheter Aortic Valve Implantation (TAVI)</description>
          </group>
          <group group_id="O2">
            <title>SAVR</title>
            <description>Surgical Aortic Valve Replacement (SAVR)</description>
          </group>
        </group_list>
        <measure>
          <title>Index Procedure Related Major Adverse Events (MAEs)</title>
          <description>Index procedure related MAEs were defined as events occurring during, or as a direct result of, the index procedure.</description>
          <population>Participant Population= Consisted of all randomized subjects with an index procedure</population>
          <units>percentage of participants</units>
          <param>Number</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="863"/>
                <count group_id="O2" value="795"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="23.5"/>
                    <measurement group_id="O2" value="30.4"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Length of Index Procedure Hospital Stay</title>
        <time_frame>Number of days from admission to discharge (expected average of 7 days)</time_frame>
        <population>Participant Population= Consisted of all randomized subjects with an index procedure</population>
        <group_list>
          <group group_id="O1">
            <title>Medtronic CoreValve® System TAVI</title>
            <description>Medtronic CoreValve® System Transcatheter Aortic Valve Implantation (TAVI)
Medtronic CoreValve® Evolut R System Transcatheter Aortic Valve Implantation (TAVI)</description>
          </group>
          <group group_id="O2">
            <title>SAVR</title>
            <description>Surgical Aortic Valve Replacement (SAVR)</description>
          </group>
        </group_list>
        <measure>
          <title>Length of Index Procedure Hospital Stay</title>
          <population>Participant Population= Consisted of all randomized subjects with an index procedure</population>
          <units>days</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="863"/>
                <count group_id="O2" value="795"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="5.7" spread="4.9"/>
                    <measurement group_id="O2" value="9.8" spread="8.0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Presence of Atrial Fibrillation</title>
        <time_frame>post-procedure, discharge, 30 days, 6 months, 12 months, 18 months, and 24 months. Data for 3-5 years will be posted once data is complete.</time_frame>
        <population>Participant Population= Consisted of all randomized subjects with an attempted implant procedure.</population>
        <group_list>
          <group group_id="O1">
            <title>Medtronic CoreValve® System TAVI</title>
            <description>Medtronic CoreValve® System Transcatheter Aortic Valve Implantation (TAVI)
Medtronic CoreValve® Evolut R System Transcatheter Aortic Valve Implantation (TAVI)</description>
          </group>
          <group group_id="O2">
            <title>SAVR</title>
            <description>Surgical Aortic Valve Replacement (SAVR)</description>
          </group>
        </group_list>
        <measure>
          <title>Presence of Atrial Fibrillation</title>
          <population>Participant Population= Consisted of all randomized subjects with an attempted implant procedure.</population>
          <units>percentage of participants</units>
          <param>Number</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="864"/>
                <count group_id="O2" value="796"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>post procedure</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="12.8"/>
                    <measurement group_id="O2" value="8.7"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>discharge</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="14.0"/>
                    <measurement group_id="O2" value="22.2"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>30 days</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="13.6"/>
                    <measurement group_id="O2" value="14.4"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>6 months</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="14.1"/>
                    <measurement group_id="O2" value="12.1"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>12 months</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="13.4"/>
                    <measurement group_id="O2" value="11.7"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>18 months</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="13.6"/>
                    <measurement group_id="O2" value="11.9"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>24 months</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="15.1"/>
                    <measurement group_id="O2" value="12.2"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Device Success (Medtronic CoreValve® System Subjects Only)</title>
        <description>Absence of procedural mortality
Correct positioning of a single prosthetic heart valve into the proper anatomical location
Intended performance of the prosthetic heart valve (no prosthesis-patient mismatch and mean aortic valve gradient &lt;20 mmHg or peak velocity &lt;3 m/s, AND no moderate or severe prosthetic valve regurgitation)</description>
        <time_frame>Number of days from admission to discharge (expected average of 7 days)</time_frame>
        <population>Participant Population =Consisted of all randomized subjects with a TAVR index procedure who were evaluable for device success.</population>
        <group_list>
          <group group_id="O1">
            <title>Medtronic CoreValve® System TAVI</title>
            <description>Medtronic CoreValve® System Transcatheter Aortic Valve Implantation (TAVI)
Medtronic CoreValve® System Transcatheter Aortic Valve Implantation (TAVI)
Medtronic CoreValve® Evolut R System Transcatheter Aortic Valve Implantation (TAVI)</description>
          </group>
        </group_list>
        <measure>
          <title>Device Success (Medtronic CoreValve® System Subjects Only)</title>
          <description>Absence of procedural mortality
Correct positioning of a single prosthetic heart valve into the proper anatomical location
Intended performance of the prosthetic heart valve (no prosthesis-patient mismatch and mean aortic valve gradient &lt;20 mmHg or peak velocity &lt;3 m/s, AND no moderate or severe prosthetic valve regurgitation)</description>
          <population>Participant Population =Consisted of all randomized subjects with a TAVR index procedure who were evaluable for device success.</population>
          <units>percentage of participants</units>
          <param>Number</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="863"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="77.0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Procedural Success (Medtronic CoreValve® System Subjects Only)</title>
        <description>Defined by device success and absence of in-hospital major adverse cardiovascular and cerebrovascular events (MACCE)</description>
        <time_frame>Number of days from admission to discharge (expected average of 7 days)</time_frame>
        <population>Participant Population= Consisted of all randomized subjects with a TAVR index procedure who were evaluable for procedural success.</population>
        <group_list>
          <group group_id="O1">
            <title>Medtronic CoreValve® System TAVI</title>
            <description>Medtronic CoreValve® System Transcatheter Aortic Valve Implantation (TAVI)
Medtronic CoreValve® System Transcatheter Aortic Valve Implantation (TAVI)
Medtronic CoreValve® Evolut R System Transcatheter Aortic Valve Implantation (TAVI)</description>
          </group>
        </group_list>
        <measure>
          <title>Procedural Success (Medtronic CoreValve® System Subjects Only)</title>
          <description>Defined by device success and absence of in-hospital major adverse cardiovascular and cerebrovascular events (MACCE)</description>
          <population>Participant Population= Consisted of all randomized subjects with a TAVR index procedure who were evaluable for procedural success.</population>
          <units>percentage of participants</units>
          <param>Number</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="863"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="74.7"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Evidence of Prosthetic Valve Dysfunction (Medtronic CoreValve® System Subjects Only)</title>
        <description>Prosthetic Valve Dysfunction (PVD) was defined according to Valve Academic Research Consortium (VARC) II using the Core Lab Echocardiography assessments including aortic regurgitation (AR) and aortic stenosis (AS) evaluations. Total aortic regurgitation (AR) reported as moderate or severe was considered
PVD defined as:
Mean aortic valve gradient ≥20 mmHg AND ((EOA ≤0.9 cm2 if BSA &lt;1.6 or ≤1.1 cm2 if BSA ≥1.6) OR DVI &lt;0. 35 m/s) OR
moderate or severe total AR</description>
        <time_frame>6 months, 12 months, and 24 months. Data for 3-5 years will be posted once data is complete.</time_frame>
        <population>Participant Population= Consisted of all subjects with a valve implanted</population>
        <group_list>
          <group group_id="O1">
            <title>Medtronic CoreValve® System TAVI</title>
            <description>Medtronic CoreValve® System Transcatheter Aortic Valve Implantation (TAVI)
Medtronic CoreValve® System Transcatheter Aortic Valve Implantation (TAVI)
Medtronic CoreValve® Evolut R System Transcatheter Aortic Valve Implantation (TAVI)</description>
          </group>
          <group group_id="O2">
            <title>SAVR</title>
            <description>Surgical Aortic Valve Replacement (SAVR)</description>
          </group>
        </group_list>
        <measure>
          <title>Evidence of Prosthetic Valve Dysfunction (Medtronic CoreValve® System Subjects Only)</title>
          <description>Prosthetic Valve Dysfunction (PVD) was defined according to Valve Academic Research Consortium (VARC) II using the Core Lab Echocardiography assessments including aortic regurgitation (AR) and aortic stenosis (AS) evaluations. Total aortic regurgitation (AR) reported as moderate or severe was considered
PVD defined as:
Mean aortic valve gradient ≥20 mmHg AND ((EOA ≤0.9 cm2 if BSA &lt;1.6 or ≤1.1 cm2 if BSA ≥1.6) OR DVI &lt;0. 35 m/s) OR
moderate or severe total AR</description>
          <population>Participant Population= Consisted of all subjects with a valve implanted</population>
          <units>percentage of participants</units>
          <param>Number</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="864"/>
                <count group_id="O2" value="796"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>6 month</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="6.0"/>
                    <measurement group_id="O2" value="4.1"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>12 month</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="6.7"/>
                    <measurement group_id="O2" value="6.4"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>24 month</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="6.0"/>
                    <measurement group_id="O2" value="5.8"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Percentage of Participants With Early Safety Endpoint</title>
        <description>Percentage of participants with VARC II early safety composite at 30 days</description>
        <time_frame>30 Days</time_frame>
        <population>Participant Population= Consisted of all randomized subjects with an attempted implant procedure.</population>
        <group_list>
          <group group_id="O1">
            <title>Medtronic CoreValve® System TAVI</title>
            <description>Medtronic CoreValve® System Transcatheter Aortic Valve Implantation (TAVI)
Medtronic CoreValve® Evolut R System Transcatheter Aortic Valve Implantation (TAVI)</description>
          </group>
          <group group_id="O2">
            <title>SAVR</title>
            <description>Surgical Aortic Valve Replacement (SAVR)</description>
          </group>
        </group_list>
        <measure>
          <title>Percentage of Participants With Early Safety Endpoint</title>
          <description>Percentage of participants with VARC II early safety composite at 30 days</description>
          <population>Participant Population= Consisted of all randomized subjects with an attempted implant procedure.</population>
          <units>percentage of participants</units>
          <param>Number</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="864"/>
                <count group_id="O2" value="796"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="12.5"/>
                    <measurement group_id="O2" value="15.8"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Percentage of Participants With Clinical Efficacy (After 30 Days)</title>
        <description>Combined clinical efficacy after 30 days was defined as the composite of all-cause mortality, all strokes (disabling and non-disabling), hospitalization for valve-related symptoms or worsening congestive heart failure, NYHA III or IV, and valve-related dysfunction.</description>
        <time_frame>6 months, 12 months, 18 months, and 24 months. Data for 3-5 years will be posted once data is complete</time_frame>
        <population>Participant Population= Consisted of all randomized subjects with an attempted implant procedure.</population>
        <group_list>
          <group group_id="O1">
            <title>Medtronic CoreValve® System TAVI</title>
            <description>Medtronic CoreValve® System Transcatheter Aortic Valve Implantation (TAVI)
Medtronic CoreValve® Evolut R System Transcatheter Aortic Valve Implantation (TAVI)</description>
          </group>
          <group group_id="O2">
            <title>SAVR</title>
            <description>Surgical Aortic Valve Replacement (SAVR)</description>
          </group>
        </group_list>
        <measure>
          <title>Percentage of Participants With Clinical Efficacy (After 30 Days)</title>
          <description>Combined clinical efficacy after 30 days was defined as the composite of all-cause mortality, all strokes (disabling and non-disabling), hospitalization for valve-related symptoms or worsening congestive heart failure, NYHA III or IV, and valve-related dysfunction.</description>
          <population>Participant Population= Consisted of all randomized subjects with an attempted implant procedure.</population>
          <units>percentage of participants</units>
          <param>Number</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="864"/>
                <count group_id="O2" value="796"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>6 months</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="12.8"/>
                    <measurement group_id="O2" value="9.9"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>12 months</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="23.5"/>
                    <measurement group_id="O2" value="21.0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>18 months</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="26.3"/>
                    <measurement group_id="O2" value="22.6"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>24 months</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="33.9"/>
                    <measurement group_id="O2" value="33.0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Percentage of Participants With Time-Related Safety</title>
        <description>The VARC II time-related valve safety composite was defined as the rate of valve-related dysfunction (mean aortic valve gradient ≥ 20 mm Hg, EOA ≤ 0.9-1.1 cm2 depending on body surface area and/or DVI &lt;0.35, AND/ OR moderate or severe prosthetic valve regurgitation), aortic valve reintervention, prosthetic valve endocarditis, prosthetic valve thrombosis, thromboembolic events, and VARC II bleeding events.</description>
        <time_frame>30 days, 6 months, 12 months, 18 months, and 24 months. Data for 3-5 years will be posted once data is available.</time_frame>
        <population>Participant Population= Consisted of all randomized subjects with an attempted implant procedure.</population>
        <group_list>
          <group group_id="O1">
            <title>Medtronic CoreValve® System TAVI</title>
            <description>Medtronic CoreValve® System Transcatheter Aortic Valve Implantation (TAVI)
Medtronic CoreValve® Evolut R System Transcatheter Aortic Valve Implantation (TAVI)</description>
          </group>
          <group group_id="O2">
            <title>SAVR</title>
            <description>Surgical Aortic Valve Replacement (SAVR)</description>
          </group>
        </group_list>
        <measure>
          <title>Percentage of Participants With Time-Related Safety</title>
          <description>The VARC II time-related valve safety composite was defined as the rate of valve-related dysfunction (mean aortic valve gradient ≥ 20 mm Hg, EOA ≤ 0.9-1.1 cm2 depending on body surface area and/or DVI &lt;0.35, AND/ OR moderate or severe prosthetic valve regurgitation), aortic valve reintervention, prosthetic valve endocarditis, prosthetic valve thrombosis, thromboembolic events, and VARC II bleeding events.</description>
          <population>Participant Population= Consisted of all randomized subjects with an attempted implant procedure.</population>
          <units>percentage of participants</units>
          <param>Number</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="864"/>
                <count group_id="O2" value="796"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>30 days</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="28.8"/>
                    <measurement group_id="O2" value="61.7"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>6 months</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="38.5"/>
                    <measurement group_id="O2" value="69.6"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>12 months</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="45.1"/>
                    <measurement group_id="O2" value="72.1"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>18 months</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="42.1"/>
                    <measurement group_id="O2" value="67.8"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>24 months</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="53.0"/>
                    <measurement group_id="O2" value="77.3"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Resheath and Recapture Success (Evolut R Only)</title>
        <description>The Evolut™ R system provides operators with the ability to resheath or recapture the valve before it is completely deployed in the event of initial suboptimal positioning. Successful resheath was defined as successfully retrieving a portion of the valve into the capsule of the delivery catheter, and successful recapture was defined as successfully recapturing the entirety of the valve into the capsule of the delivery catheter.</description>
        <time_frame>Procedure</time_frame>
        <population>Participant Population= Consisted of all subjects in whom the resheath or recapture feature of the Evolut R system was attempted</population>
        <group_list>
          <group group_id="O1">
            <title>Medtronic CoreValve® System TAVI</title>
            <description>Medtronic CoreValve® Evolut R System Transcatheter Aortic Valve Implantation (TAVI)</description>
          </group>
        </group_list>
        <measure>
          <title>Resheath and Recapture Success (Evolut R Only)</title>
          <description>The Evolut™ R system provides operators with the ability to resheath or recapture the valve before it is completely deployed in the event of initial suboptimal positioning. Successful resheath was defined as successfully retrieving a portion of the valve into the capsule of the delivery catheter, and successful recapture was defined as successfully recapturing the entirety of the valve into the capsule of the delivery catheter.</description>
          <population>Participant Population= Consisted of all subjects in whom the resheath or recapture feature of the Evolut R system was attempted</population>
          <units>percentage of attempts</units>
          <param>Number</param>
          <units_analyzed>attempts</units_analyzed>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="31"/>
              </count_list>
            </analyzed>
            <analyzed>
              <units>attempts</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="53"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>Resheath</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="100"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Recapture</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="89.7"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Resheath or Recapture</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="92.5"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
    </outcome_list>

    <reported_events>
      <time_frame>Adverse events (AEs) were collected from study enrollment through the 24 month follow-up visit. Adverse event data are currently available and reported for up to 24 months.</time_frame>
      <desc>All new or worsening AEs were collected through 24 months.</desc>
      <group_list>
        <group group_id="E1">
          <title>Medtronic CoreValve® System TAVI</title>
          <description>Medtronic CoreValve® System Transcatheter Aortic Valve Implantation (TAVI)
Medtronic CoreValve® Evolut R System Transcatheter Aortic Valve Implantation (TAVI)</description>
        </group>
        <group group_id="E2">
          <title>SAVR</title>
          <description>Surgical Aortic Valve Replacement (SAVR)</description>
        </group>
      </group_list>
      <serious_events>
        <default_vocab>MedDRA 21.0</default_vocab>
        <default_assessment>Systematic Assessment</default_assessment>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, all-cause mortality</sub_title>
                <counts group_id="E1" subjects_affected="98" subjects_at_risk="864"/>
                <counts group_id="E2" subjects_affected="80" subjects_at_risk="796"/>
              </event>
              <event>
                <sub_title>Total, serious adverse events</sub_title>
                <counts group_id="E1" subjects_affected="718" subjects_at_risk="864"/>
                <counts group_id="E2" subjects_affected="694" subjects_at_risk="796"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Blood and lymphatic system disorders</title>
            <event_list>
              <event>
                <sub_title>ANAEMIA</sub_title>
                <counts group_id="E1" events="117" subjects_affected="102" subjects_at_risk="864"/>
                <counts group_id="E2" events="222" subjects_affected="203" subjects_at_risk="796"/>
              </event>
              <event>
                <sub_title>AUTOIMMUNE HAEMOLYTIC ANAEMIA</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="864"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="796"/>
              </event>
              <event>
                <sub_title>BLOOD DISORDER</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="864"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="796"/>
              </event>
              <event>
                <sub_title>COAGULOPATHY</sub_title>
                <counts group_id="E1" events="6" subjects_affected="6" subjects_at_risk="864"/>
                <counts group_id="E2" events="11" subjects_affected="11" subjects_at_risk="796"/>
              </event>
              <event>
                <sub_title>DISSEMINATED INTRAVASCULAR COAGULATION</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="864"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="796"/>
              </event>
              <event>
                <sub_title>HAEMOLYTIC ANAEMIA</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="864"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="796"/>
              </event>
              <event>
                <sub_title>HAEMORRHAGIC ANAEMIA</sub_title>
                <counts group_id="E1" events="40" subjects_affected="40" subjects_at_risk="864"/>
                <counts group_id="E2" events="87" subjects_affected="84" subjects_at_risk="796"/>
              </event>
              <event>
                <sub_title>HYPOCHROMIC ANAEMIA</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="864"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="796"/>
              </event>
              <event>
                <sub_title>IRON DEFICIENCY ANAEMIA</sub_title>
                <counts group_id="E1" events="7" subjects_affected="7" subjects_at_risk="864"/>
                <counts group_id="E2" events="2" subjects_affected="2" subjects_at_risk="796"/>
              </event>
              <event>
                <sub_title>LEUKOCYTOSIS</sub_title>
                <counts group_id="E1" events="4" subjects_affected="4" subjects_at_risk="864"/>
                <counts group_id="E2" events="8" subjects_affected="7" subjects_at_risk="796"/>
              </event>
              <event>
                <sub_title>LYMPHADENOPATHY</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="864"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="796"/>
              </event>
              <event>
                <sub_title>MICROCYTIC ANAEMIA</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="864"/>
                <counts group_id="E2" events="3" subjects_affected="3" subjects_at_risk="796"/>
              </event>
              <event>
                <sub_title>NORMOCYTIC ANAEMIA</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="864"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="796"/>
              </event>
              <event>
                <sub_title>PANCYTOPENIA</sub_title>
                <counts group_id="E1" events="4" subjects_affected="4" subjects_at_risk="864"/>
                <counts group_id="E2" events="6" subjects_affected="6" subjects_at_risk="796"/>
              </event>
              <event>
                <sub_title>SPLENIC HAEMATOMA</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="864"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="796"/>
              </event>
              <event>
                <sub_title>THROMBOCYTOPENIA</sub_title>
                <counts group_id="E1" events="10" subjects_affected="10" subjects_at_risk="864"/>
                <counts group_id="E2" events="45" subjects_affected="44" subjects_at_risk="796"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Cardiac disorders</title>
            <event_list>
              <event>
                <sub_title>ACUTE CORONARY SYNDROME</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="864"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="796"/>
              </event>
              <event>
                <sub_title>ACUTE LEFT VENTRICULAR FAILURE</sub_title>
                <counts group_id="E1" events="12" subjects_affected="12" subjects_at_risk="864"/>
                <counts group_id="E2" events="15" subjects_affected="9" subjects_at_risk="796"/>
              </event>
              <event>
                <sub_title>ACUTE MYOCARDIAL INFARCTION</sub_title>
                <counts group_id="E1" events="17" subjects_affected="17" subjects_at_risk="864"/>
                <counts group_id="E2" events="19" subjects_affected="19" subjects_at_risk="796"/>
              </event>
              <event>
                <sub_title>ANGINA PECTORIS</sub_title>
                <counts group_id="E1" events="11" subjects_affected="11" subjects_at_risk="864"/>
                <counts group_id="E2" events="5" subjects_affected="4" subjects_at_risk="796"/>
              </event>
              <event>
                <sub_title>ANGINA UNSTABLE</sub_title>
                <counts group_id="E1" events="4" subjects_affected="4" subjects_at_risk="864"/>
                <counts group_id="E2" events="3" subjects_affected="3" subjects_at_risk="796"/>
              </event>
              <event>
                <sub_title>AORTIC VALVE DISEASE</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="864"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="796"/>
              </event>
              <event>
                <sub_title>AORTIC VALVE INCOMPETENCE</sub_title>
                <counts group_id="E1" events="46" subjects_affected="43" subjects_at_risk="864"/>
                <counts group_id="E2" events="5" subjects_affected="5" subjects_at_risk="796"/>
              </event>
              <event>
                <sub_title>AORTIC VALVE STENOSIS</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="864"/>
                <counts group_id="E2" events="5" subjects_affected="4" subjects_at_risk="796"/>
              </event>
              <event>
                <sub_title>ARRHYTHMIA</sub_title>
                <counts group_id="E1" events="3" subjects_affected="3" subjects_at_risk="864"/>
                <counts group_id="E2" events="3" subjects_affected="3" subjects_at_risk="796"/>
              </event>
              <event>
                <sub_title>ARRHYTHMIA SUPRAVENTRICULAR</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="864"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="796"/>
              </event>
              <event>
                <sub_title>ATRIAL FIBRILLATION</sub_title>
                <counts group_id="E1" events="105" subjects_affected="86" subjects_at_risk="864"/>
                <counts group_id="E2" events="185" subjects_affected="169" subjects_at_risk="796"/>
              </event>
              <event>
                <sub_title>ATRIAL FLUTTER</sub_title>
                <counts group_id="E1" events="11" subjects_affected="10" subjects_at_risk="864"/>
                <counts group_id="E2" events="19" subjects_affected="19" subjects_at_risk="796"/>
              </event>
              <event>
                <sub_title>ATRIAL RUPTURE</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="864"/>
                <counts group_id="E2" events="2" subjects_affected="2" subjects_at_risk="796"/>
              </event>
              <event>
                <sub_title>ATRIAL TACHYCARDIA</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="864"/>
                <counts group_id="E2" events="4" subjects_affected="4" subjects_at_risk="796"/>
              </event>
              <event>
                <sub_title>ATRIAL THROMBOSIS</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="864"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="796"/>
              </event>
              <event>
                <sub_title>ATRIOVENTRICULAR BLOCK</sub_title>
                <counts group_id="E1" events="18" subjects_affected="18" subjects_at_risk="864"/>
                <counts group_id="E2" events="5" subjects_affected="5" subjects_at_risk="796"/>
              </event>
              <event>
                <sub_title>ATRIOVENTRICULAR BLOCK COMPLETE</sub_title>
                <counts group_id="E1" events="157" subjects_affected="157" subjects_at_risk="864"/>
                <counts group_id="E2" events="44" subjects_affected="44" subjects_at_risk="796"/>
              </event>
              <event>
                <sub_title>ATRIOVENTRICULAR BLOCK FIRST DEGREE</sub_title>
                <counts group_id="E1" events="16" subjects_affected="16" subjects_at_risk="864"/>
                <counts group_id="E2" events="2" subjects_affected="2" subjects_at_risk="796"/>
              </event>
              <event>
                <sub_title>ATRIOVENTRICULAR BLOCK SECOND DEGREE</sub_title>
                <counts group_id="E1" events="18" subjects_affected="17" subjects_at_risk="864"/>
                <counts group_id="E2" events="6" subjects_affected="6" subjects_at_risk="796"/>
              </event>
              <event>
                <sub_title>ATRIOVENTRICULAR DISSOCIATION</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="864"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="796"/>
              </event>
              <event>
                <sub_title>BRADYARRHYTHMIA</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="864"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="796"/>
              </event>
              <event>
                <sub_title>BRADYCARDIA</sub_title>
                <counts group_id="E1" events="27" subjects_affected="27" subjects_at_risk="864"/>
                <counts group_id="E2" events="18" subjects_affected="17" subjects_at_risk="796"/>
              </event>
              <event>
                <sub_title>BUNDLE BRANCH BLOCK</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="864"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="796"/>
              </event>
              <event>
                <sub_title>BUNDLE BRANCH BLOCK LEFT</sub_title>
                <counts group_id="E1" events="58" subjects_affected="58" subjects_at_risk="864"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="796"/>
              </event>
              <event>
                <sub_title>BUNDLE BRANCH BLOCK RIGHT</sub_title>
                <counts group_id="E1" events="8" subjects_affected="7" subjects_at_risk="864"/>
                <counts group_id="E2" events="3" subjects_affected="3" subjects_at_risk="796"/>
              </event>
              <event>
                <sub_title>CARDIAC ARREST</sub_title>
                <counts group_id="E1" events="21" subjects_affected="21" subjects_at_risk="864"/>
                <counts group_id="E2" events="15" subjects_affected="15" subjects_at_risk="796"/>
              </event>
              <event>
                <sub_title>CARDIAC FAILURE</sub_title>
                <counts group_id="E1" events="28" subjects_affected="21" subjects_at_risk="864"/>
                <counts group_id="E2" events="27" subjects_affected="21" subjects_at_risk="796"/>
              </event>
              <event>
                <sub_title>CARDIAC FAILURE ACUTE</sub_title>
                <counts group_id="E1" events="11" subjects_affected="10" subjects_at_risk="864"/>
                <counts group_id="E2" events="6" subjects_affected="6" subjects_at_risk="796"/>
              </event>
              <event>
                <sub_title>CARDIAC FAILURE CHRONIC</sub_title>
                <counts group_id="E1" events="3" subjects_affected="3" subjects_at_risk="864"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="796"/>
              </event>
              <event>
                <sub_title>CARDIAC FAILURE CONGESTIVE</sub_title>
                <counts group_id="E1" events="104" subjects_affected="82" subjects_at_risk="864"/>
                <counts group_id="E2" events="74" subjects_affected="61" subjects_at_risk="796"/>
              </event>
              <event>
                <sub_title>CARDIAC PERFORATION</sub_title>
                <counts group_id="E1" events="13" subjects_affected="12" subjects_at_risk="864"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="796"/>
              </event>
              <event>
                <sub_title>CARDIAC SEPTAL HYPERTROPHY</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="864"/>
                <counts group_id="E2" events="2" subjects_affected="2" subjects_at_risk="796"/>
              </event>
              <event>
                <sub_title>CARDIAC TAMPONADE</sub_title>
                <counts group_id="E1" events="12" subjects_affected="12" subjects_at_risk="864"/>
                <counts group_id="E2" events="9" subjects_affected="9" subjects_at_risk="796"/>
              </event>
              <event>
                <sub_title>CARDIO-RESPIRATORY ARREST</sub_title>
                <counts group_id="E1" events="6" subjects_affected="6" subjects_at_risk="864"/>
                <counts group_id="E2" events="5" subjects_affected="5" subjects_at_risk="796"/>
              </event>
              <event>
                <sub_title>CARDIOGENIC SHOCK</sub_title>
                <counts group_id="E1" events="9" subjects_affected="9" subjects_at_risk="864"/>
                <counts group_id="E2" events="32" subjects_affected="32" subjects_at_risk="796"/>
              </event>
              <event>
                <sub_title>CARDIOMYOPATHY</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="864"/>
                <counts group_id="E2" events="3" subjects_affected="3" subjects_at_risk="796"/>
              </event>
              <event>
                <sub_title>CARDIORENAL SYNDROME</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="864"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="796"/>
              </event>
              <event>
                <sub_title>CARDIOVASCULAR DECONDITIONING</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="864"/>
                <counts group_id="E2" events="3" subjects_affected="3" subjects_at_risk="796"/>
              </event>
              <event>
                <sub_title>CHRONOTROPIC INCOMPETENCE</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="864"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="796"/>
              </event>
              <event>
                <sub_title>CONDUCTION DISORDER</sub_title>
                <counts group_id="E1" events="3" subjects_affected="3" subjects_at_risk="864"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="796"/>
              </event>
              <event>
                <sub_title>COR PULMONALE</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="864"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="796"/>
              </event>
              <event>
                <sub_title>CORONARY ARTERY DISEASE</sub_title>
                <counts group_id="E1" events="6" subjects_affected="6" subjects_at_risk="864"/>
                <counts group_id="E2" events="5" subjects_affected="5" subjects_at_risk="796"/>
              </event>
              <event>
                <sub_title>CORONARY ARTERY EMBOLISM</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="864"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="796"/>
              </event>
              <event>
                <sub_title>CORONARY ARTERY OCCLUSION</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="864"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="796"/>
              </event>
              <event>
                <sub_title>CORONARY ARTERY STENOSIS</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="864"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="796"/>
              </event>
              <event>
                <sub_title>CORONARY OSTIAL STENOSIS</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="864"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="796"/>
              </event>
              <event>
                <sub_title>DEFECT CONDUCTION INTRAVENTRICULAR</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="864"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="796"/>
              </event>
              <event>
                <sub_title>DIASTOLIC DYSFUNCTION</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="864"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="796"/>
              </event>
              <event>
                <sub_title>DRESSLER'S SYNDROME</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="864"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="796"/>
              </event>
              <event>
                <sub_title>EXTRASYSTOLES</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="864"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="796"/>
              </event>
              <event>
                <sub_title>INTRAPERICARDIAL THROMBOSIS</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="864"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="796"/>
              </event>
              <event>
                <sub_title>ISCHAEMIC CARDIOMYOPATHY</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="864"/>
                <counts group_id="E2" events="3" subjects_affected="3" subjects_at_risk="796"/>
              </event>
              <event>
                <sub_title>LEFT VENTRICULAR DYSFUNCTION</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="864"/>
                <counts group_id="E2" events="5" subjects_affected="5" subjects_at_risk="796"/>
              </event>
              <event>
                <sub_title>LEFT VENTRICULAR FAILURE</sub_title>
                <counts group_id="E1" events="3" subjects_affected="3" subjects_at_risk="864"/>
                <counts group_id="E2" events="4" subjects_affected="4" subjects_at_risk="796"/>
              </event>
              <event>
                <sub_title>LOW CARDIAC OUTPUT SYNDROME</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="864"/>
                <counts group_id="E2" events="4" subjects_affected="4" subjects_at_risk="796"/>
              </event>
              <event>
                <sub_title>MITRAL VALVE CALCIFICATION</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="864"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="796"/>
              </event>
              <event>
                <sub_title>MITRAL VALVE DISEASE MIXED</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="864"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="796"/>
              </event>
              <event>
                <sub_title>MITRAL VALVE INCOMPETENCE</sub_title>
                <counts group_id="E1" events="11" subjects_affected="10" subjects_at_risk="864"/>
                <counts group_id="E2" events="6" subjects_affected="6" subjects_at_risk="796"/>
              </event>
              <event>
                <sub_title>MITRAL VALVE STENOSIS</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="864"/>
                <counts group_id="E2" events="3" subjects_affected="3" subjects_at_risk="796"/>
              </event>
              <event>
                <sub_title>MYOCARDIAL INFARCTION</sub_title>
                <counts group_id="E1" events="4" subjects_affected="4" subjects_at_risk="864"/>
                <counts group_id="E2" events="4" subjects_affected="4" subjects_at_risk="796"/>
              </event>
              <event>
                <sub_title>MYOCARDIAL ISCHAEMIA</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="864"/>
                <counts group_id="E2" events="3" subjects_affected="3" subjects_at_risk="796"/>
              </event>
              <event>
                <sub_title>NODAL ARRHYTHMIA</sub_title>
                <counts group_id="E1" events="3" subjects_affected="3" subjects_at_risk="864"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="796"/>
              </event>
              <event>
                <sub_title>NODAL RHYTHM</sub_title>
                <counts group_id="E1" events="5" subjects_affected="5" subjects_at_risk="864"/>
                <counts group_id="E2" events="6" subjects_affected="6" subjects_at_risk="796"/>
              </event>
              <event>
                <sub_title>PALPITATIONS</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="864"/>
                <counts group_id="E2" events="3" subjects_affected="3" subjects_at_risk="796"/>
              </event>
              <event>
                <sub_title>PARAVALVULAR AORTIC REGURGITATION</sub_title>
                <counts group_id="E1" events="7" subjects_affected="7" subjects_at_risk="864"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="796"/>
              </event>
              <event>
                <sub_title>PAROXYSMAL ATRIOVENTRICULAR BLOCK</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="864"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="796"/>
              </event>
              <event>
                <sub_title>PERICARDIAL EFFUSION</sub_title>
                <counts group_id="E1" events="12" subjects_affected="12" subjects_at_risk="864"/>
                <counts group_id="E2" events="16" subjects_affected="15" subjects_at_risk="796"/>
              </event>
              <event>
                <sub_title>PERICARDIAL HAEMORRHAGE</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="864"/>
                <counts group_id="E2" events="2" subjects_affected="2" subjects_at_risk="796"/>
              </event>
              <event>
                <sub_title>PERICARDITIS</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="864"/>
                <counts group_id="E2" events="5" subjects_affected="5" subjects_at_risk="796"/>
              </event>
              <event>
                <sub_title>PROSTHETIC CARDIAC VALVE THROMBOSIS</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="864"/>
                <counts group_id="E2" events="3" subjects_affected="3" subjects_at_risk="796"/>
              </event>
              <event>
                <sub_title>PULMONARY VALVE INCOMPETENCE</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="864"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="796"/>
              </event>
              <event>
                <sub_title>PULSELESS ELECTRICAL ACTIVITY</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="864"/>
                <counts group_id="E2" events="3" subjects_affected="3" subjects_at_risk="796"/>
              </event>
              <event>
                <sub_title>RHYTHM IDIOVENTRICULAR</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="864"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="796"/>
              </event>
              <event>
                <sub_title>RIGHT VENTRICULAR DYSFUNCTION</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="864"/>
                <counts group_id="E2" events="2" subjects_affected="2" subjects_at_risk="796"/>
              </event>
              <event>
                <sub_title>RIGHT VENTRICULAR ENLARGEMENT</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="864"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="796"/>
              </event>
              <event>
                <sub_title>RIGHT VENTRICULAR FAILURE</sub_title>
                <counts group_id="E1" events="4" subjects_affected="4" subjects_at_risk="864"/>
                <counts group_id="E2" events="4" subjects_affected="4" subjects_at_risk="796"/>
              </event>
              <event>
                <sub_title>SINUS ARREST</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="864"/>
                <counts group_id="E2" events="2" subjects_affected="2" subjects_at_risk="796"/>
              </event>
              <event>
                <sub_title>SINUS BRADYCARDIA</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="864"/>
                <counts group_id="E2" events="3" subjects_affected="3" subjects_at_risk="796"/>
              </event>
              <event>
                <sub_title>SINUS NODE DYSFUNCTION</sub_title>
                <counts group_id="E1" events="9" subjects_affected="9" subjects_at_risk="864"/>
                <counts group_id="E2" events="10" subjects_affected="9" subjects_at_risk="796"/>
              </event>
              <event>
                <sub_title>SINUS TACHYCARDIA</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="864"/>
                <counts group_id="E2" events="3" subjects_affected="3" subjects_at_risk="796"/>
              </event>
              <event>
                <sub_title>SUPRAVENTRICULAR EXTRASYSTOLES</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="864"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="796"/>
              </event>
              <event>
                <sub_title>SUPRAVENTRICULAR TACHYCARDIA</sub_title>
                <counts group_id="E1" events="7" subjects_affected="7" subjects_at_risk="864"/>
                <counts group_id="E2" events="5" subjects_affected="5" subjects_at_risk="796"/>
              </event>
              <event>
                <sub_title>SYSTOLIC DYSFUNCTION</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="864"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="796"/>
              </event>
              <event>
                <sub_title>TACHYCARDIA</sub_title>
                <counts group_id="E1" events="6" subjects_affected="6" subjects_at_risk="864"/>
                <counts group_id="E2" events="3" subjects_affected="3" subjects_at_risk="796"/>
              </event>
              <event>
                <sub_title>TORSADE DE POINTES</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="864"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="796"/>
              </event>
              <event>
                <sub_title>TRICUSPID VALVE INCOMPETENCE</sub_title>
                <counts group_id="E1" events="8" subjects_affected="8" subjects_at_risk="864"/>
                <counts group_id="E2" events="12" subjects_affected="12" subjects_at_risk="796"/>
              </event>
              <event>
                <sub_title>TRIFASCICULAR BLOCK</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="864"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="796"/>
              </event>
              <event>
                <sub_title>VENTRICULAR ARRHYTHMIA</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="864"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="796"/>
              </event>
              <event>
                <sub_title>VENTRICULAR ASYSTOLE</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="864"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="796"/>
              </event>
              <event>
                <sub_title>VENTRICULAR EXTRASYSTOLES</sub_title>
                <counts group_id="E1" events="3" subjects_affected="3" subjects_at_risk="864"/>
                <counts group_id="E2" events="3" subjects_affected="3" subjects_at_risk="796"/>
              </event>
              <event>
                <sub_title>VENTRICULAR FIBRILLATION</sub_title>
                <counts group_id="E1" events="5" subjects_affected="5" subjects_at_risk="864"/>
                <counts group_id="E2" events="7" subjects_affected="7" subjects_at_risk="796"/>
              </event>
              <event>
                <sub_title>VENTRICULAR TACHYCARDIA</sub_title>
                <counts group_id="E1" events="17" subjects_affected="15" subjects_at_risk="864"/>
                <counts group_id="E2" events="16" subjects_affected="15" subjects_at_risk="796"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Congenital, familial and genetic disorders</title>
            <event_list>
              <event>
                <sub_title>HAEMOPHILIA</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="864"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="796"/>
              </event>
              <event>
                <sub_title>LEFT VENTRICLE OUTFLOW TRACT OBSTRUCTION</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="864"/>
                <counts group_id="E2" events="3" subjects_affected="3" subjects_at_risk="796"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Ear and labyrinth disorders</title>
            <event_list>
              <event>
                <sub_title>CERUMEN IMPACTION</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="864"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="796"/>
              </event>
              <event>
                <sub_title>MIDDLE EAR INFLAMMATION</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="864"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="796"/>
              </event>
              <event>
                <sub_title>VERTIGO</sub_title>
                <counts group_id="E1" events="3" subjects_affected="3" subjects_at_risk="864"/>
                <counts group_id="E2" events="2" subjects_affected="2" subjects_at_risk="796"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Endocrine disorders</title>
            <event_list>
              <event>
                <sub_title>GOITRE</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="864"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="796"/>
              </event>
              <event>
                <sub_title>HYPERPARATHYROIDISM PRIMARY</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="864"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="796"/>
              </event>
              <event>
                <sub_title>HYPOTHYROIDISM</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="864"/>
                <counts group_id="E2" events="2" subjects_affected="2" subjects_at_risk="796"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Eye disorders</title>
            <event_list>
              <event>
                <sub_title>AMAUROSIS FUGAX</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="864"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="796"/>
              </event>
              <event>
                <sub_title>CATARACT</sub_title>
                <counts group_id="E1" events="11" subjects_affected="10" subjects_at_risk="864"/>
                <counts group_id="E2" events="9" subjects_affected="7" subjects_at_risk="796"/>
              </event>
              <event>
                <sub_title>CATARACT NUCLEAR</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="864"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="796"/>
              </event>
              <event>
                <sub_title>CHARLES BONNET SYNDROME</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="864"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="796"/>
              </event>
              <event>
                <sub_title>CONJUNCTIVAL HAEMORRHAGE</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="864"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="796"/>
              </event>
              <event>
                <sub_title>DIABETIC RETINAL OEDEMA</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="864"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="796"/>
              </event>
              <event>
                <sub_title>DIPLOPIA</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="864"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="796"/>
              </event>
              <event>
                <sub_title>GLAUCOMA</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="864"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="796"/>
              </event>
              <event>
                <sub_title>MACULAR FIBROSIS</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="864"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="796"/>
              </event>
              <event>
                <sub_title>OPEN ANGLE GLAUCOMA</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="864"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="796"/>
              </event>
              <event>
                <sub_title>OPTIC ISCHAEMIC NEUROPATHY</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="864"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="796"/>
              </event>
              <event>
                <sub_title>RETINAL ARTERY OCCLUSION</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="864"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="796"/>
              </event>
              <event>
                <sub_title>RETINAL DETACHMENT</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="864"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="796"/>
              </event>
              <event>
                <sub_title>RETINAL VEIN OCCLUSION</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="864"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="796"/>
              </event>
              <event>
                <sub_title>VISION BLURRED</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="864"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="796"/>
              </event>
              <event>
                <sub_title>VISUAL IMPAIRMENT</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="864"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="796"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Gastrointestinal disorders</title>
            <event_list>
              <event>
                <sub_title>ABDOMINAL PAIN</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="864"/>
                <counts group_id="E2" events="4" subjects_affected="4" subjects_at_risk="796"/>
              </event>
              <event>
                <sub_title>ABDOMINAL PAIN LOWER</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="864"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="796"/>
              </event>
              <event>
                <sub_title>ABDOMINAL PAIN UPPER</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="864"/>
                <counts group_id="E2" events="3" subjects_affected="3" subjects_at_risk="796"/>
              </event>
              <event>
                <sub_title>ABDOMINAL WALL HAEMATOMA</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="864"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="796"/>
              </event>
              <event>
                <sub_title>ANAL INCONTINENCE</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="864"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="796"/>
              </event>
              <event>
                <sub_title>ASCITES</sub_title>
                <counts group_id="E1" events="3" subjects_affected="2" subjects_at_risk="864"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="796"/>
              </event>
              <event>
                <sub_title>COLITIS</sub_title>
                <counts group_id="E1" events="3" subjects_affected="3" subjects_at_risk="864"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="796"/>
              </event>
              <event>
                <sub_title>COLITIS ISCHAEMIC</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="864"/>
                <counts group_id="E2" events="2" subjects_affected="2" subjects_at_risk="796"/>
              </event>
              <event>
                <sub_title>CONSTIPATION</sub_title>
                <counts group_id="E1" events="4" subjects_affected="4" subjects_at_risk="864"/>
                <counts group_id="E2" events="4" subjects_affected="3" subjects_at_risk="796"/>
              </event>
              <event>
                <sub_title>DIARRHOEA</sub_title>
                <counts group_id="E1" events="3" subjects_affected="3" subjects_at_risk="864"/>
                <counts group_id="E2" events="7" subjects_affected="7" subjects_at_risk="796"/>
              </event>
              <event>
                <sub_title>DIVERTICULAR PERFORATION</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="864"/>
                <counts group_id="E2" events="2" subjects_affected="2" subjects_at_risk="796"/>
              </event>
              <event>
                <sub_title>DIVERTICULUM</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="864"/>
                <counts group_id="E2" events="4" subjects_affected="4" subjects_at_risk="796"/>
              </event>
              <event>
                <sub_title>DIVERTICULUM INTESTINAL HAEMORRHAGIC</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="864"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="796"/>
              </event>
              <event>
                <sub_title>DUODENAL ULCER</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="864"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="796"/>
              </event>
              <event>
                <sub_title>DUODENAL ULCER PERFORATION</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="864"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="796"/>
              </event>
              <event>
                <sub_title>DYSKINESIA OESOPHAGEAL</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="864"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="796"/>
              </event>
              <event>
                <sub_title>DYSPEPSIA</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="864"/>
                <counts group_id="E2" events="2" subjects_affected="2" subjects_at_risk="796"/>
              </event>
              <event>
                <sub_title>DYSPHAGIA</sub_title>
                <counts group_id="E1" events="10" subjects_affected="10" subjects_at_risk="864"/>
                <counts group_id="E2" events="22" subjects_affected="22" subjects_at_risk="796"/>
              </event>
              <event>
                <sub_title>FAECALOMA</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="864"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="796"/>
              </event>
              <event>
                <sub_title>FLATULENCE</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="864"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="796"/>
              </event>
              <event>
                <sub_title>GASTRIC ULCER</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="864"/>
                <counts group_id="E2" events="2" subjects_affected="2" subjects_at_risk="796"/>
              </event>
              <event>
                <sub_title>GASTRIC ULCER HAEMORRHAGE</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="864"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="796"/>
              </event>
              <event>
                <sub_title>GASTRITIS</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="864"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="796"/>
              </event>
              <event>
                <sub_title>GASTRITIS EROSIVE</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="864"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="796"/>
              </event>
              <event>
                <sub_title>GASTROINTESTINAL HAEMORRHAGE</sub_title>
                <counts group_id="E1" events="28" subjects_affected="24" subjects_at_risk="864"/>
                <counts group_id="E2" events="34" subjects_affected="28" subjects_at_risk="796"/>
              </event>
              <event>
                <sub_title>GASTROINTESTINAL ULCER</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="864"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="796"/>
              </event>
              <event>
                <sub_title>GINGIVAL PAIN</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="864"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="796"/>
              </event>
              <event>
                <sub_title>HAEMATEMESIS</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="864"/>
                <counts group_id="E2" events="3" subjects_affected="3" subjects_at_risk="796"/>
              </event>
              <event>
                <sub_title>HAEMATOCHEZIA</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="864"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="796"/>
              </event>
              <event>
                <sub_title>HAEMORRHOIDS</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="864"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="796"/>
              </event>
              <event>
                <sub_title>HIATUS HERNIA</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="864"/>
                <counts group_id="E2" events="2" subjects_affected="2" subjects_at_risk="796"/>
              </event>
              <event>
                <sub_title>ILEUS</sub_title>
                <counts group_id="E1" events="4" subjects_affected="4" subjects_at_risk="864"/>
                <counts group_id="E2" events="4" subjects_affected="4" subjects_at_risk="796"/>
              </event>
              <event>
                <sub_title>ILEUS PARALYTIC</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="864"/>
                <counts group_id="E2" events="2" subjects_affected="2" subjects_at_risk="796"/>
              </event>
              <event>
                <sub_title>INCARCERATED INGUINAL HERNIA</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="864"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="796"/>
              </event>
              <event>
                <sub_title>INCARCERATED UMBILICAL HERNIA</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="864"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="796"/>
              </event>
              <event>
                <sub_title>INGUINAL HERNIA</sub_title>
                <counts group_id="E1" events="4" subjects_affected="4" subjects_at_risk="864"/>
                <counts group_id="E2" events="3" subjects_affected="3" subjects_at_risk="796"/>
              </event>
              <event>
                <sub_title>INTESTINAL ISCHAEMIA</sub_title>
                <counts group_id="E1" events="3" subjects_affected="2" subjects_at_risk="864"/>
                <counts group_id="E2" events="2" subjects_affected="2" subjects_at_risk="796"/>
              </event>
              <event>
                <sub_title>INTESTINAL MASS</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="864"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="796"/>
              </event>
              <event>
                <sub_title>INTESTINAL OBSTRUCTION</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="864"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="796"/>
              </event>
              <event>
                <sub_title>LARGE INTESTINAL STENOSIS</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="864"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="796"/>
              </event>
              <event>
                <sub_title>LARGE INTESTINE PERFORATION</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="864"/>
                <counts group_id="E2" events="2" subjects_affected="2" subjects_at_risk="796"/>
              </event>
              <event>
                <sub_title>LARGE INTESTINE POLYP</sub_title>
                <counts group_id="E1" events="4" subjects_affected="3" subjects_at_risk="864"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="796"/>
              </event>
              <event>
                <sub_title>LOOSE TOOTH</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="864"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="796"/>
              </event>
              <event>
                <sub_title>LOWER GASTROINTESTINAL HAEMORRHAGE</sub_title>
                <counts group_id="E1" events="7" subjects_affected="6" subjects_at_risk="864"/>
                <counts group_id="E2" events="3" subjects_affected="3" subjects_at_risk="796"/>
              </event>
              <event>
                <sub_title>MELAENA</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="864"/>
                <counts group_id="E2" events="4" subjects_affected="4" subjects_at_risk="796"/>
              </event>
              <event>
                <sub_title>MESENTERIC ARTERY STENOSIS</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="864"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="796"/>
              </event>
              <event>
                <sub_title>NAUSEA</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="864"/>
                <counts group_id="E2" events="2" subjects_affected="2" subjects_at_risk="796"/>
              </event>
              <event>
                <sub_title>ODYNOPHAGIA</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="864"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="796"/>
              </event>
              <event>
                <sub_title>OESOPHAGEAL DISORDER</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="864"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="796"/>
              </event>
              <event>
                <sub_title>OESOPHAGEAL PERFORATION</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="864"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="796"/>
              </event>
              <event>
                <sub_title>OESOPHAGEAL RUPTURE</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="864"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="796"/>
              </event>
              <event>
                <sub_title>OESOPHAGEAL STENOSIS</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="864"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="796"/>
              </event>
              <event>
                <sub_title>PANCREATITIS</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="864"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="796"/>
              </event>
              <event>
                <sub_title>PERITONEAL HAEMORRHAGE</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="864"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="796"/>
              </event>
              <event>
                <sub_title>PERITONEAL LESION</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="864"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="796"/>
              </event>
              <event>
                <sub_title>PNEUMOPERITONEUM</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="864"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="796"/>
              </event>
              <event>
                <sub_title>RECTAL HAEMORRHAGE</sub_title>
                <counts group_id="E1" events="4" subjects_affected="4" subjects_at_risk="864"/>
                <counts group_id="E2" events="4" subjects_affected="4" subjects_at_risk="796"/>
              </event>
              <event>
                <sub_title>RECTAL PROLAPSE</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="864"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="796"/>
              </event>
              <event>
                <sub_title>RECTOURETHRAL FISTULA</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="864"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="796"/>
              </event>
              <event>
                <sub_title>RETROPERITONEAL HAEMATOMA</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="864"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="796"/>
              </event>
              <event>
                <sub_title>RETROPERITONEAL HAEMORRHAGE</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="864"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="796"/>
              </event>
              <event>
                <sub_title>SALIVARY GLAND MASS</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="864"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="796"/>
              </event>
              <event>
                <sub_title>SMALL INTESTINAL OBSTRUCTION</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="864"/>
                <counts group_id="E2" events="3" subjects_affected="3" subjects_at_risk="796"/>
              </event>
              <event>
                <sub_title>SWOLLEN TONGUE</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="864"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="796"/>
              </event>
              <event>
                <sub_title>UMBILICAL HERNIA</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="864"/>
                <counts group_id="E2" events="3" subjects_affected="3" subjects_at_risk="796"/>
              </event>
              <event>
                <sub_title>UPPER GASTROINTESTINAL HAEMORRHAGE</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="864"/>
                <counts group_id="E2" events="4" subjects_affected="4" subjects_at_risk="796"/>
              </event>
              <event>
                <sub_title>VOLVULUS</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="864"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="796"/>
              </event>
              <event>
                <sub_title>VOMITING</sub_title>
                <counts group_id="E1" events="3" subjects_affected="3" subjects_at_risk="864"/>
                <counts group_id="E2" events="4" subjects_affected="4" subjects_at_risk="796"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>General disorders</title>
            <event_list>
              <event>
                <sub_title>ADVERSE DRUG REACTION</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="864"/>
                <counts group_id="E2" events="2" subjects_affected="2" subjects_at_risk="796"/>
              </event>
              <event>
                <sub_title>ASTHENIA</sub_title>
                <counts group_id="E1" events="9" subjects_affected="9" subjects_at_risk="864"/>
                <counts group_id="E2" events="9" subjects_affected="7" subjects_at_risk="796"/>
              </event>
              <event>
                <sub_title>CATHETER SITE DISCHARGE</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="864"/>
                <counts group_id="E2" events="2" subjects_affected="2" subjects_at_risk="796"/>
              </event>
              <event>
                <sub_title>CATHETER SITE HAEMATOMA</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="864"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="796"/>
              </event>
              <event>
                <sub_title>CATHETER SITE HAEMORRHAGE</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="864"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="796"/>
              </event>
              <event>
                <sub_title>CHEST DISCOMFORT</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="864"/>
                <counts group_id="E2" events="2" subjects_affected="2" subjects_at_risk="796"/>
              </event>
              <event>
                <sub_title>CHEST PAIN</sub_title>
                <counts group_id="E1" events="20" subjects_affected="18" subjects_at_risk="864"/>
                <counts group_id="E2" events="18" subjects_affected="17" subjects_at_risk="796"/>
              </event>
              <event>
                <sub_title>COMPLICATION ASSOCIATED WITH DEVICE</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="864"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="796"/>
              </event>
              <event>
                <sub_title>COMPLICATION OF DEVICE INSERTION</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="864"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="796"/>
              </event>
              <event>
                <sub_title>DEATH</sub_title>
                <counts group_id="E1" events="5" subjects_affected="5" subjects_at_risk="864"/>
                <counts group_id="E2" events="4" subjects_affected="4" subjects_at_risk="796"/>
              </event>
              <event>
                <sub_title>DEVICE EMBOLISATION</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="864"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="796"/>
              </event>
              <event>
                <sub_title>DRUG WITHDRAWAL SYNDROME</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="864"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="796"/>
              </event>
              <event>
                <sub_title>EFFUSION</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="864"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="796"/>
              </event>
              <event>
                <sub_title>FATIGUE</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="864"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="796"/>
              </event>
              <event>
                <sub_title>GAIT DISTURBANCE</sub_title>
                <counts group_id="E1" events="4" subjects_affected="4" subjects_at_risk="864"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="796"/>
              </event>
              <event>
                <sub_title>GENERALISED OEDEMA</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="864"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="796"/>
              </event>
              <event>
                <sub_title>HERNIA</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="864"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="796"/>
              </event>
              <event>
                <sub_title>HYPOTHERMIA</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="864"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="796"/>
              </event>
              <event>
                <sub_title>IMPAIRED HEALING</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="864"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="796"/>
              </event>
              <event>
                <sub_title>IMPLANT SITE DISCHARGE</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="864"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="796"/>
              </event>
              <event>
                <sub_title>IMPLANT SITE EROSION</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="864"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="796"/>
              </event>
              <event>
                <sub_title>MALAISE</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="864"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="796"/>
              </event>
              <event>
                <sub_title>MULTIPLE ORGAN DYSFUNCTION SYNDROME</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="864"/>
                <counts group_id="E2" events="5" subjects_affected="5" subjects_at_risk="796"/>
              </event>
              <event>
                <sub_title>NON-CARDIAC CHEST PAIN</sub_title>
                <counts group_id="E1" events="7" subjects_affected="7" subjects_at_risk="864"/>
                <counts group_id="E2" events="13" subjects_affected="12" subjects_at_risk="796"/>
              </event>
              <event>
                <sub_title>OEDEMA PERIPHERAL</sub_title>
                <counts group_id="E1" events="4" subjects_affected="4" subjects_at_risk="864"/>
                <counts group_id="E2" events="12" subjects_affected="11" subjects_at_risk="796"/>
              </event>
              <event>
                <sub_title>PERIPHERAL SWELLING</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="864"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="796"/>
              </event>
              <event>
                <sub_title>POLYP</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="864"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="796"/>
              </event>
              <event>
                <sub_title>PUNCTURE SITE HAEMORRHAGE</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="864"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="796"/>
              </event>
              <event>
                <sub_title>PYREXIA</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="864"/>
                <counts group_id="E2" events="8" subjects_affected="8" subjects_at_risk="796"/>
              </event>
              <event>
                <sub_title>SUDDEN CARDIAC DEATH</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="864"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="796"/>
              </event>
              <event>
                <sub_title>SUDDEN DEATH</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="864"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="796"/>
              </event>
              <event>
                <sub_title>SYSTEMIC INFLAMMATORY RESPONSE SYNDROME</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="864"/>
                <counts group_id="E2" events="6" subjects_affected="6" subjects_at_risk="796"/>
              </event>
              <event>
                <sub_title>ULCER HAEMORRHAGE</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="864"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="796"/>
              </event>
              <event>
                <sub_title>VASCULAR STENT STENOSIS</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="864"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="796"/>
              </event>
              <event>
                <sub_title>VASCULAR STENT THROMBOSIS</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="864"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="796"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Hepatobiliary disorders</title>
            <event_list>
              <event>
                <sub_title>ACUTE HEPATIC FAILURE</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="864"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="796"/>
              </event>
              <event>
                <sub_title>BILIARY COLIC</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="864"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="796"/>
              </event>
              <event>
                <sub_title>CHOLANGITIS</sub_title>
                <counts group_id="E1" events="3" subjects_affected="3" subjects_at_risk="864"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="796"/>
              </event>
              <event>
                <sub_title>CHOLANGITIS ACUTE</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="864"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="796"/>
              </event>
              <event>
                <sub_title>CHOLECYSTITIS</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="864"/>
                <counts group_id="E2" events="4" subjects_affected="4" subjects_at_risk="796"/>
              </event>
              <event>
                <sub_title>CHOLECYSTITIS ACUTE</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="864"/>
                <counts group_id="E2" events="2" subjects_affected="2" subjects_at_risk="796"/>
              </event>
              <event>
                <sub_title>CHOLELITHIASIS</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="864"/>
                <counts group_id="E2" events="5" subjects_affected="5" subjects_at_risk="796"/>
              </event>
              <event>
                <sub_title>CHRONIC HEPATIC FAILURE</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="864"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="796"/>
              </event>
              <event>
                <sub_title>GALLBLADDER DISORDER</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="864"/>
                <counts group_id="E2" events="2" subjects_affected="2" subjects_at_risk="796"/>
              </event>
              <event>
                <sub_title>HEPATIC CIRRHOSIS</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="864"/>
                <counts group_id="E2" events="2" subjects_affected="2" subjects_at_risk="796"/>
              </event>
              <event>
                <sub_title>HEPATIC FAILURE</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="864"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="796"/>
              </event>
              <event>
                <sub_title>ISCHAEMIC HEPATITIS</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="864"/>
                <counts group_id="E2" events="2" subjects_affected="2" subjects_at_risk="796"/>
              </event>
              <event>
                <sub_title>LIVER DISORDER</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="864"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="796"/>
              </event>
              <event>
                <sub_title>LIVER INJURY</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="864"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="796"/>
              </event>
              <event>
                <sub_title>PORTAL VEIN THROMBOSIS</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="864"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="796"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Immune system disorders</title>
            <event_list>
              <event>
                <sub_title>ANAPHYLACTIC REACTION</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="864"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="796"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Infections and infestations</title>
            <event_list>
              <event>
                <sub_title>ABDOMINAL ABSCESS</sub_title>
                <counts group_id="E1" events="2" subjects_affected="1" subjects_at_risk="864"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="796"/>
              </event>
              <event>
                <sub_title>ABSCESS JAW</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="864"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="796"/>
              </event>
              <event>
                <sub_title>APPENDICITIS</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="864"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="796"/>
              </event>
              <event>
                <sub_title>APPENDICITIS PERFORATED</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="864"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="796"/>
              </event>
              <event>
                <sub_title>ARTHRITIS INFECTIVE</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="864"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="796"/>
              </event>
              <event>
                <sub_title>BACTERAEMIA</sub_title>
                <counts group_id="E1" events="13" subjects_affected="12" subjects_at_risk="864"/>
                <counts group_id="E2" events="4" subjects_affected="4" subjects_at_risk="796"/>
              </event>
              <event>
                <sub_title>BACTERIAL INFECTION</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="864"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="796"/>
              </event>
              <event>
                <sub_title>BACTERIAL SEPSIS</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="864"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="796"/>
              </event>
              <event>
                <sub_title>BRONCHITIS</sub_title>
                <counts group_id="E1" events="6" subjects_affected="6" subjects_at_risk="864"/>
                <counts group_id="E2" events="5" subjects_affected="5" subjects_at_risk="796"/>
              </event>
              <event>
                <sub_title>CAMPYLOBACTER SEPSIS</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="864"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="796"/>
              </event>
              <event>
                <sub_title>CARDIAC VALVE ABSCESS</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="864"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="796"/>
              </event>
              <event>
                <sub_title>CATHETER SITE CELLULITIS</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="864"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="796"/>
              </event>
              <event>
                <sub_title>CELLULITIS</sub_title>
                <counts group_id="E1" events="17" subjects_affected="16" subjects_at_risk="864"/>
                <counts group_id="E2" events="15" subjects_affected="15" subjects_at_risk="796"/>
              </event>
              <event>
                <sub_title>CLOSTRIDIUM DIFFICILE INFECTION</sub_title>
                <counts group_id="E1" events="3" subjects_affected="3" subjects_at_risk="864"/>
                <counts group_id="E2" events="5" subjects_affected="5" subjects_at_risk="796"/>
              </event>
              <event>
                <sub_title>CYSTITIS</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="864"/>
                <counts group_id="E2" events="2" subjects_affected="2" subjects_at_risk="796"/>
              </event>
              <event>
                <sub_title>CYTOMEGALOVIRUS VIRAEMIA</sub_title>
                <counts group_id="E1" events="2" subjects_affected="1" subjects_at_risk="864"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="796"/>
              </event>
              <event>
                <sub_title>DEVICE RELATED INFECTION</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="864"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="796"/>
              </event>
              <event>
                <sub_title>DEVICE RELATED SEPSIS</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="864"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="796"/>
              </event>
              <event>
                <sub_title>DIVERTICULITIS</sub_title>
                <counts group_id="E1" events="4" subjects_affected="4" subjects_at_risk="864"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="796"/>
              </event>
              <event>
                <sub_title>EMPYEMA</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="864"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="796"/>
              </event>
              <event>
                <sub_title>ENCEPHALITIS</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="864"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="796"/>
              </event>
              <event>
                <sub_title>ENCEPHALITIS VIRAL</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="864"/>
                <counts group_id="E2" events="2" subjects_affected="2" subjects_at_risk="796"/>
              </event>
              <event>
                <sub_title>ENDOCARDITIS</sub_title>
                <counts group_id="E1" events="6" subjects_affected="6" subjects_at_risk="864"/>
                <counts group_id="E2" events="8" subjects_affected="8" subjects_at_risk="796"/>
              </event>
              <event>
                <sub_title>ENDOCARDITIS BACTERIAL</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="864"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="796"/>
              </event>
              <event>
                <sub_title>ENTEROBACTER SEPSIS</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="864"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="796"/>
              </event>
              <event>
                <sub_title>ENTEROCOCCAL BACTERAEMIA</sub_title>
                <counts group_id="E1" events="4" subjects_affected="3" subjects_at_risk="864"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="796"/>
              </event>
              <event>
                <sub_title>ENTEROCOCCAL SEPSIS</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="864"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="796"/>
              </event>
              <event>
                <sub_title>EPIDIDYMITIS</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="864"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="796"/>
              </event>
              <event>
                <sub_title>ESCHERICHIA BACTERAEMIA</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="864"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="796"/>
              </event>
              <event>
                <sub_title>ESCHERICHIA SEPSIS</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="864"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="796"/>
              </event>
              <event>
                <sub_title>ESCHERICHIA URINARY TRACT INFECTION</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="864"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="796"/>
              </event>
              <event>
                <sub_title>FUNGAL OESOPHAGITIS</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="864"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="796"/>
              </event>
              <event>
                <sub_title>GANGRENE</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="864"/>
                <counts group_id="E2" events="3" subjects_affected="3" subjects_at_risk="796"/>
              </event>
              <event>
                <sub_title>GASTROENTERITIS</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="864"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="796"/>
              </event>
              <event>
                <sub_title>GASTROENTERITIS VIRAL</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="864"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="796"/>
              </event>
              <event>
                <sub_title>GASTROINTESTINAL INFECTION</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="864"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="796"/>
              </event>
              <event>
                <sub_title>GASTROINTESTINAL VIRAL INFECTION</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="864"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="796"/>
              </event>
              <event>
                <sub_title>GROIN INFECTION</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="864"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="796"/>
              </event>
              <event>
                <sub_title>HAEMOPHILUS SEPSIS</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="864"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="796"/>
              </event>
              <event>
                <sub_title>HELICOBACTER INFECTION</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="864"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="796"/>
              </event>
              <event>
                <sub_title>HERPES ZOSTER</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="864"/>
                <counts group_id="E2" events="2" subjects_affected="2" subjects_at_risk="796"/>
              </event>
              <event>
                <sub_title>INCISION SITE CELLULITIS</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="864"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="796"/>
              </event>
              <event>
                <sub_title>INFECTED SEROMA</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="864"/>
                <counts group_id="E2" events="2" subjects_affected="1" subjects_at_risk="796"/>
              </event>
              <event>
                <sub_title>INFECTION</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="864"/>
                <counts group_id="E2" events="3" subjects_affected="3" subjects_at_risk="796"/>
              </event>
              <event>
                <sub_title>INFECTIOUS PLEURAL EFFUSION</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="864"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="796"/>
              </event>
              <event>
                <sub_title>INFLUENZA</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="864"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="796"/>
              </event>
              <event>
                <sub_title>INTERVERTEBRAL DISCITIS</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="864"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="796"/>
              </event>
              <event>
                <sub_title>LABYRINTHITIS</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="864"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="796"/>
              </event>
              <event>
                <sub_title>LARYNGITIS</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="864"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="796"/>
              </event>
              <event>
                <sub_title>LIVER ABSCESS</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="864"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="796"/>
              </event>
              <event>
                <sub_title>LOCALISED INFECTION</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="864"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="796"/>
              </event>
              <event>
                <sub_title>LUNG INFECTION</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="864"/>
                <counts group_id="E2" events="2" subjects_affected="2" subjects_at_risk="796"/>
              </event>
              <event>
                <sub_title>LYME DISEASE</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="864"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="796"/>
              </event>
              <event>
                <sub_title>MEDIASTINITIS</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="864"/>
                <counts group_id="E2" events="2" subjects_affected="2" subjects_at_risk="796"/>
              </event>
              <event>
                <sub_title>NASAL ABSCESS</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="864"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="796"/>
              </event>
              <event>
                <sub_title>ORCHITIS</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="864"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="796"/>
              </event>
              <event>
                <sub_title>OSTEOMYELITIS</sub_title>
                <counts group_id="E1" events="3" subjects_affected="3" subjects_at_risk="864"/>
                <counts group_id="E2" events="7" subjects_affected="4" subjects_at_risk="796"/>
              </event>
              <event>
                <sub_title>OSTEOMYELITIS ACUTE</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="864"/>
                <counts group_id="E2" events="3" subjects_affected="2" subjects_at_risk="796"/>
              </event>
              <event>
                <sub_title>PERITONITIS</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="864"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="796"/>
              </event>
              <event>
                <sub_title>PNEUMONIA</sub_title>
                <counts group_id="E1" events="65" subjects_affected="58" subjects_at_risk="864"/>
                <counts group_id="E2" events="60" subjects_affected="55" subjects_at_risk="796"/>
              </event>
              <event>
                <sub_title>PNEUMONIA BACTERIAL</sub_title>
                <counts group_id="E1" events="5" subjects_affected="4" subjects_at_risk="864"/>
                <counts group_id="E2" events="2" subjects_affected="2" subjects_at_risk="796"/>
              </event>
              <event>
                <sub_title>PNEUMONIA CYTOMEGALOVIRAL</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="864"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="796"/>
              </event>
              <event>
                <sub_title>PNEUMONIA HAEMOPHILUS</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="864"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="796"/>
              </event>
              <event>
                <sub_title>PNEUMONIA KLEBSIELLA</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="864"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="796"/>
              </event>
              <event>
                <sub_title>POST PROCEDURAL PNEUMONIA</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="864"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="796"/>
              </event>
              <event>
                <sub_title>POSTOPERATIVE WOUND INFECTION</sub_title>
                <counts group_id="E1" events="6" subjects_affected="6" subjects_at_risk="864"/>
                <counts group_id="E2" events="19" subjects_affected="13" subjects_at_risk="796"/>
              </event>
              <event>
                <sub_title>PSEUDOMONAL BACTERAEMIA</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="864"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="796"/>
              </event>
              <event>
                <sub_title>PSEUDOMONAS INFECTION</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="864"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="796"/>
              </event>
              <event>
                <sub_title>PULMONARY SEPSIS</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="864"/>
                <counts group_id="E2" events="2" subjects_affected="2" subjects_at_risk="796"/>
              </event>
              <event>
                <sub_title>PYELONEPHRITIS</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="864"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="796"/>
              </event>
              <event>
                <sub_title>PYELONEPHRITIS ACUTE</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="864"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="796"/>
              </event>
              <event>
                <sub_title>RESPIRATORY SYNCYTIAL VIRUS BRONCHITIS</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="864"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="796"/>
              </event>
              <event>
                <sub_title>RESPIRATORY SYNCYTIAL VIRUS INFECTION</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="864"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="796"/>
              </event>
              <event>
                <sub_title>RESPIRATORY TRACT INFECTION</sub_title>
                <counts group_id="E1" events="3" subjects_affected="3" subjects_at_risk="864"/>
                <counts group_id="E2" events="5" subjects_affected="5" subjects_at_risk="796"/>
              </event>
              <event>
                <sub_title>SALMONELLA BACTERAEMIA</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="864"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="796"/>
              </event>
              <event>
                <sub_title>SEPSIS</sub_title>
                <counts group_id="E1" events="28" subjects_affected="24" subjects_at_risk="864"/>
                <counts group_id="E2" events="25" subjects_affected="24" subjects_at_risk="796"/>
              </event>
              <event>
                <sub_title>SEPTIC ENCEPHALOPATHY</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="864"/>
                <counts group_id="E2" events="2" subjects_affected="2" subjects_at_risk="796"/>
              </event>
              <event>
                <sub_title>SEPTIC SHOCK</sub_title>
                <counts group_id="E1" events="5" subjects_affected="5" subjects_at_risk="864"/>
                <counts group_id="E2" events="6" subjects_affected="5" subjects_at_risk="796"/>
              </event>
              <event>
                <sub_title>SINUSITIS</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="864"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="796"/>
              </event>
              <event>
                <sub_title>SKIN CANDIDA</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="864"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="796"/>
              </event>
              <event>
                <sub_title>SPINAL CORD INFECTION</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="864"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="796"/>
              </event>
              <event>
                <sub_title>STAPHYLOCOCCAL BACTERAEMIA</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="864"/>
                <counts group_id="E2" events="2" subjects_affected="2" subjects_at_risk="796"/>
              </event>
              <event>
                <sub_title>STAPHYLOCOCCAL SEPSIS</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="864"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="796"/>
              </event>
              <event>
                <sub_title>STREPTOCOCCAL BACTERAEMIA</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="864"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="796"/>
              </event>
              <event>
                <sub_title>SUBCUTANEOUS ABSCESS</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="864"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="796"/>
              </event>
              <event>
                <sub_title>TOOTH ABSCESS</sub_title>
                <counts group_id="E1" events="3" subjects_affected="2" subjects_at_risk="864"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="796"/>
              </event>
              <event>
                <sub_title>TRACHEOBRONCHITIS</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="864"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="796"/>
              </event>
              <event>
                <sub_title>UPPER RESPIRATORY TRACT INFECTION</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="864"/>
                <counts group_id="E2" events="2" subjects_affected="2" subjects_at_risk="796"/>
              </event>
              <event>
                <sub_title>URINARY TRACT INFECTION</sub_title>
                <counts group_id="E1" events="41" subjects_affected="33" subjects_at_risk="864"/>
                <counts group_id="E2" events="26" subjects_affected="25" subjects_at_risk="796"/>
              </event>
              <event>
                <sub_title>URINARY TRACT INFECTION BACTERIAL</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="864"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="796"/>
              </event>
              <event>
                <sub_title>UROSEPSIS</sub_title>
                <counts group_id="E1" events="10" subjects_affected="8" subjects_at_risk="864"/>
                <counts group_id="E2" events="12" subjects_affected="12" subjects_at_risk="796"/>
              </event>
              <event>
                <sub_title>VASCULAR ACCESS SITE INFECTION</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="864"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="796"/>
              </event>
              <event>
                <sub_title>VIRAL CARDIOMYOPATHY</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="864"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="796"/>
              </event>
              <event>
                <sub_title>VIRAL INFECTION</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="864"/>
                <counts group_id="E2" events="2" subjects_affected="2" subjects_at_risk="796"/>
              </event>
              <event>
                <sub_title>WOUND INFECTION</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="864"/>
                <counts group_id="E2" events="4" subjects_affected="4" subjects_at_risk="796"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Injury, poisoning and procedural complications</title>
            <event_list>
              <event>
                <sub_title>ABDOMINAL INJURY</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="864"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="796"/>
              </event>
              <event>
                <sub_title>ACCIDENTAL OVERDOSE</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="864"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="796"/>
              </event>
              <event>
                <sub_title>ALCOHOL POISONING</sub_title>
                <counts group_id="E1" events="2" subjects_affected="1" subjects_at_risk="864"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="796"/>
              </event>
              <event>
                <sub_title>ALLERGIC TRANSFUSION REACTION</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="864"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="796"/>
              </event>
              <event>
                <sub_title>ANAEMIA POSTOPERATIVE</sub_title>
                <counts group_id="E1" events="17" subjects_affected="17" subjects_at_risk="864"/>
                <counts group_id="E2" events="36" subjects_affected="36" subjects_at_risk="796"/>
              </event>
              <event>
                <sub_title>ANASTOMOTIC HAEMORRHAGE</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="864"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="796"/>
              </event>
              <event>
                <sub_title>ANKLE FRACTURE</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="864"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="796"/>
              </event>
              <event>
                <sub_title>AORTIC INJURY</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="864"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="796"/>
              </event>
              <event>
                <sub_title>ARTERIAL BYPASS OCCLUSION</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="864"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="796"/>
              </event>
              <event>
                <sub_title>ARTERIAL INJURY</sub_title>
                <counts group_id="E1" events="6" subjects_affected="6" subjects_at_risk="864"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="796"/>
              </event>
              <event>
                <sub_title>BRACHIAL PLEXUS INJURY</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="864"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="796"/>
              </event>
              <event>
                <sub_title>CARBON MONOXIDE POISONING</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="864"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="796"/>
              </event>
              <event>
                <sub_title>CARDIAC VALVE RUPTURE</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="864"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="796"/>
              </event>
              <event>
                <sub_title>CARDIAC VEIN PERFORATION</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="864"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="796"/>
              </event>
              <event>
                <sub_title>CERVICAL VERTEBRAL FRACTURE</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="864"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="796"/>
              </event>
              <event>
                <sub_title>CLAVICLE FRACTURE</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="864"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="796"/>
              </event>
              <event>
                <sub_title>COMPLICATIONS OF TRANSPLANTED HEART</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="864"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="796"/>
              </event>
              <event>
                <sub_title>COMPRESSION FRACTURE</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="864"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="796"/>
              </event>
              <event>
                <sub_title>CONTUSION</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="864"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="796"/>
              </event>
              <event>
                <sub_title>CORNEAL ABRASION</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="864"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="796"/>
              </event>
              <event>
                <sub_title>DEVICE DEPLOYMENT ISSUE</sub_title>
                <counts group_id="E1" events="25" subjects_affected="24" subjects_at_risk="864"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="796"/>
              </event>
              <event>
                <sub_title>EXTRADURAL HAEMATOMA</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="864"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="796"/>
              </event>
              <event>
                <sub_title>FACIAL BONES FRACTURE</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="864"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="796"/>
              </event>
              <event>
                <sub_title>FALL</sub_title>
                <counts group_id="E1" events="14" subjects_affected="13" subjects_at_risk="864"/>
                <counts group_id="E2" events="9" subjects_affected="9" subjects_at_risk="796"/>
              </event>
              <event>
                <sub_title>FEMORAL NECK FRACTURE</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="864"/>
                <counts group_id="E2" events="3" subjects_affected="3" subjects_at_risk="796"/>
              </event>
              <event>
                <sub_title>FEMUR FRACTURE</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="864"/>
                <counts group_id="E2" events="3" subjects_affected="3" subjects_at_risk="796"/>
              </event>
              <event>
                <sub_title>FIBULA FRACTURE</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="864"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="796"/>
              </event>
              <event>
                <sub_title>FOREARM FRACTURE</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="864"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="796"/>
              </event>
              <event>
                <sub_title>FOREIGN BODY IN EAR</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="864"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="796"/>
              </event>
              <event>
                <sub_title>HAEMODILUTION</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="864"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="796"/>
              </event>
              <event>
                <sub_title>HAND FRACTURE</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="864"/>
                <counts group_id="E2" events="2" subjects_affected="2" subjects_at_risk="796"/>
              </event>
              <event>
                <sub_title>HEAD INJURY</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="864"/>
                <counts group_id="E2" events="2" subjects_affected="2" subjects_at_risk="796"/>
              </event>
              <event>
                <sub_title>HEART INJURY</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="864"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="796"/>
              </event>
              <event>
                <sub_title>HIP FRACTURE</sub_title>
                <counts group_id="E1" events="11" subjects_affected="11" subjects_at_risk="864"/>
                <counts group_id="E2" events="10" subjects_affected="10" subjects_at_risk="796"/>
              </event>
              <event>
                <sub_title>HUMERUS FRACTURE</sub_title>
                <counts group_id="E1" events="5" subjects_affected="4" subjects_at_risk="864"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="796"/>
              </event>
              <event>
                <sub_title>INCISION SITE COMPLICATION</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="864"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="796"/>
              </event>
              <event>
                <sub_title>INCISION SITE HAEMORRHAGE</sub_title>
                <counts group_id="E1" events="5" subjects_affected="5" subjects_at_risk="864"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="796"/>
              </event>
              <event>
                <sub_title>INCISIONAL HERNIA, OBSTRUCTIVE</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="864"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="796"/>
              </event>
              <event>
                <sub_title>INJURY</sub_title>
                <counts group_id="E1" events="3" subjects_affected="3" subjects_at_risk="864"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="796"/>
              </event>
              <event>
                <sub_title>JOINT DISLOCATION</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="864"/>
                <counts group_id="E2" events="3" subjects_affected="3" subjects_at_risk="796"/>
              </event>
              <event>
                <sub_title>JOINT INJURY</sub_title>
                <counts group_id="E1" events="4" subjects_affected="4" subjects_at_risk="864"/>
                <counts group_id="E2" events="2" subjects_affected="2" subjects_at_risk="796"/>
              </event>
              <event>
                <sub_title>LACERATION</sub_title>
                <counts group_id="E1" events="5" subjects_affected="5" subjects_at_risk="864"/>
                <counts group_id="E2" events="6" subjects_affected="6" subjects_at_risk="796"/>
              </event>
              <event>
                <sub_title>LIMB TRAUMATIC AMPUTATION</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="864"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="796"/>
              </event>
              <event>
                <sub_title>LOWER LIMB FRACTURE</sub_title>
                <counts group_id="E1" events="4" subjects_affected="4" subjects_at_risk="864"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="796"/>
              </event>
              <event>
                <sub_title>LUMBAR VERTEBRAL FRACTURE</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="864"/>
                <counts group_id="E2" events="2" subjects_affected="2" subjects_at_risk="796"/>
              </event>
              <event>
                <sub_title>MENISCUS INJURY</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="864"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="796"/>
              </event>
              <event>
                <sub_title>MULTIPLE FRACTURES</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="864"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="796"/>
              </event>
              <event>
                <sub_title>NERVE INJURY</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="864"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="796"/>
              </event>
              <event>
                <sub_title>OVERDOSE</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="864"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="796"/>
              </event>
              <event>
                <sub_title>PELVIC FRACTURE</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="864"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="796"/>
              </event>
              <event>
                <sub_title>PERIPROCEDURAL MYOCARDIAL INFARCTION</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="864"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="796"/>
              </event>
              <event>
                <sub_title>POST LAMINECTOMY SYNDROME</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="864"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="796"/>
              </event>
              <event>
                <sub_title>POST PROCEDURAL COMPLICATION</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="864"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="796"/>
              </event>
              <event>
                <sub_title>POST PROCEDURAL HAEMATOMA</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="864"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="796"/>
              </event>
              <event>
                <sub_title>POST PROCEDURAL HAEMORRHAGE</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="864"/>
                <counts group_id="E2" events="20" subjects_affected="19" subjects_at_risk="796"/>
              </event>
              <event>
                <sub_title>POSTOPERATIVE DELIRIUM</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="864"/>
                <counts group_id="E2" events="2" subjects_affected="2" subjects_at_risk="796"/>
              </event>
              <event>
                <sub_title>POSTOPERATIVE ILEUS</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="864"/>
                <counts group_id="E2" events="4" subjects_affected="4" subjects_at_risk="796"/>
              </event>
              <event>
                <sub_title>POSTOPERATIVE RESPIRATORY FAILURE</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="864"/>
                <counts group_id="E2" events="4" subjects_affected="4" subjects_at_risk="796"/>
              </event>
              <event>
                <sub_title>POSTOPERATIVE THORACIC PROCEDURE COMPLICATION</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="864"/>
                <counts group_id="E2" events="2" subjects_affected="2" subjects_at_risk="796"/>
              </event>
              <event>
                <sub_title>POSTOPERATIVE THROMBOSIS</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="864"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="796"/>
              </event>
              <event>
                <sub_title>POSTPERICARDIOTOMY SYNDROME</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="864"/>
                <counts group_id="E2" events="2" subjects_affected="2" subjects_at_risk="796"/>
              </event>
              <event>
                <sub_title>PROCEDURAL COMPLICATION</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="864"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="796"/>
              </event>
              <event>
                <sub_title>PROCEDURAL HAEMORRHAGE</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="864"/>
                <counts group_id="E2" events="9" subjects_affected="9" subjects_at_risk="796"/>
              </event>
              <event>
                <sub_title>PROCEDURAL HYPERTENSION</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="864"/>
                <counts group_id="E2" events="2" subjects_affected="2" subjects_at_risk="796"/>
              </event>
              <event>
                <sub_title>PROCEDURAL HYPOTENSION</sub_title>
                <counts group_id="E1" events="5" subjects_affected="5" subjects_at_risk="864"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="796"/>
              </event>
              <event>
                <sub_title>PROCEDURAL PNEUMOTHORAX</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="864"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="796"/>
              </event>
              <event>
                <sub_title>RADIUS FRACTURE</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="864"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="796"/>
              </event>
              <event>
                <sub_title>RIB FRACTURE</sub_title>
                <counts group_id="E1" events="3" subjects_affected="3" subjects_at_risk="864"/>
                <counts group_id="E2" events="6" subjects_affected="6" subjects_at_risk="796"/>
              </event>
              <event>
                <sub_title>ROAD TRAFFIC ACCIDENT</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="864"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="796"/>
              </event>
              <event>
                <sub_title>SEROMA</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="864"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="796"/>
              </event>
              <event>
                <sub_title>SKIN ABRASION</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="864"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="796"/>
              </event>
              <event>
                <sub_title>SPINAL COMPRESSION FRACTURE</sub_title>
                <counts group_id="E1" events="3" subjects_affected="3" subjects_at_risk="864"/>
                <counts group_id="E2" events="3" subjects_affected="3" subjects_at_risk="796"/>
              </event>
              <event>
                <sub_title>SPINAL FRACTURE</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="864"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="796"/>
              </event>
              <event>
                <sub_title>SUBARACHNOID HAEMORRHAGE</sub_title>
                <counts group_id="E1" events="5" subjects_affected="5" subjects_at_risk="864"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="796"/>
              </event>
              <event>
                <sub_title>SUBCUTANEOUS HAEMATOMA</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="864"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="796"/>
              </event>
              <event>
                <sub_title>SUBDURAL HAEMATOMA</sub_title>
                <counts group_id="E1" events="6" subjects_affected="6" subjects_at_risk="864"/>
                <counts group_id="E2" events="2" subjects_affected="2" subjects_at_risk="796"/>
              </event>
              <event>
                <sub_title>SUTURE RELATED COMPLICATION</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="864"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="796"/>
              </event>
              <event>
                <sub_title>TENDON RUPTURE</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="864"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="796"/>
              </event>
              <event>
                <sub_title>THORACIC VERTEBRAL FRACTURE</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="864"/>
                <counts group_id="E2" events="2" subjects_affected="2" subjects_at_risk="796"/>
              </event>
              <event>
                <sub_title>TOOTH FRACTURE</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="864"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="796"/>
              </event>
              <event>
                <sub_title>TOXICITY TO VARIOUS AGENTS</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="864"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="796"/>
              </event>
              <event>
                <sub_title>TRAUMATIC LUNG INJURY</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="864"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="796"/>
              </event>
              <event>
                <sub_title>ULNA FRACTURE</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="864"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="796"/>
              </event>
              <event>
                <sub_title>UPPER LIMB FRACTURE</sub_title>
                <counts group_id="E1" events="3" subjects_affected="3" subjects_at_risk="864"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="796"/>
              </event>
              <event>
                <sub_title>URETERIC INJURY</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="864"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="796"/>
              </event>
              <event>
                <sub_title>URINARY RETENTION POSTOPERATIVE</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="864"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="796"/>
              </event>
              <event>
                <sub_title>VASCULAR ACCESS COMPLICATION</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="864"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="796"/>
              </event>
              <event>
                <sub_title>VASCULAR ACCESS SITE COMPLICATION</sub_title>
                <counts group_id="E1" events="9" subjects_affected="9" subjects_at_risk="864"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="796"/>
              </event>
              <event>
                <sub_title>VASCULAR ACCESS SITE HAEMATOMA</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="864"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="796"/>
              </event>
              <event>
                <sub_title>VASCULAR ACCESS SITE HAEMORRHAGE</sub_title>
                <counts group_id="E1" events="3" subjects_affected="3" subjects_at_risk="864"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="796"/>
              </event>
              <event>
                <sub_title>VASCULAR GRAFT COMPLICATION</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="864"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="796"/>
              </event>
              <event>
                <sub_title>VASCULAR PSEUDOANEURYSM</sub_title>
                <counts group_id="E1" events="7" subjects_affected="7" subjects_at_risk="864"/>
                <counts group_id="E2" events="2" subjects_affected="2" subjects_at_risk="796"/>
              </event>
              <event>
                <sub_title>VASOPLEGIA SYNDROME</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="864"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="796"/>
              </event>
              <event>
                <sub_title>VENOUS INJURY</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="864"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="796"/>
              </event>
              <event>
                <sub_title>WEANING FAILURE</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="864"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="796"/>
              </event>
              <event>
                <sub_title>WOUND</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="864"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="796"/>
              </event>
              <event>
                <sub_title>WOUND DEHISCENCE</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="864"/>
                <counts group_id="E2" events="2" subjects_affected="2" subjects_at_risk="796"/>
              </event>
              <event>
                <sub_title>WOUND SECRETION</sub_title>
                <counts group_id="E1" events="8" subjects_affected="8" subjects_at_risk="864"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="796"/>
              </event>
              <event>
                <sub_title>WRIST FRACTURE</sub_title>
                <counts group_id="E1" events="3" subjects_affected="3" subjects_at_risk="864"/>
                <counts group_id="E2" events="2" subjects_affected="2" subjects_at_risk="796"/>
              </event>
              <event>
                <sub_title>XIITH NERVE INJURY</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="864"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="796"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Investigations</title>
            <event_list>
              <event>
                <sub_title>ANTICOAGULATION DRUG LEVEL ABOVE THERAPEUTIC</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="864"/>
                <counts group_id="E2" events="5" subjects_affected="5" subjects_at_risk="796"/>
              </event>
              <event>
                <sub_title>ANTICOAGULATION DRUG LEVEL BELOW THERAPEUTIC</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="864"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="796"/>
              </event>
              <event>
                <sub_title>BLOOD CREATINE PHOSPHOKINASE INCREASED</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="864"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="796"/>
              </event>
              <event>
                <sub_title>BLOOD CREATININE INCREASED</sub_title>
                <counts group_id="E1" events="3" subjects_affected="3" subjects_at_risk="864"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="796"/>
              </event>
              <event>
                <sub_title>BLOOD CULTURE POSITIVE</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="864"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="796"/>
              </event>
              <event>
                <sub_title>BLOOD ERYTHROPOIETIN DECREASED</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="864"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="796"/>
              </event>
              <event>
                <sub_title>BLOOD FIBRINOGEN DECREASED</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="864"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="796"/>
              </event>
              <event>
                <sub_title>BLOOD GLUCOSE DECREASED</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="864"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="796"/>
              </event>
              <event>
                <sub_title>BLOOD GLUCOSE INCREASED</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="864"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="796"/>
              </event>
              <event>
                <sub_title>BLOOD POTASSIUM ABNORMAL</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="864"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="796"/>
              </event>
              <event>
                <sub_title>BLOOD POTASSIUM DECREASED</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="864"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="796"/>
              </event>
              <event>
                <sub_title>BODY TEMPERATURE INCREASED</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="864"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="796"/>
              </event>
              <event>
                <sub_title>BRAIN NATRIURETIC PEPTIDE INCREASED</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="864"/>
                <counts group_id="E2" events="2" subjects_affected="2" subjects_at_risk="796"/>
              </event>
              <event>
                <sub_title>C-REACTIVE PROTEIN INCREASED</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="864"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="796"/>
              </event>
              <event>
                <sub_title>CALCIUM IONISED DECREASED</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="864"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="796"/>
              </event>
              <event>
                <sub_title>CARDIAC INDEX DECREASED</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="864"/>
                <counts group_id="E2" events="3" subjects_affected="3" subjects_at_risk="796"/>
              </event>
              <event>
                <sub_title>CARDIAC INDEX INCREASED</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="864"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="796"/>
              </event>
              <event>
                <sub_title>CARDIAC MURMUR</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="864"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="796"/>
              </event>
              <event>
                <sub_title>CARDIAC OUTPUT DECREASED</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="864"/>
                <counts group_id="E2" events="9" subjects_affected="9" subjects_at_risk="796"/>
              </event>
              <event>
                <sub_title>CARDIOVASCULAR FUNCTION TEST NORMAL</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="864"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="796"/>
              </event>
              <event>
                <sub_title>COAGULATION TIME PROLONGED</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="864"/>
                <counts group_id="E2" events="2" subjects_affected="2" subjects_at_risk="796"/>
              </event>
              <event>
                <sub_title>CYSTOSCOPY ABNORMAL</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="864"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="796"/>
              </event>
              <event>
                <sub_title>ECHOCARDIOGRAM ABNORMAL</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="864"/>
                <counts group_id="E2" events="3" subjects_affected="3" subjects_at_risk="796"/>
              </event>
              <event>
                <sub_title>EJECTION FRACTION DECREASED</sub_title>
                <counts group_id="E1" events="3" subjects_affected="3" subjects_at_risk="864"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="796"/>
              </event>
              <event>
                <sub_title>ELECTROCARDIOGRAM ABNORMAL</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="864"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="796"/>
              </event>
              <event>
                <sub_title>ELECTROCARDIOGRAM ST SEGMENT ABNORMAL</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="864"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="796"/>
              </event>
              <event>
                <sub_title>FIBRIN D DIMER INCREASED</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="864"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="796"/>
              </event>
              <event>
                <sub_title>FUNGAL TEST POSITIVE</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="864"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="796"/>
              </event>
              <event>
                <sub_title>HAEMATOCRIT DECREASED</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="864"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="796"/>
              </event>
              <event>
                <sub_title>HAEMOGLOBIN DECREASED</sub_title>
                <counts group_id="E1" events="6" subjects_affected="6" subjects_at_risk="864"/>
                <counts group_id="E2" events="5" subjects_affected="5" subjects_at_risk="796"/>
              </event>
              <event>
                <sub_title>INTERNATIONAL NORMALISED RATIO ABNORMAL</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="864"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="796"/>
              </event>
              <event>
                <sub_title>INTERNATIONAL NORMALISED RATIO INCREASED</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="864"/>
                <counts group_id="E2" events="5" subjects_affected="5" subjects_at_risk="796"/>
              </event>
              <event>
                <sub_title>INVESTIGATION</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="864"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="796"/>
              </event>
              <event>
                <sub_title>LIVER FUNCTION TEST ABNORMAL</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="864"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="796"/>
              </event>
              <event>
                <sub_title>NUTRITIONAL CONDITION ABNORMAL</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="864"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="796"/>
              </event>
              <event>
                <sub_title>OCCULT BLOOD</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="864"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="796"/>
              </event>
              <event>
                <sub_title>OCCULT BLOOD POSITIVE</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="864"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="796"/>
              </event>
              <event>
                <sub_title>OXYGEN SATURATION DECREASED</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="864"/>
                <counts group_id="E2" events="2" subjects_affected="2" subjects_at_risk="796"/>
              </event>
              <event>
                <sub_title>PLATELET COUNT DECREASED</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="864"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="796"/>
              </event>
              <event>
                <sub_title>PULMONARY ARTERIAL PRESSURE ABNORMAL</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="864"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="796"/>
              </event>
              <event>
                <sub_title>PULSE ABSENT</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="864"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="796"/>
              </event>
              <event>
                <sub_title>TROPONIN INCREASED</sub_title>
                <counts group_id="E1" events="4" subjects_affected="4" subjects_at_risk="864"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="796"/>
              </event>
              <event>
                <sub_title>URINE OUTPUT DECREASED</sub_title>
                <counts group_id="E1" events="5" subjects_affected="5" subjects_at_risk="864"/>
                <counts group_id="E2" events="3" subjects_affected="3" subjects_at_risk="796"/>
              </event>
              <event>
                <sub_title>VENOUS OXYGEN SATURATION ABNORMAL</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="864"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="796"/>
              </event>
              <event>
                <sub_title>WEIGHT DECREASED</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="864"/>
                <counts group_id="E2" events="2" subjects_affected="2" subjects_at_risk="796"/>
              </event>
              <event>
                <sub_title>WEIGHT INCREASED</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="864"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="796"/>
              </event>
              <event>
                <sub_title>WHITE BLOOD CELL COUNT INCREASED</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="864"/>
                <counts group_id="E2" events="2" subjects_affected="2" subjects_at_risk="796"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Metabolism and nutrition disorders</title>
            <event_list>
              <event>
                <sub_title>ABNORMAL LOSS OF WEIGHT</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="864"/>
                <counts group_id="E2" events="2" subjects_affected="2" subjects_at_risk="796"/>
              </event>
              <event>
                <sub_title>ACIDOSIS</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="864"/>
                <counts group_id="E2" events="2" subjects_affected="2" subjects_at_risk="796"/>
              </event>
              <event>
                <sub_title>CALCIPHYLAXIS</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="864"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="796"/>
              </event>
              <event>
                <sub_title>DECREASED APPETITE</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="864"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="796"/>
              </event>
              <event>
                <sub_title>DEHYDRATION</sub_title>
                <counts group_id="E1" events="8" subjects_affected="7" subjects_at_risk="864"/>
                <counts group_id="E2" events="5" subjects_affected="5" subjects_at_risk="796"/>
              </event>
              <event>
                <sub_title>DIABETES MELLITUS</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="864"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="796"/>
              </event>
              <event>
                <sub_title>DIABETES MELLITUS INADEQUATE CONTROL</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="864"/>
                <counts group_id="E2" events="2" subjects_affected="2" subjects_at_risk="796"/>
              </event>
              <event>
                <sub_title>DIABETIC KETOACIDOSIS</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="864"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="796"/>
              </event>
              <event>
                <sub_title>ELECTROLYTE IMBALANCE</sub_title>
                <counts group_id="E1" events="3" subjects_affected="3" subjects_at_risk="864"/>
                <counts group_id="E2" events="3" subjects_affected="3" subjects_at_risk="796"/>
              </event>
              <event>
                <sub_title>FAILURE TO THRIVE</sub_title>
                <counts group_id="E1" events="7" subjects_affected="7" subjects_at_risk="864"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="796"/>
              </event>
              <event>
                <sub_title>FLUID OVERLOAD</sub_title>
                <counts group_id="E1" events="14" subjects_affected="13" subjects_at_risk="864"/>
                <counts group_id="E2" events="29" subjects_affected="29" subjects_at_risk="796"/>
              </event>
              <event>
                <sub_title>GOUT</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="864"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="796"/>
              </event>
              <event>
                <sub_title>HYPERCALCAEMIA</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="864"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="796"/>
              </event>
              <event>
                <sub_title>HYPERGLYCAEMIA</sub_title>
                <counts group_id="E1" events="10" subjects_affected="10" subjects_at_risk="864"/>
                <counts group_id="E2" events="14" subjects_affected="14" subjects_at_risk="796"/>
              </event>
              <event>
                <sub_title>HYPERKALAEMIA</sub_title>
                <counts group_id="E1" events="3" subjects_affected="3" subjects_at_risk="864"/>
                <counts group_id="E2" events="7" subjects_affected="7" subjects_at_risk="796"/>
              </event>
              <event>
                <sub_title>HYPERNATRAEMIA</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="864"/>
                <counts group_id="E2" events="2" subjects_affected="2" subjects_at_risk="796"/>
              </event>
              <event>
                <sub_title>HYPERPHOSPHATAEMIA</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="864"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="796"/>
              </event>
              <event>
                <sub_title>HYPERVOLAEMIA</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="864"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="796"/>
              </event>
              <event>
                <sub_title>HYPOCALCAEMIA</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="864"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="796"/>
              </event>
              <event>
                <sub_title>HYPOGLYCAEMIA</sub_title>
                <counts group_id="E1" events="5" subjects_affected="5" subjects_at_risk="864"/>
                <counts group_id="E2" events="2" subjects_affected="2" subjects_at_risk="796"/>
              </event>
              <event>
                <sub_title>HYPOKALAEMIA</sub_title>
                <counts group_id="E1" events="6" subjects_affected="6" subjects_at_risk="864"/>
                <counts group_id="E2" events="9" subjects_affected="8" subjects_at_risk="796"/>
              </event>
              <event>
                <sub_title>HYPOMAGNEseriousMIA</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="864"/>
                <counts group_id="E2" events="2" subjects_affected="2" subjects_at_risk="796"/>
              </event>
              <event>
                <sub_title>HYPONATRAEMIA</sub_title>
                <counts group_id="E1" events="14" subjects_affected="12" subjects_at_risk="864"/>
                <counts group_id="E2" events="18" subjects_affected="16" subjects_at_risk="796"/>
              </event>
              <event>
                <sub_title>HYPOPHOSPHATAEMIA</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="864"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="796"/>
              </event>
              <event>
                <sub_title>HYPOVOLAEMIA</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="864"/>
                <counts group_id="E2" events="17" subjects_affected="17" subjects_at_risk="796"/>
              </event>
              <event>
                <sub_title>LACTIC ACIDOSIS</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="864"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="796"/>
              </event>
              <event>
                <sub_title>MALNUTRITION</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="864"/>
                <counts group_id="E2" events="9" subjects_affected="9" subjects_at_risk="796"/>
              </event>
              <event>
                <sub_title>METABOLIC ACIDOSIS</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="864"/>
                <counts group_id="E2" events="4" subjects_affected="4" subjects_at_risk="796"/>
              </event>
              <event>
                <sub_title>TYPE 2 DIABETES MELLITUS</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="864"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="796"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Musculoskeletal and connective tissue disorders</title>
            <event_list>
              <event>
                <sub_title>ARTHRALGIA</sub_title>
                <counts group_id="E1" events="4" subjects_affected="4" subjects_at_risk="864"/>
                <counts group_id="E2" events="4" subjects_affected="4" subjects_at_risk="796"/>
              </event>
              <event>
                <sub_title>ARTHRITIS</sub_title>
                <counts group_id="E1" events="5" subjects_affected="5" subjects_at_risk="864"/>
                <counts group_id="E2" events="3" subjects_affected="3" subjects_at_risk="796"/>
              </event>
              <event>
                <sub_title>BACK PAIN</sub_title>
                <counts group_id="E1" events="10" subjects_affected="10" subjects_at_risk="864"/>
                <counts group_id="E2" events="4" subjects_affected="4" subjects_at_risk="796"/>
              </event>
              <event>
                <sub_title>BURSITIS</sub_title>
                <counts group_id="E1" events="3" subjects_affected="3" subjects_at_risk="864"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="796"/>
              </event>
              <event>
                <sub_title>CERVICAL SPINAL STENOSIS</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="864"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="796"/>
              </event>
              <event>
                <sub_title>EXOSTOSIS</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="864"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="796"/>
              </event>
              <event>
                <sub_title>FISTULA</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="864"/>
                <counts group_id="E2" events="2" subjects_affected="2" subjects_at_risk="796"/>
              </event>
              <event>
                <sub_title>FLANK PAIN</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="864"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="796"/>
              </event>
              <event>
                <sub_title>FOOT DEFORMITY</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="864"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="796"/>
              </event>
              <event>
                <sub_title>JAW CYST</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="864"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="796"/>
              </event>
              <event>
                <sub_title>JOINT EFFUSION</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="864"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="796"/>
              </event>
              <event>
                <sub_title>LUMBAR SPINAL STENOSIS</sub_title>
                <counts group_id="E1" events="5" subjects_affected="5" subjects_at_risk="864"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="796"/>
              </event>
              <event>
                <sub_title>MUSCLE HAEMORRHAGE</sub_title>
                <counts group_id="E1" events="3" subjects_affected="3" subjects_at_risk="864"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="796"/>
              </event>
              <event>
                <sub_title>MUSCULAR WEAKNESS</sub_title>
                <counts group_id="E1" events="4" subjects_affected="4" subjects_at_risk="864"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="796"/>
              </event>
              <event>
                <sub_title>MUSCULOSKELETAL CHEST PAIN</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="864"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="796"/>
              </event>
              <event>
                <sub_title>MUSCULOSKELETAL PAIN</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="864"/>
                <counts group_id="E2" events="2" subjects_affected="2" subjects_at_risk="796"/>
              </event>
              <event>
                <sub_title>MYALGIA</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="864"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="796"/>
              </event>
              <event>
                <sub_title>OSTEOARTHRITIS</sub_title>
                <counts group_id="E1" events="17" subjects_affected="16" subjects_at_risk="864"/>
                <counts group_id="E2" events="12" subjects_affected="12" subjects_at_risk="796"/>
              </event>
              <event>
                <sub_title>PAIN IN EXTREMITY</sub_title>
                <counts group_id="E1" events="3" subjects_affected="3" subjects_at_risk="864"/>
                <counts group_id="E2" events="3" subjects_affected="3" subjects_at_risk="796"/>
              </event>
              <event>
                <sub_title>PLANTAR FASCIITIS</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="864"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="796"/>
              </event>
              <event>
                <sub_title>RHABDOMYOLYSIS</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="864"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="796"/>
              </event>
              <event>
                <sub_title>ROTATOR CUFF SYNDROME</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="864"/>
                <counts group_id="E2" events="2" subjects_affected="2" subjects_at_risk="796"/>
              </event>
              <event>
                <sub_title>SACROILIITIS</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="864"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="796"/>
              </event>
              <event>
                <sub_title>SPINAL COLUMN STENOSIS</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="864"/>
                <counts group_id="E2" events="2" subjects_affected="2" subjects_at_risk="796"/>
              </event>
              <event>
                <sub_title>SPINAL OSTEOARTHRITIS</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="864"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="796"/>
              </event>
              <event>
                <sub_title>SPINAL PAIN</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="864"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="796"/>
              </event>
              <event>
                <sub_title>SPONDYLOLYSIS</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="864"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="796"/>
              </event>
              <event>
                <sub_title>SYNOVIAL CYST</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="864"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="796"/>
              </event>
              <event>
                <sub_title>TEMPOROMANDIBULAR JOINT SYNDROME</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="864"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="796"/>
              </event>
              <event>
                <sub_title>TENDONITIS</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="864"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="796"/>
              </event>
              <event>
                <sub_title>TENOSYNOVITIS STENOSANS</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="864"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="796"/>
              </event>
              <event>
                <sub_title>TRIGGER FINGER</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="864"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="796"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Neoplasms benign, malignant and unspecified (incl cysts and polyps)</title>
            <event_list>
              <event>
                <sub_title>ACUTE MYELOID LEUKAEMIA</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="864"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="796"/>
              </event>
              <event>
                <sub_title>ADENOCARCINOMA</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="864"/>
                <counts group_id="E2" events="2" subjects_affected="2" subjects_at_risk="796"/>
              </event>
              <event>
                <sub_title>ADENOCARCINOMA OF COLON</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="864"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="796"/>
              </event>
              <event>
                <sub_title>B-CELL LYMPHOMA</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="864"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="796"/>
              </event>
              <event>
                <sub_title>BASAL CELL CARCINOMA</sub_title>
                <counts group_id="E1" events="5" subjects_affected="5" subjects_at_risk="864"/>
                <counts group_id="E2" events="7" subjects_affected="7" subjects_at_risk="796"/>
              </event>
              <event>
                <sub_title>BASOSQUAMOUS CARCINOMA</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="864"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="796"/>
              </event>
              <event>
                <sub_title>BENIGN BONE NEOPLASM</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="864"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="796"/>
              </event>
              <event>
                <sub_title>BLADDER CANCER</sub_title>
                <counts group_id="E1" events="5" subjects_affected="5" subjects_at_risk="864"/>
                <counts group_id="E2" events="6" subjects_affected="6" subjects_at_risk="796"/>
              </event>
              <event>
                <sub_title>BLADDER CANCER RECURRENT</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="864"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="796"/>
              </event>
              <event>
                <sub_title>BLADDER NEOPLASM</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="864"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="796"/>
              </event>
              <event>
                <sub_title>BONE CANCER METASTATIC</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="864"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="796"/>
              </event>
              <event>
                <sub_title>BRAIN NEOPLASM</sub_title>
                <counts group_id="E1" events="3" subjects_affected="2" subjects_at_risk="864"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="796"/>
              </event>
              <event>
                <sub_title>BREAST CANCER</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="864"/>
                <counts group_id="E2" events="3" subjects_affected="3" subjects_at_risk="796"/>
              </event>
              <event>
                <sub_title>CHRONIC LEUKAEMIA</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="864"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="796"/>
              </event>
              <event>
                <sub_title>COLON ADENOMA</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="864"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="796"/>
              </event>
              <event>
                <sub_title>COLON CANCER</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="864"/>
                <counts group_id="E2" events="4" subjects_affected="4" subjects_at_risk="796"/>
              </event>
              <event>
                <sub_title>COLORECTAL CANCER</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="864"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="796"/>
              </event>
              <event>
                <sub_title>ENDOMETRIAL CANCER</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="864"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="796"/>
              </event>
              <event>
                <sub_title>GALLBLADDER CANCER</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="864"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="796"/>
              </event>
              <event>
                <sub_title>GASTROINTESTINAL CARCINOMA</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="864"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="796"/>
              </event>
              <event>
                <sub_title>GASTROINTESTINAL STROMAL TUMOUR</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="864"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="796"/>
              </event>
              <event>
                <sub_title>LENTIGO MALIGNA</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="864"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="796"/>
              </event>
              <event>
                <sub_title>LEUKAEMIA</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="864"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="796"/>
              </event>
              <event>
                <sub_title>LIPOSARCOMA</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="864"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="796"/>
              </event>
              <event>
                <sub_title>LUNG ADENOCARCINOMA</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="864"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="796"/>
              </event>
              <event>
                <sub_title>LUNG CANCER METASTATIC</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="864"/>
                <counts group_id="E2" events="2" subjects_affected="2" subjects_at_risk="796"/>
              </event>
              <event>
                <sub_title>LUNG NEOPLASM MALIGNANT</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="864"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="796"/>
              </event>
              <event>
                <sub_title>LYMPHOCYTIC LEUKAEMIA</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="864"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="796"/>
              </event>
              <event>
                <sub_title>LYMPHOMA</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="864"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="796"/>
              </event>
              <event>
                <sub_title>MALIGNANT MELANOMA</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="864"/>
                <counts group_id="E2" events="2" subjects_affected="2" subjects_at_risk="796"/>
              </event>
              <event>
                <sub_title>MALIGNANT NEOPLASM OF SPERMATIC CORD</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="864"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="796"/>
              </event>
              <event>
                <sub_title>MELANOCYTIC NAEVUS</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="864"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="796"/>
              </event>
              <event>
                <sub_title>METASTASES TO BONE</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="864"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="796"/>
              </event>
              <event>
                <sub_title>METASTATIC NEOPLASM</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="864"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="796"/>
              </event>
              <event>
                <sub_title>MYELODYSPLASTIC SYNDROME</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="864"/>
                <counts group_id="E2" events="2" subjects_affected="2" subjects_at_risk="796"/>
              </event>
              <event>
                <sub_title>NEOPLASM MALIGNANT</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="864"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="796"/>
              </event>
              <event>
                <sub_title>OVARIAN CANCER</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="864"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="796"/>
              </event>
              <event>
                <sub_title>OVARIAN CANCER METASTATIC</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="864"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="796"/>
              </event>
              <event>
                <sub_title>PARATHYROID TUMOUR BENIGN</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="864"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="796"/>
              </event>
              <event>
                <sub_title>PLASMA CELL MYELOMA</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="864"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="796"/>
              </event>
              <event>
                <sub_title>PROSTATE CANCER</sub_title>
                <counts group_id="E1" events="3" subjects_affected="3" subjects_at_risk="864"/>
                <counts group_id="E2" events="2" subjects_affected="2" subjects_at_risk="796"/>
              </event>
              <event>
                <sub_title>PROSTATE CANCER METASTATIC</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="864"/>
                <counts group_id="E2" events="2" subjects_affected="2" subjects_at_risk="796"/>
              </event>
              <event>
                <sub_title>RECTAL CANCER</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="864"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="796"/>
              </event>
              <event>
                <sub_title>RENAL CANCER METASTATIC</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="864"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="796"/>
              </event>
              <event>
                <sub_title>RENAL CELL CARCINOMA</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="864"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="796"/>
              </event>
              <event>
                <sub_title>SKIN CANCER</sub_title>
                <counts group_id="E1" events="6" subjects_affected="6" subjects_at_risk="864"/>
                <counts group_id="E2" events="2" subjects_affected="2" subjects_at_risk="796"/>
              </event>
              <event>
                <sub_title>SQUAMOUS CELL CARCINOMA</sub_title>
                <counts group_id="E1" events="6" subjects_affected="6" subjects_at_risk="864"/>
                <counts group_id="E2" events="5" subjects_affected="5" subjects_at_risk="796"/>
              </event>
              <event>
                <sub_title>SQUAMOUS CELL CARCINOMA OF SKIN</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="864"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="796"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Nervous system disorders</title>
            <event_list>
              <event>
                <sub_title>ALTERED STATE OF CONSCIOUSNESS</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="864"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="796"/>
              </event>
              <event>
                <sub_title>AMNESIA</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="864"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="796"/>
              </event>
              <event>
                <sub_title>APHASIA</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="864"/>
                <counts group_id="E2" events="2" subjects_affected="2" subjects_at_risk="796"/>
              </event>
              <event>
                <sub_title>BRAIN INJURY</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="864"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="796"/>
              </event>
              <event>
                <sub_title>BRAIN OEDEMA</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="864"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="796"/>
              </event>
              <event>
                <sub_title>CAROTID ARTERY DISEASE</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="864"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="796"/>
              </event>
              <event>
                <sub_title>CAROTID ARTERY OCCLUSION</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="864"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="796"/>
              </event>
              <event>
                <sub_title>CAROTID ARTERY STENOSIS</sub_title>
                <counts group_id="E1" events="6" subjects_affected="6" subjects_at_risk="864"/>
                <counts group_id="E2" events="4" subjects_affected="4" subjects_at_risk="796"/>
              </event>
              <event>
                <sub_title>CARPAL TUNNEL SYNDROME</sub_title>
                <counts group_id="E1" events="4" subjects_affected="3" subjects_at_risk="864"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="796"/>
              </event>
              <event>
                <sub_title>CEREBELLAR HAEMORRHAGE</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="864"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="796"/>
              </event>
              <event>
                <sub_title>CEREBELLAR INFARCTION</sub_title>
                <counts group_id="E1" events="3" subjects_affected="3" subjects_at_risk="864"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="796"/>
              </event>
              <event>
                <sub_title>CEREBRAL ATROPHY</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="864"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="796"/>
              </event>
              <event>
                <sub_title>CEREBRAL HAEMORRHAGE</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="864"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="796"/>
              </event>
              <event>
                <sub_title>CEREBRAL INFARCTION</sub_title>
                <counts group_id="E1" events="3" subjects_affected="3" subjects_at_risk="864"/>
                <counts group_id="E2" events="7" subjects_affected="7" subjects_at_risk="796"/>
              </event>
              <event>
                <sub_title>CEREBROVASCULAR ACCIDENT</sub_title>
                <counts group_id="E1" events="25" subjects_affected="24" subjects_at_risk="864"/>
                <counts group_id="E2" events="31" subjects_affected="30" subjects_at_risk="796"/>
              </event>
              <event>
                <sub_title>COGNITIVE DISORDER</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="864"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="796"/>
              </event>
              <event>
                <sub_title>COMA</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="864"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="796"/>
              </event>
              <event>
                <sub_title>DEMENTIA</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="864"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="796"/>
              </event>
              <event>
                <sub_title>DEMENTIA ALZHEIMER'S TYPE</sub_title>
                <counts group_id="E1" events="3" subjects_affected="3" subjects_at_risk="864"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="796"/>
              </event>
              <event>
                <sub_title>DIZZINESS</sub_title>
                <counts group_id="E1" events="9" subjects_affected="8" subjects_at_risk="864"/>
                <counts group_id="E2" events="3" subjects_affected="3" subjects_at_risk="796"/>
              </event>
              <event>
                <sub_title>DYSARTHRIA</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="864"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="796"/>
              </event>
              <event>
                <sub_title>EMBOLIC CEREBRAL INFARCTION</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="864"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="796"/>
              </event>
              <event>
                <sub_title>EMBOLIC STROKE</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="864"/>
                <counts group_id="E2" events="2" subjects_affected="2" subjects_at_risk="796"/>
              </event>
              <event>
                <sub_title>ENCEPHALOPATHY</sub_title>
                <counts group_id="E1" events="6" subjects_affected="6" subjects_at_risk="864"/>
                <counts group_id="E2" events="7" subjects_affected="6" subjects_at_risk="796"/>
              </event>
              <event>
                <sub_title>EPILEPSY</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="864"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="796"/>
              </event>
              <event>
                <sub_title>GENERALISED TONIC-CLONIC SEIZURE</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="864"/>
                <counts group_id="E2" events="2" subjects_affected="2" subjects_at_risk="796"/>
              </event>
              <event>
                <sub_title>HAEMORRHAGE INTRACRANIAL</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="864"/>
                <counts group_id="E2" events="5" subjects_affected="5" subjects_at_risk="796"/>
              </event>
              <event>
                <sub_title>HAEMORRHAGIC STROKE</sub_title>
                <counts group_id="E1" events="4" subjects_affected="4" subjects_at_risk="864"/>
                <counts group_id="E2" events="4" subjects_affected="4" subjects_at_risk="796"/>
              </event>
              <event>
                <sub_title>HEADACHE</sub_title>
                <counts group_id="E1" events="3" subjects_affected="3" subjects_at_risk="864"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="796"/>
              </event>
              <event>
                <sub_title>HEMIANOPIA</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="864"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="796"/>
              </event>
              <event>
                <sub_title>HEMIPARESIS</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="864"/>
                <counts group_id="E2" events="2" subjects_affected="2" subjects_at_risk="796"/>
              </event>
              <event>
                <sub_title>HEPATIC ENCEPHALOPATHY</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="864"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="796"/>
              </event>
              <event>
                <sub_title>HYDROCEPHALUS</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="864"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="796"/>
              </event>
              <event>
                <sub_title>HYPERREFLEXIA</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="864"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="796"/>
              </event>
              <event>
                <sub_title>HYPERTENSIVE ENCEPHALOPATHY</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="864"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="796"/>
              </event>
              <event>
                <sub_title>HYPOAESTHESIA</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="864"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="796"/>
              </event>
              <event>
                <sub_title>HYPOXIC-ISCHAEMIC ENCEPHALOPATHY</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="864"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="796"/>
              </event>
              <event>
                <sub_title>IIIRD NERVE PARALYSIS</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="864"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="796"/>
              </event>
              <event>
                <sub_title>ISCHAEMIC STROKE</sub_title>
                <counts group_id="E1" events="4" subjects_affected="4" subjects_at_risk="864"/>
                <counts group_id="E2" events="8" subjects_affected="8" subjects_at_risk="796"/>
              </event>
              <event>
                <sub_title>LACUNAR INFARCTION</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="864"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="796"/>
              </event>
              <event>
                <sub_title>LETHARGY</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="864"/>
                <counts group_id="E2" events="2" subjects_affected="2" subjects_at_risk="796"/>
              </event>
              <event>
                <sub_title>LOSS OF CONSCIOUSNESS</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="864"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="796"/>
              </event>
              <event>
                <sub_title>METABOLIC ENCEPHALOPATHY</sub_title>
                <counts group_id="E1" events="5" subjects_affected="5" subjects_at_risk="864"/>
                <counts group_id="E2" events="7" subjects_affected="7" subjects_at_risk="796"/>
              </event>
              <event>
                <sub_title>MIGRAINE</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="864"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="796"/>
              </event>
              <event>
                <sub_title>NEURALGIA</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="864"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="796"/>
              </event>
              <event>
                <sub_title>NEUROPATHY PERIPHERAL</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="864"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="796"/>
              </event>
              <event>
                <sub_title>OPTIC NEURITIS</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="864"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="796"/>
              </event>
              <event>
                <sub_title>PARKINSON'S DISEASE</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="864"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="796"/>
              </event>
              <event>
                <sub_title>PERONEAL NERVE PALSY</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="864"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="796"/>
              </event>
              <event>
                <sub_title>POLYNEUROPATHY</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="864"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="796"/>
              </event>
              <event>
                <sub_title>PRESYNCOPE</sub_title>
                <counts group_id="E1" events="12" subjects_affected="9" subjects_at_risk="864"/>
                <counts group_id="E2" events="4" subjects_affected="4" subjects_at_risk="796"/>
              </event>
              <event>
                <sub_title>SEIZURE</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="864"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="796"/>
              </event>
              <event>
                <sub_title>SEIZURE LIKE PHENOMENA</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="864"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="796"/>
              </event>
              <event>
                <sub_title>SENSORY DISTURBANCE</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="864"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="796"/>
              </event>
              <event>
                <sub_title>SEROTONIN SYNDROME</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="864"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="796"/>
              </event>
              <event>
                <sub_title>SYNCOPE</sub_title>
                <counts group_id="E1" events="24" subjects_affected="24" subjects_at_risk="864"/>
                <counts group_id="E2" events="20" subjects_affected="19" subjects_at_risk="796"/>
              </event>
              <event>
                <sub_title>TOXIC ENCEPHALOPATHY</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="864"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="796"/>
              </event>
              <event>
                <sub_title>TRANSIENT ISCHAEMIC ATTACK</sub_title>
                <counts group_id="E1" events="25" subjects_affected="25" subjects_at_risk="864"/>
                <counts group_id="E2" events="10" subjects_affected="10" subjects_at_risk="796"/>
              </event>
              <event>
                <sub_title>TREMOR</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="864"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="796"/>
              </event>
              <event>
                <sub_title>UNRESPONSIVE TO STIMULI</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="864"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="796"/>
              </event>
              <event>
                <sub_title>VERTEBROBASILAR INSUFFICIENCY</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="864"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="796"/>
              </event>
              <event>
                <sub_title>VOCAL CORD PARALYSIS</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="864"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="796"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Product Issues</title>
            <event_list>
              <event>
                <sub_title>DEVICE ADHESION ISSUE</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="864"/>
                <counts group_id="E2" events="2" subjects_affected="2" subjects_at_risk="796"/>
              </event>
              <event>
                <sub_title>DEVICE CAPTURING ISSUE</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="864"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="796"/>
              </event>
              <event>
                <sub_title>DEVICE DISLOCATION</sub_title>
                <counts group_id="E1" events="3" subjects_affected="3" subjects_at_risk="864"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="796"/>
              </event>
              <event>
                <sub_title>DEVICE FAILURE</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="864"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="796"/>
              </event>
              <event>
                <sub_title>DEVICE ISSUE</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="864"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="796"/>
              </event>
              <event>
                <sub_title>DEVICE LEAD ISSUE</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="864"/>
                <counts group_id="E2" events="2" subjects_affected="2" subjects_at_risk="796"/>
              </event>
              <event>
                <sub_title>DEVICE LEAKAGE</sub_title>
                <counts group_id="E1" events="30" subjects_affected="28" subjects_at_risk="864"/>
                <counts group_id="E2" events="2" subjects_affected="2" subjects_at_risk="796"/>
              </event>
              <event>
                <sub_title>DEVICE LOOSENING</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="864"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="796"/>
              </event>
              <event>
                <sub_title>DEVICE MALFUNCTION</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="864"/>
                <counts group_id="E2" events="2" subjects_affected="2" subjects_at_risk="796"/>
              </event>
              <event>
                <sub_title>DEVICE PACING ISSUE</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="864"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="796"/>
              </event>
              <event>
                <sub_title>LEAD DISLODGEMENT</sub_title>
                <counts group_id="E1" events="6" subjects_affected="6" subjects_at_risk="864"/>
                <counts group_id="E2" events="2" subjects_affected="2" subjects_at_risk="796"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Psychiatric disorders</title>
            <event_list>
              <event>
                <sub_title>ADJUSTMENT DISORDER</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="864"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="796"/>
              </event>
              <event>
                <sub_title>AFFECTIVE DISORDER</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="864"/>
                <counts group_id="E2" events="2" subjects_affected="1" subjects_at_risk="796"/>
              </event>
              <event>
                <sub_title>AGITATION</sub_title>
                <counts group_id="E1" events="3" subjects_affected="3" subjects_at_risk="864"/>
                <counts group_id="E2" events="3" subjects_affected="3" subjects_at_risk="796"/>
              </event>
              <event>
                <sub_title>ANXIETY</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="864"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="796"/>
              </event>
              <event>
                <sub_title>CONFUSIONAL STATE</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="864"/>
                <counts group_id="E2" events="5" subjects_affected="5" subjects_at_risk="796"/>
              </event>
              <event>
                <sub_title>DELIRIUM</sub_title>
                <counts group_id="E1" events="5" subjects_affected="5" subjects_at_risk="864"/>
                <counts group_id="E2" events="16" subjects_affected="15" subjects_at_risk="796"/>
              </event>
              <event>
                <sub_title>DELIRIUM TREMENS</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="864"/>
                <counts group_id="E2" events="2" subjects_affected="2" subjects_at_risk="796"/>
              </event>
              <event>
                <sub_title>DEPRESSION</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="864"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="796"/>
              </event>
              <event>
                <sub_title>DEPRESSION SUICIDAL</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="864"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="796"/>
              </event>
              <event>
                <sub_title>DISORIENTATION</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="864"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="796"/>
              </event>
              <event>
                <sub_title>HALLUCINATION, AUDITORY</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="864"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="796"/>
              </event>
              <event>
                <sub_title>HALLUCINATION, VISUAL</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="864"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="796"/>
              </event>
              <event>
                <sub_title>MAJOR DEPRESSION</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="864"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="796"/>
              </event>
              <event>
                <sub_title>MENTAL STATUS CHANGES</sub_title>
                <counts group_id="E1" events="13" subjects_affected="13" subjects_at_risk="864"/>
                <counts group_id="E2" events="8" subjects_affected="8" subjects_at_risk="796"/>
              </event>
              <event>
                <sub_title>PSYCHOTIC DISORDER</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="864"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="796"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Renal and urinary disorders</title>
            <event_list>
              <event>
                <sub_title>ACUTE KIDNEY INJURY</sub_title>
                <counts group_id="E1" events="75" subjects_affected="62" subjects_at_risk="864"/>
                <counts group_id="E2" events="95" subjects_affected="82" subjects_at_risk="796"/>
              </event>
              <event>
                <sub_title>ANURIA</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="864"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="796"/>
              </event>
              <event>
                <sub_title>AZOTAEMIA</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="864"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="796"/>
              </event>
              <event>
                <sub_title>BLADDER OBSTRUCTION</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="864"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="796"/>
              </event>
              <event>
                <sub_title>CHRONIC KIDNEY DISEASE</sub_title>
                <counts group_id="E1" events="6" subjects_affected="6" subjects_at_risk="864"/>
                <counts group_id="E2" events="4" subjects_affected="4" subjects_at_risk="796"/>
              </event>
              <event>
                <sub_title>DYSURIA</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="864"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="796"/>
              </event>
              <event>
                <sub_title>END STAGE RENAL DISEASE</sub_title>
                <counts group_id="E1" events="2" subjects_affected="1" subjects_at_risk="864"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="796"/>
              </event>
              <event>
                <sub_title>HAEMATURIA</sub_title>
                <counts group_id="E1" events="25" subjects_affected="22" subjects_at_risk="864"/>
                <counts group_id="E2" events="18" subjects_affected="15" subjects_at_risk="796"/>
              </event>
              <event>
                <sub_title>HAEMORRHAGE URINARY TRACT</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="864"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="796"/>
              </event>
              <event>
                <sub_title>INCONTINENCE</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="864"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="796"/>
              </event>
              <event>
                <sub_title>NEPHROLITHIASIS</sub_title>
                <counts group_id="E1" events="3" subjects_affected="2" subjects_at_risk="864"/>
                <counts group_id="E2" events="3" subjects_affected="2" subjects_at_risk="796"/>
              </event>
              <event>
                <sub_title>OLIGURIA</sub_title>
                <counts group_id="E1" events="3" subjects_affected="3" subjects_at_risk="864"/>
                <counts group_id="E2" events="2" subjects_affected="2" subjects_at_risk="796"/>
              </event>
              <event>
                <sub_title>POLYURIA</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="864"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="796"/>
              </event>
              <event>
                <sub_title>RENAL ARTERY OCCLUSION</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="864"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="796"/>
              </event>
              <event>
                <sub_title>RENAL ARTERY STENOSIS</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="864"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="796"/>
              </event>
              <event>
                <sub_title>RENAL FAILURE</sub_title>
                <counts group_id="E1" events="8" subjects_affected="7" subjects_at_risk="864"/>
                <counts group_id="E2" events="13" subjects_affected="13" subjects_at_risk="796"/>
              </event>
              <event>
                <sub_title>RENAL HAEMORRHAGE</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="864"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="796"/>
              </event>
              <event>
                <sub_title>RENAL MASS</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="864"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="796"/>
              </event>
              <event>
                <sub_title>RENAL TUBULAR DISORDER</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="864"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="796"/>
              </event>
              <event>
                <sub_title>RENAL TUBULAR NECROSIS</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="864"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="796"/>
              </event>
              <event>
                <sub_title>STAG HORN CALCULUS</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="864"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="796"/>
              </event>
              <event>
                <sub_title>URETEROLITHIASIS</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="864"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="796"/>
              </event>
              <event>
                <sub_title>URETHRAL OBSTRUCTION</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="864"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="796"/>
              </event>
              <event>
                <sub_title>URETHRAL STENOSIS</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="864"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="796"/>
              </event>
              <event>
                <sub_title>URINARY BLADDER HAEMORRHAGE</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="864"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="796"/>
              </event>
              <event>
                <sub_title>URINARY RETENTION</sub_title>
                <counts group_id="E1" events="32" subjects_affected="29" subjects_at_risk="864"/>
                <counts group_id="E2" events="21" subjects_affected="21" subjects_at_risk="796"/>
              </event>
              <event>
                <sub_title>URINE FLOW DECREASED</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="864"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="796"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Reproductive system and breast disorders</title>
            <event_list>
              <event>
                <sub_title>ACQUIRED PHIMOSIS</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="864"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="796"/>
              </event>
              <event>
                <sub_title>BENIGN PROSTATIC HYPERPLASIA</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="864"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="796"/>
              </event>
              <event>
                <sub_title>PENILE OEDEMA</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="864"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="796"/>
              </event>
              <event>
                <sub_title>PENILE PAIN</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="864"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="796"/>
              </event>
              <event>
                <sub_title>UTERINE POLYP</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="864"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="796"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Respiratory, thoracic and mediastinal disorders</title>
            <event_list>
              <event>
                <sub_title>ACUTE LUNG INJURY</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="864"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="796"/>
              </event>
              <event>
                <sub_title>ACUTE PULMONARY OEDEMA</sub_title>
                <counts group_id="E1" events="4" subjects_affected="3" subjects_at_risk="864"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="796"/>
              </event>
              <event>
                <sub_title>ACUTE RESPIRATORY DISTRESS SYNDROME</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="864"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="796"/>
              </event>
              <event>
                <sub_title>ACUTE RESPIRATORY FAILURE</sub_title>
                <counts group_id="E1" events="15" subjects_affected="13" subjects_at_risk="864"/>
                <counts group_id="E2" events="16" subjects_affected="16" subjects_at_risk="796"/>
              </event>
              <event>
                <sub_title>ASPIRATION</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="864"/>
                <counts group_id="E2" events="4" subjects_affected="4" subjects_at_risk="796"/>
              </event>
              <event>
                <sub_title>ASTHMA</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="864"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="796"/>
              </event>
              <event>
                <sub_title>ATELECTASIS</sub_title>
                <counts group_id="E1" events="3" subjects_affected="3" subjects_at_risk="864"/>
                <counts group_id="E2" events="11" subjects_affected="10" subjects_at_risk="796"/>
              </event>
              <event>
                <sub_title>CHOKING SENSATION</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="864"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="796"/>
              </event>
              <event>
                <sub_title>CHRONIC OBSTRUCTIVE PULMONARY DISEASE</sub_title>
                <counts group_id="E1" events="14" subjects_affected="13" subjects_at_risk="864"/>
                <counts group_id="E2" events="21" subjects_affected="16" subjects_at_risk="796"/>
              </event>
              <event>
                <sub_title>COUGH</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="864"/>
                <counts group_id="E2" events="2" subjects_affected="2" subjects_at_risk="796"/>
              </event>
              <event>
                <sub_title>DEPENDENCE ON RESPIRATOR</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="864"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="796"/>
              </event>
              <event>
                <sub_title>DYSPNOEA</sub_title>
                <counts group_id="E1" events="25" subjects_affected="22" subjects_at_risk="864"/>
                <counts group_id="E2" events="11" subjects_affected="11" subjects_at_risk="796"/>
              </event>
              <event>
                <sub_title>DYSPNOEA EXERTIONAL</sub_title>
                <counts group_id="E1" events="4" subjects_affected="4" subjects_at_risk="864"/>
                <counts group_id="E2" events="4" subjects_affected="4" subjects_at_risk="796"/>
              </event>
              <event>
                <sub_title>EPISTAXIS</sub_title>
                <counts group_id="E1" events="5" subjects_affected="5" subjects_at_risk="864"/>
                <counts group_id="E2" events="10" subjects_affected="10" subjects_at_risk="796"/>
              </event>
              <event>
                <sub_title>HAEMOPTYSIS</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="864"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="796"/>
              </event>
              <event>
                <sub_title>HAEMOTHORAX</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="864"/>
                <counts group_id="E2" events="8" subjects_affected="8" subjects_at_risk="796"/>
              </event>
              <event>
                <sub_title>HYPERCAPNIA</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="864"/>
                <counts group_id="E2" events="2" subjects_affected="2" subjects_at_risk="796"/>
              </event>
              <event>
                <sub_title>HYPOXIA</sub_title>
                <counts group_id="E1" events="7" subjects_affected="7" subjects_at_risk="864"/>
                <counts group_id="E2" events="8" subjects_affected="8" subjects_at_risk="796"/>
              </event>
              <event>
                <sub_title>LARYNGEAL ATROPHY</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="864"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="796"/>
              </event>
              <event>
                <sub_title>LARYNGEAL STENOSIS</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="864"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="796"/>
              </event>
              <event>
                <sub_title>LUNG CONSOLIDATION</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="864"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="796"/>
              </event>
              <event>
                <sub_title>LUNG INFILTRATION</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="864"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="796"/>
              </event>
              <event>
                <sub_title>MEDIASTINAL HAEMATOMA</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="864"/>
                <counts group_id="E2" events="3" subjects_affected="3" subjects_at_risk="796"/>
              </event>
              <event>
                <sub_title>MEDIASTINAL HAEMORRHAGE</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="864"/>
                <counts group_id="E2" events="8" subjects_affected="8" subjects_at_risk="796"/>
              </event>
              <event>
                <sub_title>MEDIASTINAL MASS</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="864"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="796"/>
              </event>
              <event>
                <sub_title>NASAL OBSTRUCTION</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="864"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="796"/>
              </event>
              <event>
                <sub_title>OROPHARYNGEAL PAIN</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="864"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="796"/>
              </event>
              <event>
                <sub_title>PLEURAL EFFUSION</sub_title>
                <counts group_id="E1" events="43" subjects_affected="38" subjects_at_risk="864"/>
                <counts group_id="E2" events="123" subjects_affected="102" subjects_at_risk="796"/>
              </event>
              <event>
                <sub_title>PLEURITIC PAIN</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="864"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="796"/>
              </event>
              <event>
                <sub_title>PNEUMONIA ASPIRATION</sub_title>
                <counts group_id="E1" events="10" subjects_affected="10" subjects_at_risk="864"/>
                <counts group_id="E2" events="8" subjects_affected="8" subjects_at_risk="796"/>
              </event>
              <event>
                <sub_title>PNEUMONITIS</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="864"/>
                <counts group_id="E2" events="2" subjects_affected="2" subjects_at_risk="796"/>
              </event>
              <event>
                <sub_title>PNEUMOTHORAX</sub_title>
                <counts group_id="E1" events="9" subjects_affected="8" subjects_at_risk="864"/>
                <counts group_id="E2" events="18" subjects_affected="18" subjects_at_risk="796"/>
              </event>
              <event>
                <sub_title>PULMONARY CONGESTION</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="864"/>
                <counts group_id="E2" events="2" subjects_affected="2" subjects_at_risk="796"/>
              </event>
              <event>
                <sub_title>PULMONARY EMBOLISM</sub_title>
                <counts group_id="E1" events="8" subjects_affected="8" subjects_at_risk="864"/>
                <counts group_id="E2" events="10" subjects_affected="10" subjects_at_risk="796"/>
              </event>
              <event>
                <sub_title>PULMONARY FIBROSIS</sub_title>
                <counts group_id="E1" events="3" subjects_affected="3" subjects_at_risk="864"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="796"/>
              </event>
              <event>
                <sub_title>PULMONARY HAEMATOMA</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="864"/>
                <counts group_id="E2" events="2" subjects_affected="2" subjects_at_risk="796"/>
              </event>
              <event>
                <sub_title>PULMONARY HAEMORRHAGE</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="864"/>
                <counts group_id="E2" events="2" subjects_affected="2" subjects_at_risk="796"/>
              </event>
              <event>
                <sub_title>PULMONARY HYPERTENSION</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="864"/>
                <counts group_id="E2" events="2" subjects_affected="2" subjects_at_risk="796"/>
              </event>
              <event>
                <sub_title>PULMONARY OEDEMA</sub_title>
                <counts group_id="E1" events="11" subjects_affected="10" subjects_at_risk="864"/>
                <counts group_id="E2" events="11" subjects_affected="11" subjects_at_risk="796"/>
              </event>
              <event>
                <sub_title>RESPIRATORY ACIDOSIS</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="864"/>
                <counts group_id="E2" events="5" subjects_affected="5" subjects_at_risk="796"/>
              </event>
              <event>
                <sub_title>RESPIRATORY ARREST</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="864"/>
                <counts group_id="E2" events="2" subjects_affected="2" subjects_at_risk="796"/>
              </event>
              <event>
                <sub_title>RESPIRATORY DISTRESS</sub_title>
                <counts group_id="E1" events="5" subjects_affected="5" subjects_at_risk="864"/>
                <counts group_id="E2" events="11" subjects_affected="11" subjects_at_risk="796"/>
              </event>
              <event>
                <sub_title>RESPIRATORY FAILURE</sub_title>
                <counts group_id="E1" events="30" subjects_affected="27" subjects_at_risk="864"/>
                <counts group_id="E2" events="56" subjects_affected="50" subjects_at_risk="796"/>
              </event>
              <event>
                <sub_title>SLEEP APNOEA SYNDROME</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="864"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="796"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Skin and subcutaneous tissue disorders</title>
            <event_list>
              <event>
                <sub_title>ACTINIC KERATOSIS</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="864"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="796"/>
              </event>
              <event>
                <sub_title>ANGIOEDEMA</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="864"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="796"/>
              </event>
              <event>
                <sub_title>DECUBITUS ULCER</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="864"/>
                <counts group_id="E2" events="3" subjects_affected="3" subjects_at_risk="796"/>
              </event>
              <event>
                <sub_title>DIABETIC ULCER</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="864"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="796"/>
              </event>
              <event>
                <sub_title>ECCHYMOSIS</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="864"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="796"/>
              </event>
              <event>
                <sub_title>ERYTHEMA</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="864"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="796"/>
              </event>
              <event>
                <sub_title>PANNICULITIS</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="864"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="796"/>
              </event>
              <event>
                <sub_title>PETECHIAE</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="864"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="796"/>
              </event>
              <event>
                <sub_title>RASH</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="864"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="796"/>
              </event>
              <event>
                <sub_title>SKIN FISSURES</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="864"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="796"/>
              </event>
              <event>
                <sub_title>SKIN LESION</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="864"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="796"/>
              </event>
              <event>
                <sub_title>SKIN ULCER</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="864"/>
                <counts group_id="E2" events="3" subjects_affected="3" subjects_at_risk="796"/>
              </event>
              <event>
                <sub_title>SUBCUTANEOUS EMPHYSEMA</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="864"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="796"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Surgical and medical procedures</title>
            <event_list>
              <event>
                <sub_title>CARDIAC PACEMAKER BATTERY REPLACEMENT</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="864"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="796"/>
              </event>
              <event>
                <sub_title>CARDIAC PACEMAKER REPLACEMENT</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="864"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="796"/>
              </event>
              <event>
                <sub_title>CATARACT OPERATION</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="864"/>
                <counts group_id="E2" events="5" subjects_affected="4" subjects_at_risk="796"/>
              </event>
              <event>
                <sub_title>CHOLECYSTECTOMY</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="864"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="796"/>
              </event>
              <event>
                <sub_title>COLOSTOMY CLOSURE</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="864"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="796"/>
              </event>
              <event>
                <sub_title>EAR OPERATION</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="864"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="796"/>
              </event>
              <event>
                <sub_title>HERNIA REPAIR</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="864"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="796"/>
              </event>
              <event>
                <sub_title>HIP ARTHROPLASTY</sub_title>
                <counts group_id="E1" events="4" subjects_affected="4" subjects_at_risk="864"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="796"/>
              </event>
              <event>
                <sub_title>IMPLANTABLE DEFIBRILLATOR REPLACEMENT</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="864"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="796"/>
              </event>
              <event>
                <sub_title>KNEE ARTHROPLASTY</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="864"/>
                <counts group_id="E2" events="2" subjects_affected="2" subjects_at_risk="796"/>
              </event>
              <event>
                <sub_title>PREVENTIVE SURGERY</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="864"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="796"/>
              </event>
              <event>
                <sub_title>ROTATOR CUFF REPAIR</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="864"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="796"/>
              </event>
              <event>
                <sub_title>SPINAL FUSION SURGERY</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="864"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="796"/>
              </event>
              <event>
                <sub_title>TRANSFUSION</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="864"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="796"/>
              </event>
              <event>
                <sub_title>WOUND DRAINAGE</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="864"/>
                <counts group_id="E2" events="2" subjects_affected="2" subjects_at_risk="796"/>
              </event>
              <event>
                <sub_title>WOUND TREATMENT</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="864"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="796"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Vascular disorders</title>
            <event_list>
              <event>
                <sub_title>ANEURYSM</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="864"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="796"/>
              </event>
              <event>
                <sub_title>AORTIC ANEURYSM</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="864"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="796"/>
              </event>
              <event>
                <sub_title>AORTIC ARTERIOSCLEROSIS</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="864"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="796"/>
              </event>
              <event>
                <sub_title>AORTIC DISSECTION</sub_title>
                <counts group_id="E1" events="6" subjects_affected="5" subjects_at_risk="864"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="796"/>
              </event>
              <event>
                <sub_title>AORTIC RUPTURE</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="864"/>
                <counts group_id="E2" events="3" subjects_affected="3" subjects_at_risk="796"/>
              </event>
              <event>
                <sub_title>AORTIC STENOSIS</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="864"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="796"/>
              </event>
              <event>
                <sub_title>ARTERIAL RUPTURE</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="864"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="796"/>
              </event>
              <event>
                <sub_title>ARTERIOSCLEROSIS</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="864"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="796"/>
              </event>
              <event>
                <sub_title>ARTERIOVENOUS FISTULA</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="864"/>
                <counts group_id="E2" events="4" subjects_affected="4" subjects_at_risk="796"/>
              </event>
              <event>
                <sub_title>ARTERY DISSECTION</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="864"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="796"/>
              </event>
              <event>
                <sub_title>BRACHIOCEPHALIC VEIN THROMBOSIS</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="864"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="796"/>
              </event>
              <event>
                <sub_title>CIRCULATORY COLLAPSE</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="864"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="796"/>
              </event>
              <event>
                <sub_title>DEEP VEIN THROMBOSIS</sub_title>
                <counts group_id="E1" events="11" subjects_affected="11" subjects_at_risk="864"/>
                <counts group_id="E2" events="11" subjects_affected="11" subjects_at_risk="796"/>
              </event>
              <event>
                <sub_title>DRY GANGRENE</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="864"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="796"/>
              </event>
              <event>
                <sub_title>FEMORAL ARTERY DISSECTION</sub_title>
                <counts group_id="E1" events="8" subjects_affected="8" subjects_at_risk="864"/>
                <counts group_id="E2" events="2" subjects_affected="2" subjects_at_risk="796"/>
              </event>
              <event>
                <sub_title>FEMORAL ARTERY EMBOLISM</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="864"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="796"/>
              </event>
              <event>
                <sub_title>FEMORAL ARTERY PERFORATION</sub_title>
                <counts group_id="E1" events="3" subjects_affected="3" subjects_at_risk="864"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="796"/>
              </event>
              <event>
                <sub_title>HAEMATOMA</sub_title>
                <counts group_id="E1" events="24" subjects_affected="24" subjects_at_risk="864"/>
                <counts group_id="E2" events="5" subjects_affected="5" subjects_at_risk="796"/>
              </event>
              <event>
                <sub_title>HAEMODYNAMIC INSTABILITY</sub_title>
                <counts group_id="E1" events="3" subjects_affected="3" subjects_at_risk="864"/>
                <counts group_id="E2" events="3" subjects_affected="3" subjects_at_risk="796"/>
              </event>
              <event>
                <sub_title>HAEMORRHAGE</sub_title>
                <counts group_id="E1" events="17" subjects_affected="17" subjects_at_risk="864"/>
                <counts group_id="E2" events="20" subjects_affected="20" subjects_at_risk="796"/>
              </event>
              <event>
                <sub_title>HYPERTENSION</sub_title>
                <counts group_id="E1" events="35" subjects_affected="34" subjects_at_risk="864"/>
                <counts group_id="E2" events="32" subjects_affected="29" subjects_at_risk="796"/>
              </event>
              <event>
                <sub_title>HYPERTENSIVE CRISIS</sub_title>
                <counts group_id="E1" events="4" subjects_affected="2" subjects_at_risk="864"/>
                <counts group_id="E2" events="3" subjects_affected="3" subjects_at_risk="796"/>
              </event>
              <event>
                <sub_title>HYPOTENSION</sub_title>
                <counts group_id="E1" events="52" subjects_affected="51" subjects_at_risk="864"/>
                <counts group_id="E2" events="89" subjects_affected="87" subjects_at_risk="796"/>
              </event>
              <event>
                <sub_title>HYPOVOLAEMIC SHOCK</sub_title>
                <counts group_id="E1" events="4" subjects_affected="4" subjects_at_risk="864"/>
                <counts group_id="E2" events="10" subjects_affected="10" subjects_at_risk="796"/>
              </event>
              <event>
                <sub_title>ILIAC ARTERY PERFORATION</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="864"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="796"/>
              </event>
              <event>
                <sub_title>ILIAC ARTERY RUPTURE</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="864"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="796"/>
              </event>
              <event>
                <sub_title>INTERMITTENT CLAUDICATION</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="864"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="796"/>
              </event>
              <event>
                <sub_title>LABILE BLOOD PRESSURE</sub_title>
                <counts group_id="E1" events="3" subjects_affected="3" subjects_at_risk="864"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="796"/>
              </event>
              <event>
                <sub_title>LYMPHOCELE</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="864"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="796"/>
              </event>
              <event>
                <sub_title>MALIGNANT HYPERTENSION</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="864"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="796"/>
              </event>
              <event>
                <sub_title>NECROSIS ISCHAEMIC</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="864"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="796"/>
              </event>
              <event>
                <sub_title>ORTHOSTATIC HYPOTENSION</sub_title>
                <counts group_id="E1" events="4" subjects_affected="4" subjects_at_risk="864"/>
                <counts group_id="E2" events="7" subjects_affected="7" subjects_at_risk="796"/>
              </event>
              <event>
                <sub_title>PERIPHERAL ARTERIAL OCCLUSIVE DISEASE</sub_title>
                <counts group_id="E1" events="3" subjects_affected="2" subjects_at_risk="864"/>
                <counts group_id="E2" events="2" subjects_affected="2" subjects_at_risk="796"/>
              </event>
              <event>
                <sub_title>PERIPHERAL ARTERY DISSECTION</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="864"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="796"/>
              </event>
              <event>
                <sub_title>PERIPHERAL ARTERY OCCLUSION</sub_title>
                <counts group_id="E1" events="6" subjects_affected="6" subjects_at_risk="864"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="796"/>
              </event>
              <event>
                <sub_title>PERIPHERAL ARTERY STENOSIS</sub_title>
                <counts group_id="E1" events="12" subjects_affected="12" subjects_at_risk="864"/>
                <counts group_id="E2" events="3" subjects_affected="3" subjects_at_risk="796"/>
              </event>
              <event>
                <sub_title>PERIPHERAL ISCHAEMIA</sub_title>
                <counts group_id="E1" events="5" subjects_affected="5" subjects_at_risk="864"/>
                <counts group_id="E2" events="3" subjects_affected="2" subjects_at_risk="796"/>
              </event>
              <event>
                <sub_title>PERIPHERAL VASCULAR DISORDER</sub_title>
                <counts group_id="E1" events="3" subjects_affected="2" subjects_at_risk="864"/>
                <counts group_id="E2" events="2" subjects_affected="2" subjects_at_risk="796"/>
              </event>
              <event>
                <sub_title>PERIPHERAL VENOUS DISEASE</sub_title>
                <counts group_id="E1" events="2" subjects_affected="1" subjects_at_risk="864"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="796"/>
              </event>
              <event>
                <sub_title>SHOCK</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="864"/>
                <counts group_id="E2" events="7" subjects_affected="7" subjects_at_risk="796"/>
              </event>
              <event>
                <sub_title>SHOCK HAEMORRHAGIC</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="864"/>
                <counts group_id="E2" events="2" subjects_affected="2" subjects_at_risk="796"/>
              </event>
              <event>
                <sub_title>SUBCLAVIAN ARTERY THROMBOSIS</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="864"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="796"/>
              </event>
              <event>
                <sub_title>SUBCLAVIAN VEIN THROMBOSIS</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="864"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="796"/>
              </event>
              <event>
                <sub_title>THROMBOPHLEBITIS</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="864"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="796"/>
              </event>
              <event>
                <sub_title>THROMBOSIS</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="864"/>
                <counts group_id="E2" events="2" subjects_affected="2" subjects_at_risk="796"/>
              </event>
              <event>
                <sub_title>VARICOSE VEIN</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="864"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="796"/>
              </event>
              <event>
                <sub_title>VENOUS THROMBOSIS</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="864"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="796"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </serious_events>
      <other_events>
        <frequency_threshold>5</frequency_threshold>
        <default_vocab>MedDRA 21.0</default_vocab>
        <default_assessment>Systematic Assessment</default_assessment>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, other adverse events</sub_title>
                <counts group_id="E1" subjects_affected="803" subjects_at_risk="864"/>
                <counts group_id="E2" subjects_affected="754" subjects_at_risk="796"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Blood and lymphatic system disorders</title>
            <event_list>
              <event>
                <sub_title>ANAEMIA</sub_title>
                <counts group_id="E1" events="84" subjects_affected="80" subjects_at_risk="864"/>
                <counts group_id="E2" events="100" subjects_affected="99" subjects_at_risk="796"/>
              </event>
              <event>
                <sub_title>LEUKOCYTOSIS</sub_title>
                <counts group_id="E1" events="71" subjects_affected="70" subjects_at_risk="864"/>
                <counts group_id="E2" events="154" subjects_affected="146" subjects_at_risk="796"/>
              </event>
              <event>
                <sub_title>THROMBOCYTOPENIA</sub_title>
                <counts group_id="E1" events="140" subjects_affected="133" subjects_at_risk="864"/>
                <counts group_id="E2" events="198" subjects_affected="188" subjects_at_risk="796"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Cardiac disorders</title>
            <event_list>
              <event>
                <sub_title>ATRIAL FIBRILLATION</sub_title>
                <counts group_id="E1" events="120" subjects_affected="112" subjects_at_risk="864"/>
                <counts group_id="E2" events="239" subjects_affected="230" subjects_at_risk="796"/>
              </event>
              <event>
                <sub_title>ATRIOVENTRICULAR BLOCK FIRST DEGREE</sub_title>
                <counts group_id="E1" events="82" subjects_affected="80" subjects_at_risk="864"/>
                <counts group_id="E2" events="68" subjects_affected="67" subjects_at_risk="796"/>
              </event>
              <event>
                <sub_title>BUNDLE BRANCH BLOCK LEFT</sub_title>
                <counts group_id="E1" events="265" subjects_affected="258" subjects_at_risk="864"/>
                <counts group_id="E2" events="59" subjects_affected="55" subjects_at_risk="796"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Gastrointestinal disorders</title>
            <event_list>
              <event>
                <sub_title>CONSTIPATION</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="864"/>
                <counts group_id="E2" events="56" subjects_affected="53" subjects_at_risk="796"/>
              </event>
              <event>
                <sub_title>NAUSEA</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="864"/>
                <counts group_id="E2" events="43" subjects_affected="42" subjects_at_risk="796"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>General disorders</title>
            <event_list>
              <event>
                <sub_title>OEDEMA PERIPHERAL</sub_title>
                <counts group_id="E1" events="48" subjects_affected="45" subjects_at_risk="864"/>
                <counts group_id="E2" events="49" subjects_affected="47" subjects_at_risk="796"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Infections and infestations</title>
            <event_list>
              <event>
                <sub_title>URINARY TRACT INFECTION</sub_title>
                <counts group_id="E1" events="77" subjects_affected="65" subjects_at_risk="864"/>
                <counts group_id="E2" events="102" subjects_affected="88" subjects_at_risk="796"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Metabolism and nutrition disorders</title>
            <event_list>
              <event>
                <sub_title>FLUID OVERLOAD</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="864"/>
                <counts group_id="E2" events="127" subjects_affected="122" subjects_at_risk="796"/>
              </event>
              <event>
                <sub_title>HYPERGLYCAEMIA</sub_title>
                <counts group_id="E1" events="54" subjects_affected="53" subjects_at_risk="864"/>
                <counts group_id="E2" events="102" subjects_affected="102" subjects_at_risk="796"/>
              </event>
              <event>
                <sub_title>HYPERKALAEMIA</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="864"/>
                <counts group_id="E2" events="42" subjects_affected="41" subjects_at_risk="796"/>
              </event>
              <event>
                <sub_title>HYPOKALAEMIA</sub_title>
                <counts group_id="E1" events="49" subjects_affected="46" subjects_at_risk="864"/>
                <counts group_id="E2" events="55" subjects_affected="53" subjects_at_risk="796"/>
              </event>
              <event>
                <sub_title>HYPONATRAEMIA</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="864"/>
                <counts group_id="E2" events="56" subjects_affected="52" subjects_at_risk="796"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Psychiatric disorders</title>
            <event_list>
              <event>
                <sub_title>CONFUSIONAL STATE</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="864"/>
                <counts group_id="E2" events="47" subjects_affected="44" subjects_at_risk="796"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Renal and urinary disorders</title>
            <event_list>
              <event>
                <sub_title>ACUTE KIDNEY INJURY</sub_title>
                <counts group_id="E1" events="91" subjects_affected="79" subjects_at_risk="864"/>
                <counts group_id="E2" events="138" subjects_affected="125" subjects_at_risk="796"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Respiratory, thoracic and mediastinal disorders</title>
            <event_list>
              <event>
                <sub_title>ATELECTASIS</sub_title>
                <counts group_id="E1" events="64" subjects_affected="62" subjects_at_risk="864"/>
                <counts group_id="E2" events="154" subjects_affected="151" subjects_at_risk="796"/>
              </event>
              <event>
                <sub_title>DYSPNOEA</sub_title>
                <counts group_id="E1" events="50" subjects_affected="48" subjects_at_risk="864"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="796"/>
              </event>
              <event>
                <sub_title>PLEURAL EFFUSION</sub_title>
                <counts group_id="E1" events="76" subjects_affected="70" subjects_at_risk="864"/>
                <counts group_id="E2" events="223" subjects_affected="216" subjects_at_risk="796"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Vascular disorders</title>
            <event_list>
              <event>
                <sub_title>HAEMATOMA</sub_title>
                <counts group_id="E1" events="49" subjects_affected="47" subjects_at_risk="864"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="796"/>
              </event>
              <event>
                <sub_title>HYPERTENSION</sub_title>
                <counts group_id="E1" events="139" subjects_affected="123" subjects_at_risk="864"/>
                <counts group_id="E2" events="107" subjects_affected="100" subjects_at_risk="796"/>
              </event>
              <event>
                <sub_title>HYPOTENSION</sub_title>
                <counts group_id="E1" events="50" subjects_affected="47" subjects_at_risk="864"/>
                <counts group_id="E2" events="83" subjects_affected="82" subjects_at_risk="796"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </other_events>
    </reported_events>

    <certain_agreements>
      <pi_employee>Principal Investigators are NOT employed by the organization sponsoring the study.</pi_employee>
      <restrictive_agreement>There IS an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed. </restrictive_agreement>
    </certain_agreements>
    <point_of_contact>
      <name_or_title>Peggy Yunker</name_or_title>
      <organization>Medtronic, Inc.</organization>
      <phone>763-514-4000</phone>
      <email>surtavi@medtronic.com</email>
    </point_of_contact>
  </clinical_results>
</clinical_study>

